Quarterlytics / Industrials / Manufacturing - Metal Fabrication / Tredegar Corporation

Tredegar Corporation

tg · NYSE Industrials
Claim this profile
Ticker tg
Exchange NYSE
Sector Industrials
Industry Manufacturing - Metal Fabrication
Employees 1500
← All annual reports
FY2021 Annual Report · Tredegar Corporation
Sign in to download
Loading PDF…
T

R

E

D

E

G

A

R

C

O

R

P

O

R

A

T

I

O

N

|

2

0

2

1

A

N

N

U

A

L

R

E

P

O

R

T

2 0 2 1 

ANNUAL REPORT

 
 
 
 
 
 
 
 
 
Summary Financial Information

Years Ended December 31

($ in millions, except per-share data)
Income and expense relating to ongoing operations: 
  Total EBITDA for segments (a)
  Pension expense
  Corporate expenses

  Consolidated EBITDA from ongoing operations (“Consolidated EBITDA”) (b)
  Depreciation & amortization
  Stock option-based compensation costs

Interest expense
Income taxes

Net income from ongoing operations (b)
After-tax effects of special items:
  Gain (loss) on investment in kaléo
  One-time tax credit in Brazil for PIS/COFINS
  Tax valuation allowance release primarily due to sale of kaléo
  Goodwill impairment charge
  Loss on Sale of Bright View Technologies
  Losses associated with plant shutdowns, asset impairments, restructurings & other

200

800

700

Net income (loss) from continuing operations as reported under GAAP

600

150

500

Diluted earnings per share (EPS):
  Ongoing operations (b)
  Continuing operations, as reported under GAAP

400

300

200

Net Debt (c):
100
  Debt
  Less: Cash and cash equivalents

0

2020

  Net Debt

2021

100

50

0

2019

2020

2021

$ 130.8
(14.6)
(20.4)

  95.8
(26.4)
(2.1)
(2.6)
(13.9)

$ 115.3
(14.1)
(19.9)

  81.3
(24.7)
(2.5)
(3.4)
(11.1)

50.8

39.6

(47.6)
—
—
(10.5)
(1.8)
(7.7)

  10.0
6.6
5.4
—
—
(3.7)

$ (16.8)

$  57.9

$  1.51
$ (0.51)

$  1.18
$  1.72

12/31/20 12/31/21

$ 134.0
11.8

2021

$  73.0
30.5

$ 122.2

$  42.5

NET SALES BY SEGMENT
($ in millions)

CONSOLIDATED EBITDA & EPS
FROM ONGOING OPERATIONS(a)(b)
($ in millions except EPS data)

$730

456

139

135

2020

$798

539

119

140

2021

$1.51

$95.8

55.1

45.1

30.6

(14.6)
(20.4)

2020

$1.18

$81.3

55.9

27.7

31.7

(14.1)
(19.9)

2021

EPS From Ongoing Operations

Aluminum Extrusions 

PE Films

Flexible Packaging Films

Pension Expense

Ongoing Corporate Expenses

Notes:
(a)  Tredegar’s presentation of segment EBITDA from ongoing operations (“EBITDA”) aligns with key metrics used by the Chief Operating Decision Maker under Accounting 

Standards Codification (“ASC”) 280. For additional information, refer to the segment footnote within Tredegar’s consolidated financial statements.

(b)  Tredegar’s presentation of Consolidated EBITDA from ongoing operations, net income from ongoing operations and earnings per share from ongoing operations are non-GAAP 

financial measures that exclude the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, 
goodwill impairment charges and other items (which includes unrealized gains and losses for an investment accounted for under the fair value method). Consolidated EBITDA 
from ongoing operations also excludes net interest expense, income taxes, depreciation & amortization and stock option-based compensation costs.
 Consolidated EBITDA from ongoing operations, net income from ongoing operations and earnings per share from ongoing operations are key financial and analytical measures 
used by management to gauge the operating performance of Tredegar’s ongoing operations, its borrowing capacity and its estimated enterprise value. They are not intended to 
represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to cash flow, net income or earnings per share 
as defined by GAAP.  A reconciliation is provided above of these ongoing non-GAAP measures to net income and earnings per share as reported under GAAP. EPS from ongoing 
operations represents net income from ongoing operations divided by GAAP diluted shares (33.7 million shares).

(c)  Tredegar’s presentation of Net Debt is not intended to represent total debt as defined by GAAP. Net debt is utilized by management in evaluating Tredegar’s financial leverage 

and equity valuation, and management believes that investors may also find Net Debt to be helpful for the same purpose.

 
 
 
 
 
Dear Shareholders,

Who would have thought that 2021 

would in many ways be a wilder 

ride than 2020?  I applaud the 

Tredegar team for working through 

the many challenges tied to the 

pandemic, including maintaining a 

safe work environment, keeping our 

manufacturing facilities open despite 

labor shortages, overcoming supply 

150

chain issues and balancing pricing 

120

and inflationary cost pressures.
90

Our Businesses

60

John M. Steitz
President and Chief Executive Officer

The best example of inflationary cost pressures is the significant rise in raw material costs. The 

30

accompanying chart on this topic speaks for itself. But additional cost inflation has surfaced in other 

0

2020

2021

2020

2021

2020

2021

areas such as labor, supplies and transportation. Profits erode quickly if selling prices don’t keep pace, but 

our business unit management teams have been on top of the issue from the get-go. 

KEY RAW MATERIALS USED BY BONNELL 
ALUMINUM, PE FILMS AND TERPHANE
(Cents Per Pound)

139
56%

89

106
71%

62

29

41
41%

Polyester Resin
(USD Asian 
Buyer Price)

Aluminum 
(U.S. Midwest
Transaction Price)

Polyethylene
(PE) Resin
(U.S. Large
Buyer Price)

2020

2021

1

300

250

200

150

100

50

0

300

250

200

150

100

50

0

120

100

80

60

40

20

0
Jan-13

Jul-13

Jan-14

Jul-14

Jan-15

Jul-15

Jan-16

Jul-16

Jan-17

Jul-17

Jan-18

Jul-18

Jan-19

Jul-19

Jan-20

Jul-20

Jan-21

Jul-21

Jan-22

Bonnell Hourly Plant Worker “Actual” Labor Shortage
Bonnell Hourly Plant Worker “Normal” Labor Shortage

Bonnell Aluminum Backlog 
(Lbs Million)

120

100

80

60

40

20

0

Quarter Average

Month

3
1
-
n
a
J

3
1
-
l
u

J

4
1
-
n
a
J

4
1
-
l
u

J

5
1
-
n
a
J

5
1
-
l
u

J

6
1
-
n
a
J

6
1
-
l
u

J

7
1
-
n
a
J

7
1
-
l
u

J

8
1
-
n
a
J

8
1
-
l
u

J

9
1
-
n
a
J

9
1
-
l
u

J

0
2
-
n
a
J

0
2
-
l
u

J

1
2
-
n
a
J

1
2
-
l
u

J

2
2
-
n
a
J

0
2
/
6
2
/
0
1

0
2
/
6
2
/
1
1

0
2
/
6
2
/
2
1

1
2
/
6
2
/
1

1
2
/
6
2
/
2

1
2
/
6
2
/
3

1
2
/
6
2
/
4

1
2
/
6
2
/
5

1
2
/
6
2
/
6

1
2
/
6
2
/
7

1
2
/
6
2
/
8

1
2
/
6
2
/
9

1
2
/
6
2
/
0
1

1
2
/
6
2
/
1
1

1
2
/
6
2
/
2
1

The aluminum extrusions market is highly fragmented with a few large players who primarily serve 

the aerospace and transportation markets. With an estimated market share of 4%, Bonnell is one of the 

largest U.S. fully integrated manufacturers of custom fabricated and finished aluminum extrusions, 

serving primarily building and construction, specialty and automotive markets. Its value proposition of 

delivering high quality products with market-leading customer service levels and technical support has 

been stressed by pandemic-related labor shortages and supply chain issues. With these issues, production 

volume hasn’t been able to keep up with orders, driving backlog to all-time highs. Despite the continuing 

headwinds, Bonnell managed to increase EBITDA from ongoing operations to $55.9 million in 2021 

compared with $55.1 million in 2020. Our forecast for 2022 shows further improvement, especially with 

the robust backlog. 

IT systems are extremely important for Bonnell to deliver its value proposition to customers. In this 

regard, we recently approved a transformative project to replace Bonnell’s 30-year-old enterprise 

resource planning and manufacturing execution systems. This highly strategic two-year project, which 

is known throughout the organization as “Bonnell One,” will allow its five manufacturing facilities, along 

with the rest of the organization, to operate in an integrated, consistent manner. The total investment 

for this project is estimated at $31 million, including capital expenditures of $28 million and expenses 

of $3 million. Operational and commercial benefits, including higher yield, productivity and other 

improvements, are expected of $9 million annually once the systems are fully implemented  

and functioning. 

TSLOTS™ aluminum framing system

Robotics line at Clearfield, UT site

2

Our PE Films business experienced a decline in EBITDA from ongoing operations to $27.7 million in 

2021 from $45.1 million in 2020, mainly due to the adverse impact of previously disclosed significant 

customer product transitions. An additional decline of $7 million from the transitions is estimated in 

2022, at which time the transitions are expected to be complete. Unfortunately, competitive pricing 

pressures are projected to erode profits further by $6 million in 2022, which may be partly a consequence 

of the previous pass-through of significant resin cost increases. On the positive side, we are achieving 

record levels of productivity and making solid progress with targeted new business opportunities, 

using newly launched products for automotive displays, semiconductors and advanced-technology 

smartphones and displays, among others. 

Terphane, our flexible packaging films business, delivered another outstanding performance in 2021, 

despite rapidly rising resin costs and lower volumes as demand returned to pre-pandemic levels. 

EBITDA from ongoing operations was $31.7 million in 2021, up $1 million versus a strong performance 

in 2020. With top-notch management and a continuing focus on differentiated customer service levels 

and value-add products, Terphane maintained its market leadership in Brazil and saw robust demand 

in North America for clear barrier and sealable products. The market for flexible packaging films has 

and will continue to be very competitive, including in our primary market in Brazil with a threat from 

imports from a competitor’s new capacity coming on-line in Colombia and the possible addition of new 

capacity in Brazil by this same competitor. 

TERPHANE 2021 NET SALES 
OF $140 MILLION 
BY GEOGRAPHIC REGION 

U.S. and Other
34%

Latin America
Excluding Brazil
7%

Brazil
59%

3

150

120

90

60

30

0

12/31/20

3/31/21

6/30/21

9/30/21

12/31/21

QUARTERLY NET DEBT TRENDS
($ Millions)

$122.2

$121.1

$98.7

$96.7

• Strong cash generation 
  net of dividends

• Proceeds from the sale of 
  investment in kaléo of $47 
  in December 2021

$42.5

• Not reflected in chart are 
  funds borrowed in February 
  2022 of $50 that were contributed 
  to frozen pension plan

12/31/20

3/31/21

6/30/21

9/30/21

12/31/21

Another Year of Strong Cash Generation

Our net debt was $42 million as of December 31, 2021, down $80 million from the end of 2020. In 

addition to generating strong cash flow from operations after paying dividends, the decline in net debt 

reflects proceeds of $47 million from the sale of our investment in kaleo, Inc. in December 2021.  In 

February 2022, we borrowed funds under our revolving credit agreement and contributed $50 million 

to our frozen defined benefit pension plan. This contribution is part of a program to terminate and 

settle the plan, which is expected to take up to 24 months to complete. Before this recent contribution, 

the underfunded status of the pension plan was approximately $69 million under accounting rules at 

the end of 2021. No additional contributions are expected until final settlement of the plan. Pension 

expense for EBITDA from ongoing operations and for credit agreement purposes will be reduced from 

approximately $14 million in 2021 to zero in 2022. Upon final settlement of the plan, this volatile non-

operational liability will be removed from our balance sheet. 

Since introducing the five operating principles for driving shareholder value to the Tredegar team in 

2019—top-line growth, margin improvement, velocity / working capital management, new investment 

and leadership (known as The Tredegar Way)—I’ve seen them vigorously adopted throughout the 

organization. We are resolute in maintaining our dedication to The Tredegar Way and using it to 

overcome challenges as they arise. Managing through the pandemic environment has been extremely 

difficult but without application of these core principles, we would be lagging from where we are today.  

John M. Steitz 

President and Chief Executive Officer

All statements other than statements of historical facts contained in this letter, including statements regarding our plans, objectives and goals, and future events or results, are  
forward-looking statements. See “Forward-looking and Cautionary Statements” on page 13 of the accompanying Annual Report on Form 10-K.

4

 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-K

x

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2021

OR

¨

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission File Number 1-10258

TREDEGAR CORPORATION
(Exact name of registrant as specified in its charter)

Virginia

(State or other jurisdiction
of incorporation or organization)

1100 Boulders Parkway,

Richmond,  Virginia

(Address of principal executive offices)

54-1497771

(I.R.S. Employer
Identification No.)

23225
(Zip Code)

Registrant’s telephone number, including area code: 804-330-1000
Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Common Stock

Trading Symbol
TG

Name of each exchange on which registered
New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:

None

(Title of class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ¨    No  x
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  ¨    No  x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 
months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x	
No  ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 
232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth 
company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Non-accelerated filer

o

o 

Accelerated filer

x Smaller reporting company

Emerging growth company

o

o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial 
accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial 
reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ¨    No  x

Aggregate market value of voting and non-voting common equity held by non-affiliates of the registrant as of June 30, 2021 (the last business day of the registrant’s most 
recently completed second fiscal quarter): $365,890,037*

Number of shares of Common Stock outstanding as of March 4, 2022:  33,743,617

*

In determining this figure, an aggregate of 7,142,062 shares of Common Stock beneficially owned by Floyd D. Gottwald, Jr., John D. Gottwald, William M. 
Gottwald and the members of their immediate families has been excluded because the shares are deemed to be held by affiliates.  The aggregate market value has 
been computed based on the closing price in the New York Stock Exchange on June 30, 2021.

Documents Incorporated By Reference

Portions of the Tredegar Corporation Proxy Statement for the 2022 Annual Meeting of Shareholders (the “Proxy Statement”) are incorporated by reference into Part III 

of this Form 10-K.

 
Index to Annual Report on Form 10-K
Year Ended December 31, 2021

Part I
Item 1.

Business

Item 1A. Risk Factors

Item 1B. Unresolved Staff Comments

Item 2.

Properties

Item 3.

Legal Proceedings

Item 4. Mine Safety Disclosures

Part II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity 

Securities
[RESERVED]

Item 6.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

Item 8.

Financial Statements and Supplementary Data

Item 9.

Changes In and Disagreements With Accountants on Accounting and Financial Disclosure

Item 9A. Controls and Procedures

Item 9B. Other Information

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Part III
Item 10. Directors, Executive Officers and Corporate Governance

Item 11. Executive Compensation

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Item 13. Certain Relationships and Related Transactions, and Director Independence

Item 14. Principal Accounting Fees and Services

Part IV
Item 15. Exhibits and Financial Statement Schedules

Item 16. Form 10-K Summary

Page

1

5

10

10

11

11

12

13

13

32

32

32

32

34

34

35

35

35

36

36

37

77

 
 
 
Item 1. 

BUSINESS

Description of Business

PART I

Tredegar Corporation (“Tredegar”) is engaged, through its subsidiaries, in the manufacture of aluminum extrusions, 
polyethylene (“PE”) plastic films and polyester (“PET”) films.  Unless the context requires otherwise, all references herein to 
“Tredegar,” “the Company,” “we,” “us” or “our” are to Tredegar Corporation and its consolidated subsidiaries. 

The Company's reportable business segments are Aluminum Extrusions, PE Films and Flexible Packaging Films.

On October 30, 2020, the Company completed the sale of its personal care films business (“Personal Care Films”). The 
transaction excluded the packaging film lines and related operations located at the Pottsville, Pennsylvania manufacturing site 
(“Pottsville Packaging”), which are now being reported within the Surface Protection component of PE Films. Commencing in 
the third quarter of 2020, all historical results for Personal Care Films have been presented as discontinued operations.  

In December 2020, the Company entered into a definitive agreement and completed the sale of Bright View Technologies 

(“Bright View”).  The sale did not represent a strategic shift nor did it have a major effect on the Company’s historical and 
ongoing operations, thus all financial information for Bright View has been presented as continuing operations within the PE 
Films segment.

For more information on these transactions, see Note 15 “Discontinued Operations” to the Consolidated Financial 

Statements included in Item 15. “Exhibits and Financial Statement Schedules” (“Item 15”) of this Annual Report on Form 10-K 
for the year ended December 31, 2021 (“Form 10-K”).

Aluminum Extrusions

Aluminum Extrusions, also referred to as Bonnell Aluminum, produces high-quality, soft and medium-strength alloyed 

aluminum extrusions, custom fabricated and finished for the building and construction, automotive and transportation, 
consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets. Bonnell 
Aluminum has manufacturing facilities located in the United States (“U.S.”).

Aluminum Extrusions manufactures mill (unfinished), machined, anodized and painted (finished) and fabricated 
aluminum extrusions for sale directly to fabricators and distributors.  It also sells branded aluminum flooring trims under its 
Futura TransitionsTM line and aluminum framing systems under its TSLOTSTM line.  Aluminum Extrusions competes primarily 
on the basis of product quality, service and price.  Sales are made predominantly in the U.S. The end-use markets for 
Aluminum Extrusions are cyclical and seasonal in nature. 

The end-uses in each of Aluminum Extrusions’ primary market segments include:

Major Markets

End-Uses

Building & construction nonresidential

Building & construction - residential

Automotive and transportation

Consumer durables

Machinery & equipment

Distribution (metal service centers specializing in stock and 
release programs and custom fabrications to small 
manufacturers)
Electrical and renewable energy

1

Commercial windows and doors, curtain walls, storefronts 
and entrances, automatic entry doors, walkway covers, 
ducts, louvers and vents, office wall panels, partitions and 
interior enclosures, acoustical walls and ceilings, point of 
purchase displays, pre-engineered structures, and flooring 
trims (Futura TransitionsTM)
Residential windows and doors, shower and tub enclosures, 
railing and support systems, venetian blinds, and swimming 
pools
Automotive and light truck structural components, spare 
parts, after-market automotive accessories, grills for heavy 
trucks, travel trailers and recreation vehicles
Office furniture, pleasure boats, refrigerators and freezers, 
appliances and sporting goods
Material handling equipment, conveyors and conveying 
systems, medical equipment, industrial fans and aluminum 
framing systems (TSLOTSTM)
Various custom profiles including storm shutters, pleasure 
boat accessories, theater set structures and various standard 
profiles (including rod, bar, tube and pipe)
Lighting fixtures, electronic apparatus, solar panel brackets 
and rigid and flexible conduits

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aluminum Extrusions’ net sales (sales less freight) by market segment for the years ended December 31, 2021, 2020 and 

2019 is shown below: 

% of Aluminum Extrusions Net Sales by Market Segment

Building and construction:

Nonresidential

Residential

Automotive

Specialty:

Consumer durables

Machinery & equipment

Electrical

Distribution

Total

2021

50%

10%

8%

10%

8%

6%

8%

100%

2020

2019

56%

9%

8%

10%

7%

4%

6%

51%

8%

9%

11%

7%

7%

7%

100%

100%

In 2021, 2020 and 2019, Aluminum Extrusions net sales accounted for approximately 67%, 63% and 66% of Tredegar’s 

consolidated net sales, respectively.

Backlog. Overall backlog in Aluminum Extrusions was approximately $306.4 million at December 31, 2021 compared to 
approximately $74.2 million at December 31, 2020, an increase of $232.2 million, or approximately 313%.  The increased 
backlog in 2021 compared to 2020 is primarily due to increased demand (33% increase in bookings), while experiencing a 
shortage of labor to meet existing demand and desired shipment levels.  Net sales for Aluminum Extrusions, which the 
Company believes are cyclical in nature due to the seasonal nature of end-use markets, were $539.3 million in 2021, $455.7 
million in 2020 and $529.6 million in 2019.  

Raw Materials. The primary raw materials used by Aluminum Extrusions consist of aluminum ingot, aluminum scrap and 
various alloys, which are purchased from domestic and foreign producers in open-market purchases and under annual contracts. 
Refer to Quantitative and Qualitative Disclosures About Market Risk in Item 7. "Management’s Discussion and Analysis of 
Financial Condition and Results of Operations” of this Form 10-K (“Item 7”) for additional information on aluminum price 
trends.  Aluminum Extrusions believes that it has adequate supply agreements for aluminum raw materials in 2022 and is in the 
process of securing supply sources to meet expected needs in 2023.  Aluminum Extrusions continues to navigate through 
supply chain issues for paint and other non-aluminum raw materials.

PE Films

PE Films produces surface protection films, polyethylene overwrap films and films for other markets.  Tredegar’s Surface 
Protection unit produces single- and multi-layer surface protection films sold under the UltraMask®, ForceField™, ForceField 
PEARL® and Pearl A™ brand names.  These films, which are manufactured at facilities in the U.S. and China, support 
manufacturers of optical and other specialty substrates used in high-technology applications, most notably protecting high-value 
components of flat panel and flexible displays used in televisions, monitors, notebooks, smartphones, tablets, e-readers, 
automobiles and digital signage, during the manufacturing and transportation process.  In 2021, 2020 and 2019, PE Films 
accounted for approximately 15%, 19% and 17% of Tredegar’s consolidated net sales, respectively.

In October 2020, the Surface Protection unit assumed responsibility for Pottsville Packaging, which was previously 

reported within the Personal Care component of PE Films.  Pottsville Packaging produces thin-gauge films as overwrap for 
bathroom tissue and paper towels.  

Raw Materials. The primary raw materials used by PE Films are polyethylene and polypropylene resins.  These raw materials 
are obtained from domestic and foreign suppliers at competitive prices.  Refer to Quantitative and Qualitative Disclosures 
About Market Risk in Item 7 for additional information on resin price trends.  PE Films believes that there will be an adequate 
supply of polyethylene and polypropylene resins in the foreseeable future.  

Research and Development. Tredegar’s spending for research and development (“R&D”) activities in 2021, 2020 and 2019 
was primarily related to PE Films.  R&D spending by the PE Films was approximately $5.7 million, $7.7 million and $7.0 
million in 2021, 2020 and 2019, respectively. 

Customers. PE Films’ products are sold primarily in the U.S. and Asia, with the top four customers, collectively, comprising 
88%, 84% and 86% of its net sales in 2021, 2020 and 2019, respectively.  No single PE Films customer exceeds 10% of 
Tredegar’s consolidated net sales.  For additional information, see Item 1A. “Risk Factors” of this Form 10-K (“Item 1A”).

2

 
 
Flexible Packaging Films

Flexible Packaging Films is comprised of Terphane Holdings LLC (“Terphane”).  Flexible Packaging Films produces 
PET-based films for use in packaging applications that have specialized properties, such as heat resistance, strength, barrier 
protection and the ability to accept high-quality print graphics.  These differentiated, high-value films are primarily 
manufactured in Brazil and sold in Latin America and the U.S. under the Terphane®, Sealphane® and Ecophane® brand names.  
Major end uses include food packaging and industrial applications.  Flexible Packaging Films competes in all of its markets on 
the basis of product quality, service and price.  In 2021, 2020 and 2019, Terphane accounted for approximately 18%, 18% and 
17% of Tredegar’s consolidated net sales, respectively.

Raw Materials. The primary raw materials used by Flexible Packaging Films to produce polyester resins are purified 
terephthalic acid (“PTA”) and monoethylene glycol (“MEG”).  Flexible Packaging Films also purchases additional polyester 
resins directly from suppliers.  These raw materials are obtained from Brazilian and foreign suppliers at competitive prices.  
Terphane continues to monitor cost escalations to adjust selling prices as market dynamics permit and believes that there will be 
an adequate supply of polyester resins, PTA and MEG in the foreseeable future. 

General

Intellectual Property. Tredegar considers patents, licenses and trademarks to be material to PE Films.  On December 31, 2021, 
PE Films held 40 patents (including 5 U.S. patents), and 79 registered trademarks (including 4 U.S. registered trademarks).  
Flexible Packaging Films held 1 U.S. patent and 17 registered trademarks (including 4 U.S. registered trademarks).  Aluminum 
Extrusions held no U.S. patents and 4 U.S. registered trademarks. As of December 31, 2021, these patents had remaining terms 
of 2.5 to 17.5 years. 

Government Regulation.  The Company’s operations are subject to various local, state, federal and foreign government 
regulations, including environmental, privacy and anti-corruption and anti-bribery laws and regulations.

U.S. laws concerning the environment to which the Company’s domestic operations are or may be subject to include the 

Clean Water Act, the Clean Air Act, the Resource Conservation and Recovery Act, the Occupational Safety and Health Act, the 
National Environmental Policy Act, the Toxic Substances Control Act, the Comprehensive Environmental Response, 
Compensation and Liability Act (“CERCLA”), regulations promulgated under these acts, and other federal, state or local laws 
or regulations governing environmental matters.  Compliance with these laws is an important consideration because Tredegar 
uses hazardous materials in some of its operations, is a generator of hazardous waste, and wastewater from the Company’s 
operations is discharged to various types of wastewater management systems.  Under CERCLA and other laws, Tredegar may 
be subject to financial exposure for costs associated with waste management and disposal, even if the Company fully complies 
with applicable environmental laws.

The U.S. Environmental Protection Agency has adopted regulations under the Clean Air Act relating to emissions of 

carbon dioxide and other greenhouse gases (“GHG”), including mandatory reporting and permitting requirements. Several of 
the Company’s manufacturing operations result in emissions of carbon dioxide or GHG and are subject to the current GHG 
regulations.  The Company’s compliance with environmental regulations has yet to require significant capital expenditures; 
however, environmental standards tend to become more stringent over time.  Therefore, in order to comply with current or 
future environmental legislation or regulations, the Company may be subject to additional capital expenditures, operating 
expenses or other compliance costs, the amounts and timing of which are not presently determinable but which could be 
significant, including constructing new facilities or modifying existing facilities.

Like environmental regulations, current or future privacy and anti-corruption and anti-bribery legislation or regulations 
may subject the Company to additional capital expenditures, operating expenses or other compliance costs, the amounts and 
timing of which are not presently determinable but could be significant.  Any failure to comply with current or future laws and 
regulations, including environmental, privacy and anti-corruption and anti-bribery laws and regulations, could subject Tredegar 
to substantial penalties, fines, costs and expenses.  For further discussion regarding certain environmental, privacy and anti-
corruption and anti-bribery laws and regulations to which the Company is subject, see Item 1A below.

Human Capital Management.  

Overview

Tredegar employed approximately 2,400 people at December 31, 2021 located in the U.S., Brazil, and Asia, of which 80% 

are located in the U.S.  Approximately 15% of the Company’s employees are represented by labor unions located in the U.S. 
under various collective bargaining agreements with varying durations and expiration dates, none of which expire before 2025.  
All of Tredegar’s Brazilian employees are represented by a national labor union.  Generally, the total number of employees of 
Tredegar does not significantly fluctuate throughout the year.  However, acquisition or divestiture activity, or changes in the 
level of business activity may impact employee levels.   

3

Health and Safety

Tredegar has continuously exceeded the industry standards for safety.  The Company uses various forms of employee 

safety metrics to assess the health and safety performance of its Aluminum Extrusions, PE Films and Flexible Packaging 
operations, including employee safety data which is available on the Company’s website at https://tredegar.com/about-tredegar/
committed-to-our-employees.  Tredegar has also instituted additional safety precautions during the ongoing COVID-19 
pandemic as described in "The Impact of COVID-19" included in Item 7.

Additionally, Aluminum Extrusions has on-site health clinics at its Carthage and Clearfield facilities. These clinics allow 
Aluminum Extrusions to invest in its people, provide more personal and more thorough healthcare to employees, and enhance 
the employer-employee relationship.  The Carthage and Clearfield clinics serve over 540 and 380 employees, respectively. 

Talent and Development

The Company believes its employees are its most valuable asset and are critical to the success of the Company.  The 
Company seeks to retain employees by offering competitive wages, benefits and training opportunities.  To assess and monitor 
employee retention and engagement, the Company surveys employees and takes actions to address areas of employee concern.  
The annual employee engagement survey results are presented to Tredegar’s Board of Directors (“Board”).  Additionally, the 
objectives of our executive compensation programs are to attract, motivate and retain highly qualified executive officers.  To 
accomplish these objectives, the Company relies on a pay strategy that emphasizes performance-based compensation through 
annual and long-term incentives.  The Company believes that this pay strategy creates a strong link between pay and 
performance and aligns with our business strategy of generating strong operating results and shareholder value creation while 
controlling fixed costs.  

The Company is committed to holistically supporting our employees both at work and in their communities by:

•

•

•

Strictly following all applicable health, safety and non-discrimination laws in each country;

Promoting the highest standards for employee health and safety through innovative programs; and 

Providing opportunities for community outreach and supporting programs that enhance the lives of children and 
families.

Inclusion and Diversity

Tredegar strictly complies with all applicable state, local and international laws governing nondiscrimination in 

employment in every location where Tredegar and its businesses have facilities to ensure healthy and positive working 
conditions.  This applies to all terms and conditions of employment, including recruiting, hiring, job assignments, promotion, 
termination, layoff, recall, transfer, leaves of absence, compensation and training.  All applicants and employees are treated 
with the same high level of respect regardless of their race, creed, color, religion, sex, sexual orientation, gender identity, age, 
pregnancy, national origin, ethnicity, political affiliation, union membership, marital status, citizenship status, veteran status, 
disability or other protected category.  Employees who experience or witness discriminatory behavior are encouraged to report 
such behavior to their supervisor, Human Resources or Tredegar’s toll-free anonymous reporting hotline.  Additionally, the 
Company spends significant resources in developing its employees.  Among the five core principles of the “The Tredegar Way” 
that the Company uses to guide its organization, the “Leadership” principle is focused on building a team of motivated and 
engaged leaders at every level of the Company.  Each business unit has identified specific action plans to promote the 
Leadership principle among its employees.  Action plans include talent development, skills training, reinforcement of strong 
cultural values, and robust systems to ensure a safe working environment.

Information About Our Executive Officers.  See Item 10. “Directors, Executive Officers and Corporate Governance” of this 
Form 10-K.

Available Information and Corporate Governance Documents. Tredegar’s website address is www.tredegar.com.  The 
Company makes available, through its website, its annual report on Form 10-K, quarterly reports on Form 10-Q, current reports 
on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange 
Act of 1934, as amended (the “Exchange Act”), as soon as reasonably practicable after such documents are electronically filed 
with, or furnished to, the Securities and Exchange Commission (“SEC”).  Information filed electronically with the SEC can be 
accessed on its website at www.sec.gov.  In addition, the Company’s Corporate Governance Guidelines, Code of Conduct, the 
charters of the Audit, Executive Compensation, Nominating and Governance Committees and Climate Change Risk 
Assessment and many other corporate policies are available on Tredegar’s website and are available in print to any shareholder 
upon request by contacting Tredegar’s Corporate Secretary at 1100 Boulders Parkway, Richmond, Virginia 23225.  The 
information on or that can be accessed through the Company’s website is not, and shall not be deemed to be, a part of this Form 
10-K or incorporated into other filings it makes with the SEC. 

4

Item 1A.  RISK FACTORS

There are a number of risks and uncertainties that could have a material adverse effect on the Company’s consolidated 
financial condition, results of operations or cash flows.  The following risk factors should be considered, in addition to the other 
information included in this Form 10-K, when evaluating Tredegar and its businesses.

Risks Related to all Tredegar Businesses

•

•

Our results of operations, financial condition and cash flows could be adversely affected by pandemics, epidemics or 
other public health emergencies, such as coronavirus (“COVID-19”) and emerging variants.  Our business, results of 
operations,  financial  condition,  and  cash  flows  have  been,  and  may  continue  to  be,  adversely  affected  by  pandemics, 
epidemics or other public health emergencies, such as the global outbreak of COVID-19 and emerging variants.  In March 
2020,  the  World  Health  Organization  characterized  COVID-19  as  a  pandemic,  and  the  President  of  the  United  States 
declared  the  COVID-19  outbreak  a  national  emergency.  The  outbreak  resulted  in  governments  around  the  world 
implementing  increasingly  stringent  measures  to  help  control  the  spread  of  the  virus,  including  quarantines,  “shelter  in 
place”  and  “stay  at  home”  orders,  travel  restrictions,  business  curtailments,  school  closures,  and  other  measures.  
However, there have been increases in COVID-19 cases in many areas caused by a combination of the potentially more 
contagious variants of the virus, as well as vaccine hesitancy and low vaccination rates in many areas of the U.S.

The extent to which the COVID-19 pandemic will ultimately impact our business, results of operations, financial 
condition and cash flows depends on future developments that are highly uncertain, rapidly evolving and difficult to 
predict at this time, including:

•
•

•
•

•

•

•

•

the duration, spread and intensity of the pandemic;
the availability, usage and effectiveness of vaccines, low vaccination rates in many areas of the U.S., and 
employee hesitancy to get vaccinated;
increasing costs of labor, raw materials, and global transportation and logistics resources;
a sustained labor shortage due to excessive absenteeism as a result of COVID-19 cases and/or exposures and 
increased turnover rates within our employee base impacting our ability to meet desired shipping levels;
the ability of our suppliers, contractors and third-party logistics providers to meet their obligations to us 
(including supplying us with essential raw materials or shipping finished goods to our customers) on a timely 
basis and at previously anticipated costs without significant disruption, and our ability to identify alternative 
sources of materials and services, if necessary;
our ability to continue to meet our customers’ needs in the event of the suspension or interruption of essential 
elements of our manufacturing and supply arrangements and activities such as, the continued availability of 
raw materials, transportation, labor and production capacity at previously anticipated costs;
the effect of the COVID-19 pandemic on our customers, including their ability to remain in operation and pay 
for the products purchased from us on a timely basis; and
the impact of the COVID-19 pandemic on the financial and credit markets and economic activity generally, 
including our ability to maintain compliance with financial covenants, access lending, capital markets, and 
other sources of liquidity when needed on reasonable terms or at all.

While it is not possible at this time to estimate the impact that any particular epidemic, including COVID-19, could have 
on the Company’s business, the extent of that impact would likely be affected by factors outside of our control such as the 
severity, duration and spread of such an epidemic, the measures taken by the governments of countries affected and the 
ability of our customers and consumers to access government programs providing liquidity and support during the crisis. 
The impact of an epidemic on our employees, our customers, our supply chains, demand for our products, our ability to 
supply customers, our operating costs and our other business activities, could adversely affect our financial condition, 
results of operations and cash flows.  For more information on the effect of COVID-19 on our business and financial 
condition, refer to “The Impact of COVID-19” in Item 7.

Tredegar’s performance is influenced by costs incurred by its operating companies, including, for example, the cost of 
raw materials and energy.  These costs include the cost of aluminum (the raw material on which Aluminum Extrusions 
primarily depends), resin (the raw material on which PE Films primarily depends), PTA and MEG (the raw materials on 
which Flexible Packaging Films primarily depends), natural gas (the principal fuel necessary for Aluminum Extrusions’ 
plants to operate), electricity, diesel fuel and paint.  Aluminum, resin and natural gas prices are volatile as shown in the 
charts in Quantitative and Qualitative Disclosures in Item 7.  The Company continues to face inflationary pressures 
stemming from the COVID-19 operating environment, including notable increases in costs for raw materials, labor and 
freight.  Additionally, geopolitical tensions, including deteriorating relations between the United States and Russia 

5

•

•

•

•

resulting from the current situation involving Russia and Ukraine, could result in economic sanctions, tariffs, import-
export restrictions and retaliatory actions that all have the potential to adversely impact the cost of raw materials and 
energy.  The Company attempts to mitigate the effects of increased costs through price increases and contractual pass-
through provisions, but there are no assurances that higher prices can effectively be passed through to customers or that 
Tredegar will be able to offset fully or on a timely basis the effects of higher raw material and energy costs through price 
increases or pass-through arrangements.  Further, the Company’s cost control efforts may not be sufficient to offset any 
increases in raw material, energy or other costs. 

Material disruptions at one of the Company’s major manufacturing facilities could negatively impact financial results.  
Tredegar believes it has implemented measures to minimize the risks of disruption at its facilities.  However, a disruption 
could occur as a result of any number of events: an equipment failure with repairs requiring long lead times, labor 
stoppages or shortages, cybersecurity attacks, utility disruptions, constraints on the supply or delivery of critical raw 
materials, and severe weather conditions, including potential flooding at the Aluminum Extrusions facility located in 
Carthage, TN.  A material disruption in one of the Company’s operating locations could negatively impact production and 
the Company’s consolidated financial condition, results of operations and cash flows. 

Tredegar has an underfunded defined benefit (pension) plan.  Tredegar sponsors a pension plan that covers certain 
hourly and salaried employees in the U.S. The plan was closed to new participants in 2007, and substantially frozen to 
benefit accruals for active participants in 2014.  As of January 31, 2018, the plan no longer accrued benefits associated 
with crediting employees for service, thereby freezing all future benefits under the plan.  On February 10, 2022, Tredegar 
announced the initiation of a process to terminate and settle its frozen defined benefit pension plan, which could take up to 
24 months to complete.  In connection therewith, on February 9, 2022, the Company borrowed funds under its revolving 
credit agreement to contribute $50 million to the pension plan (the “Special Contribution”) to reduce its underfunding and 
as part of a program within the pension plan to hedge or fix the expected future contributions that will be needed by the 
Company through the settlement process.  As of December 31, 2021 (and before the Special Contribution), the plan was 
underfunded under U.S. generally accepted accounting principles (“GAAP”) measures by $69.5 million.  The Company 
estimates that, with the Special Contribution, there will be no required minimum contributions to the pension plan until 
final settlement.  The ultimate settlement benefit obligation may differ from the projected benefit obligation (“PBO”) of 
$314 million as of December 31, 2021, depending on market factors for buyers of pension obligations at the time of 
settlement.  Additionally, factors that could cause actual future contributions by the Company to settle the pension plan to 
differ from expectations include, without limitation, the change in the values of pension plan assets and liabilities up 
through initiating hedging activities to fix underfunding amounts and assumptions thereafter relating to differences 
between the ultimate settlement benefit obligation and the PBO, census data, administrative costs, the effectiveness of 
hedging activities and discounts required to liquidate non-public securities held by the plan.  

Noncompliance with any of the covenants in the Company’s $375 million revolving credit facility, as amended on 
December 1, 2020, which matures in June 2024, could result in all debt under the agreement outstanding at such time 
becoming due and limiting the Company’s borrowing capacity, which could have a material adverse effect on its 
consolidated financial condition and liquidity.  The credit agreement governing Tredegar’s revolving credit facility 
contains restrictions and financial covenants that, if violated, could restrict the Company’s operational and financial 
flexibility. Failure to comply with these covenants could result in an event of default, which if not cured or waived, would 
result in all outstanding debt under the credit facility at such time becoming due, which could have a material adverse 
effect on the Company’s consolidated financial condition and liquidity. 

A failure in the Company’s information technology systems as a result of cybersecurity attacks or other causes could 
negatively affect Tredegar’s business.  The Company depends on information technology (“IT”) to record and process 
customers’ orders, manufacture and ship products in a timely manner, secure its production processes and know-how, 
maintain the financial accuracy of its business records and maintain personally identified information of its employees. An 
IT system failure due to computer viruses, internal or external security breaches, cybersecurity attacks or other malicious 
causes could disrupt our operations and prevent us from being able to process transactions with our customers, operate our 
manufacturing facilities and properly report transactions in a timely manner. Increased global IT security threats and 
cyber-crime pose a potential risk to the security and availability of the Company’s IT systems, networks and services, 
including those that are managed, hosted, provided or used by third parties, as well as to the confidentiality, availability 
and integrity of the Company’s data. Additionally, increased cybersecurity risk arises due to certain employees working 
remotely during the COVID-19 pandemic.  To date, interruptions of the Company’s IT systems have been infrequent and 
have not had a material impact on the Company’s operations.  A significant protracted failure of or security breach of the 
IT systems, networks or service providers the Company relies upon, or a loss or disclosure of business or other sensitive 
information, or personally identified information, as a result of a cybersecurity incident or other cause, could result in 
substantial costs to the Company, damage to the Company’s reputation, regulatory enforcement actions and lawsuits and 
could adversely affect the Company’s results of operations, financial condition or cash flows.

6

•

•

The Company has identified material weaknesses in its internal control over financial reporting.  The Company’s 
failure to establish and maintain effective internal control over financial reporting and to maintain effective disclosure 
controls and procedures increases the risk of a material misstatement in its consolidated financial statements, and its 
failure to meet its reporting and financial obligations, could, in turn, have a negative impact on its financial condition.  
Maintaining effective internal control over financial reporting is an integral part of producing reliable financial statements.  
As discussed in Item 9A. “Controls and Procedures” of this Form 10-K (“Item 9A”), the Company’s management 
concluded that the Company’s internal control over financial reporting was not effective for the periods referred to therein 
as a result of certain deficiencies that were determined to constitute material weaknesses in the Company’s internal 
control over financial reporting.  

Under standards established by the Public Company Accounting Oversight Board, a material weakness is defined as a 
deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable 
possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a 
timely basis.  Under the criteria set forth in Internal Control - Integrated Framework 2013 issued by the Committee of 
Sponsoring Organizations of the Treadway Commission, a material weakness in the design of monitoring controls 
indicates that the Company has not sufficiently developed and/or documented internal controls by which management can 
review and oversee the Company’s financial information to detect and correct material errors or that the personnel 
responsible for performing the review did not have the sufficient skill set or knowledge of the subject matter to perform a 
proper assessment.

The Company is in the process of making certain changes in its internal control over financial reporting to remediate the 
material weaknesses as described in Item 9A.  The implementation of the material aspects of this plan began in the second 
quarter of 2019 with the continuous significant assistance and support of a well-known outside consultant, and, while 
meaningful progress has been made, completion has been delayed by the COVID-19 pandemic, turnover in positions 
relevant to internal controls and the need for additional training.  As the Company continues to evaluate and work to 
improve its internal control over financial reporting and disclosure controls and procedures, management may determine 
to take additional measures to address control deficiencies or modify the remediation plan.  The Company cannot provide 
assurance, however, as to when it will remediate all such weaknesses, nor can it be certain of whether additional actions 
will be required or the costs of any such actions. Moreover, the Company cannot provide assurance that additional 
material weaknesses will not arise in the future.

See Item 9A for details regarding the numerous activities in the remediation plan that were completed through the fourth 
quarter of 2021 and the remaining activities that are scheduled for completion in the first half of 2022, in anticipation of 
conducting management’s testing beginning in the first half of 2022.  The material weaknesses cannot be considered 
remediated until the applicable controls have operated for a sufficient period of time and management has concluded, 
through testing, that these controls are operating effectively. 

The material weaknesses discussed in Item 9A did not result in material misstatements of the Company’s financial 
statements as of and for the years ended December 31, 2021, 2020 and 2019 or in the intervening interim periods during 
those respective years.  Any failure to remediate the material weaknesses, or the development of new material weaknesses 
in its internal control over financial reporting, could result in material misstatements in the Company’s consolidated 
financial statements and cause it to fail to meet its reporting and financial obligations, which in turn could have a negative 
impact on its financial condition.  

Tredegar is subject to current and future governmental regulation, including environmental laws and regulations, and 
could become exposed to material liabilities and costs associated with such regulation. The Company is subject to 
regulation by local, state, federal and foreign governmental authorities.  New laws and regulations, or changes to existing 
laws, including those relating to environmental matters (including global climate change and plastic products), and 
privacy matters, could subject Tredegar to significant additional capital expenditures, operating expenses or other 
compliance costs. Moreover, future developments in federal, state, local and international laws and regulations, including 
environmental laws, are difficult to predict. Environmental laws and privacy restrictions have become and are expected to 
continue to become increasingly strict. As a result, Tredegar expects to be subject to new environmental and privacy laws 
and regulations. However, any such changes are uncertain and, therefore, it is not possible for the Company to predict 
with certainty the amount of additional capital expenditures or operating expenses that could be necessary for compliance 
with respect to any such changes. 

The Company is subject to the U.S. Foreign Corrupt Practices Act, Brazilian anti-corruption laws and similar anti-bribery 
laws in other jurisdictions, which generally prohibit companies and their intermediaries from making improper payments 
to foreign officials for the purpose of obtaining or retaining business. Although we have policies and procedures designed 
to facilitate compliance with these laws and regulations, our employees, contractors and agents may take actions in 
violation of our policies. Any such violation, even if prohibited by our policies, could adversely affect our business and/or 
our reputation.  See Government Regulation in Item 1. “Business” of this Form 10-K for a further discussion of this risk 
factor.

7

•

The transition away from the use of the London interbank offered rate ("LIBOR") settings as an interest rate 
benchmark may negatively impact our debt agreements and financial position, results of operations and liquidity.  On 
March 5, 2021, the United Kingdom’s Financial Conduct Authority published the dates that the use of LIBOR as an index 
for commercial loans will be phased out.  Foreign currency indices, including the British pound, the Euro, and Swiss 
franc, along with the U.S. dollar 1-week and 2-month settings ceased after December 31, 2021. Also, after June 30, 2023, 
the remaining U.S. dollar settings will cease.  Our most significant exposure to LIBOR relates to our revolving 
domestically held credit facility, which may be negatively impacted by renegotiated terms and costs of indebtedness 
associated with the latter of these transition dates.  In addition, the overall financial markets may be disrupted as a result 
of the replacement of LIBOR, which could have an adverse effect on our cost of capital and our financial position. We 
continue to monitor the LIBOR transition and will work to minimize any impact.

Risks Related to Aluminum Extrusions

•

•

•

•

Sales volume and profitability of Aluminum Extrusions is cyclical and seasonal and highly dependent on economic 
conditions of end-use markets in the U.S., particularly in the construction sector.  Aluminum Extrusions’ end-use 
markets can be cyclical and subject to seasonal swings in volume and have been adversely impacted during the 
COVID-19 pandemic.  Because of the capital-intensive nature and level of fixed costs inherent in the aluminum 
extrusions business, the percentage drop in earnings before interest, taxes, depreciation and amortization (“EBITDA”) 
from ongoing operations in a cyclical downturn will likely exceed the percentage drop in volume.  In addition, during an 
economic slowdown, excess industry capacity often drives increased pricing pressure in many end-use markets as 
competitors seek to protect their position with key customers.  Any benefits associated with cost reductions and 
productivity improvements may not be sufficient to offset the adverse effects on profitability from pricing and margin 
pressure and higher bad debts (including a greater chance of loss associated with customers defaulting on fixed-price 
forward sales contracts) that usually accompany a downturn.  In addition, higher energy costs can reduce profits unless 
offset by price increases or cost reductions and productivity improvements.

The failure to successfully implement the new enterprise resource planning and manufacturing execution systems 
could adversely impact the Aluminum Extrusions business and results of operations.  On January 28, 2022, Aluminum 
Extrusions obtained approval from the Board to engage in the implementation project of a new enterprise resource 
planning and  manufacturing execution systems (“ERP/MES”) across all locations of the Aluminum Extrusions business.  
The ERP/MES project is expected to cost $28 million over a two-year time span.  The implementation of these systems is 
a major undertaking from a financial, management, and personnel perspective.  The implementations may prove to be 
more difficult, costly, or time consuming than expected, and there can be no assurance that these systems will be 
beneficial to the extent anticipated. Any disruptions, delays or deficiencies in the design and implementation of the new 
systems could adversely affect our financial position, results of operations and cash flows; additionally, any disruptions, 
delays or deficiencies could adversely affect our remediation efforts with respect to the effectiveness of our internal 
controls over financial reporting.

Failure to prevent competitors from evading anti-dumping and countervailing duties, or a reduction in such duties, 
could adversely impact Aluminum Extrusions.  Chinese and other overseas manufacturers continue to try to evade the 
anti-dumping and countervailing orders to avoid duties.  Effective April 25, 2017, the anti-dumping duty and 
countervailing duty orders on aluminum extrusions were extended for a period of five years.  The orders will be reviewed 
again beginning in March 2022.  A failure by, or the inability of, U.S. trade officials to curtail the evasion of these duties, 
or the potential reduction of applicable duties pursuant to annual administrative reviews of the orders by the Department 
of Commerce, could have a material adverse effect on the financial condition, results of operations and cash flows of 
Aluminum Extrusions.

The duty-free importation of goods allowed under the United States-Mexico-Canada Agreement (“USMCA”), or other 
free trade agreements or duty-preference regimes, could result in lower demand for aluminum extrusions made in the 
U.S., which could materially and negatively affect Aluminum Extrusions’ business and results of operations.  In March 
2018, the U.S. imposed tariffs of 10% on aluminum ingot and semi-finished aluminum imported into the U.S. from certain 
countries, including countries from which Aluminum Extrusions has historically sourced aluminum products.  In 
September 2019, the U.S., Canada and Mexico entered into the USMCA.  As a result of the 10% tariffs on aluminum 
ingot imported to the U.S. and the duty-free importation of goods allowed under USMCA or other trade agreement 
regimes or duty-preference programs, aluminum extrusions from outside the United States that are able to take advantage 
of duty-preference programs upon importation into the United States made in Canada and Mexico are free of the 10% 
tariff and can now be imported into and sold in the U.S. at very competitive prices.  This could result in lower demand for 
aluminum extrusions made in the U.S., which could materially and negatively affect Aluminum Extrusions’ business and 
results of operations. 

•

The markets for Aluminum Extrusions’ products are highly competitive with product quality, service, delivery 
performance and price being the principal competitive factors.  Aluminum Extrusions has approximately 1,370 

8

customers that are in a variety of end-use markets within the broad categories of building and construction, distribution, 
automotive and other transportation, machinery and equipment, electrical and consumer durables.  No single Aluminum 
Extrusions’ customer exceeds 4% of consolidated net sales. Future success and prospects depend on Aluminum 
Extrusions’ ability to provide superior service, high quality products, timely delivery and competitive pricing to retain 
existing customers and participate in overall industry cross-cycle growth.  Failure in any of these areas could lead to a loss 
of customers, which could have an adverse material effect on the financial condition, results of operations and cash flows 
of Aluminum Extrusions.

Risks Related to PE Films

•

•

•

•

PE Films is highly dependent on sales associated with relatively few large customers.  PE Films’ top four customers 
comprised approximately 13%, 16% and 14% of Tredegar’s consolidated net sales in 2021, 2020 and 2019, respectively.  
The loss or significant reduction of sales associated with one or more of these customers without replacement by new 
business could have a material adverse effect on the Company.

The Company previously reported the risk that a portion of its film products used in surface protection applications would 
be made obsolete by customer product transitions to less costly alternative processes or materials. The Company estimates 
that these transitions, which principally relate to one customer, adversely impacted EBITDA from ongoing operations for 
PE Films by $14.8 million during 2021 versus 2020.  A further decline of $7 million in EBITDA from ongoing operations 
due to the transitions is expected in 2022 versus 2021, at which time the transitions are expected to be complete. 

The Surface Protection business is also experiencing competitive pricing pressures, unrelated to the customer product 
transitions, that are expected to adversely impact EBITDA from ongoing operations by approximately $6 million in 2022 
versus 2021.  To offset the expected adverse impact of the customer transitions and pricing pressures, the Company is 
aggressively pursuing and making progress in generating contribution from sales of new surface protection products, 
applications and customers and driving production efficiencies and cost savings.  Annual contribution to EBITDA from 
ongoing operations for PE Films from sales of products unrelated to previously disclosed customer product transitions 
increased $7 million for the two-year period ended December 31, 2021, which excludes the impact of resin pass-through 
lag but includes the adverse impact of customer inventory corrections, customer production slowdowns associated with 
COVID-19-related factors, and a slowdown in the television market in the fourth quarter of 2021.

While PE Films is undertaking efforts to expand its customer base, there can be no assurance that such efforts will be 
successful, or that they will offset any loss of sales and profits associated with customer transitions and other large 
customer declines. 

Failure of PE Films’ customers, who are subject to cyclical downturns, to achieve success or maintain market share 
could adversely impact PE Films’ sales and operating margins.  PE Films’ plastic films are used in the production of 
various consumer products sold worldwide.  A customer’s ability to successfully develop, manufacture and market those 
products is integral to PE Films’ success.  Cyclical downturns and changing consumer preferences may negatively affect 
businesses that use PE Films’ plastic film products, which could adversely affect sales and operating margins. Other 
factors that could adversely affect the business include (i) failure by a key customer to achieve success or maintain share 
in markets in which they sell products containing PE Films’ materials, including as a result of customer preferences for 
products other than plastics, (ii) key customers using products developed by others that replace PE Films’ business with 
such customers, (iii) delays in a key customer rolling out products utilizing new technologies developed by PE Films, and 
(iv) operational decisions by a key customer that result in component substitution, inventory reductions and similar 
changes.  

The Company’s inability to protect its intellectual property rights or its infringement of the intellectual property rights 
of others could have a material adverse impact on PE Films.  The continued success of the PE Films’ business depends 
on its ability not only to protect its own technologies and trade secrets, but also to develop and sell new products that do 
not infringe upon existing patents.  Intellectual property litigation is very costly and could result in substantial expense 
and diversions of Company resources, both of which could adversely affect its consolidated financial condition, results of 
operations and cash flows.  In addition, there may be no effective legal recourse against infringement of the Company’s 
intellectual property by third parties, whether due to limitations on enforcement of rights in foreign jurisdictions or as a 
result of other factors. 

Disruptions to PE Films’ supply chain could have a material adverse impact on PE Films.  Certain raw materials used 
in manufacturing PE Films’ products are sourced from single suppliers, and PE Films may not be able to quickly or 
inexpensively re-source from other suppliers.  The risk of damage or disruption to its supply chain may increase if and 
when different suppliers consolidate their product portfolios, experience financial distress or disruption of manufacturing 
operations (such as, for example, the impact of hurricanes on petrochemical production).  Failure to take adequate steps to 
effectively manage such events, which are intensified when a product is procured from a single supplier or location, could 

9

adversely affect PE Films’ consolidated financial condition, results of operations and cash flows, and also require 
additional resources to restore its supply chain.

•

Rising trade tensions could cause an increase in the cost of PE Films’ products or otherwise negatively impact the 
Company.  A portion of PE Film’s business involves imports to and from the U.S. and other countries where the 
Company produces and sells its products.  Trade tensions have been rising between the U.S. and other countries, 
particularly China.  An increase in tariffs and other trade barriers between the U.S. and China, or between the U.S. and 
other countries, could cause an increase in the cost of PE Films’ products or otherwise negatively impact the production 
and sale of the Company’s products in world markets.

Risks Related to Flexible Packaging Films

•

•

A history of uncertain economic conditions in Brazil could adversely impact the financial condition, results of 
operations and cash flows of Flexible Packaging Films.  For flexible packaging films produced in Brazil, selling prices 
and key raw material costs are principally determined in U.S. Dollars and are impacted by local economic conditions and 
local and global competitive dynamics. Flexible Packaging Films is exposed to foreign exchange translation risk (its 
functional currency is the Brazilian Real) because almost 90% of the sales of Flexible Packaging Films business unit in 
Brazil (“Terphane Ltda.”) and substantially all of its related raw material costs are quoted or priced in U.S. Dollars while 
its variable conversion, fixed conversion and sales, general and administrative costs before depreciation & amortization 
(collectively “Terphane Ltda. Operating Costs”) are quoted or priced in Brazilian Real. This mismatch, together with a 
variety of economic variables impacting currency exchange rates, causes volatility that could negatively or positively 
impact EBITDA from ongoing operations for Flexible Packaging Films.  While Flexible Packaging Films hedges this 
exposure on a short-term basis with foreign exchange forward rate contracts, the exposure continues to exist beyond the 
hedging periods.

Overcapacity in Latin American polyester film production and governmental failure to extend anti-dumping duties in 
Brazil on imported products or prevent competitors from circumventing such duties could adversely impact Flexible 
Packaging Films.  In recent years, excess global capacity in the industry has led to increased competitive pressures from 
imports into Brazil. The Company believes that these conditions have shifted the competitive environment from a regional 
to a global landscape and have driven price convergence and lower product margins for Flexible Packaging Films. 
Favorable anti-dumping rulings or countervailing duties are in effect for products imported from China, Egypt, India, 
Mexico, United Arab Emirates, Turkey, Peru and Bahrain. Competitors not currently subject to anti-dumping duties may 
choose to utilize their excess capacity by selling product in Brazil, which may result in pricing pressures that Flexible 
Packaging Films may not be able to offset with cost savings measures and/or manufacturing efficiency initiatives. In May 
2021, the Brazilian authorities concluded the sunset review relating to the anti-dumping process for polyester film 
imported from China, India and Egypt, and decided to extend duties for another five years. However, due to its doubts that 
films would continue to be imported from China and Egypt, the government immediately suspended the implementation 
of the tariffs for those countries.  If in the future there are volumes imported from China or Egypt which are harming the 
Brazilian market, authorities may promptly reinstate tariffs.  For India, the Brazilian authorities also reviewed measures 
against countervailing duties and extended those for five years as well. Considering the expiration date for anti-dumping 
rulings against Mexico, United Arab Emirates and Turkey in first quarter 2023, Terphane may request a sunset review in 
the fourth quarter of 2022, if there are indications of continuous dumping practices from those sources into the Brazilian 
market.

Item 1B. 

UNRESOLVED STAFF COMMENTS

None.

Item 2. 

PROPERTIES

General

Most of the improved real property and the other assets used in the Company’s operations are owned.  Certain of the 
owned property is subject to an encumbrance under the Company’s credit agreement (see Note 7 “Debt and Credit Agreements” 
to the Consolidated Financial Statements in Item 15 for more information).  

Tredegar considers the manufacturing facilities, warehouses and other properties and assets that it owns or leases to be in 

generally good condition.  Capacity utilization at its various manufacturing facilities can vary with product mix and normal 
fluctuations in sales levels.  The Company believes that its Bonnell Aluminum, PE Films and Flexible Packaging Films 
manufacturing facilities have sufficient capacity to meet current production requirements.  Tredegar’s corporate headquarters, 
which is leased, is located at 1100 Boulders Parkway, Richmond, Virginia 23225.

10

The Company’s principal manufacturing plants and facilities as of December 31, 2021 are listed below:

Aluminum Extrusions

Locations in the U.S.
Carthage, Tennessee
Clearfield, Utah (leased)
Elkhart, Indiana
Newnan, Georgia
Niles, Michigan

PE Films

   Locations Outside the U.S.

   Principal Operations

None

Production of aluminum 
extrusions, fabrication and 
finishing

Locations in the U.S.

   Locations Outside the U.S.

   Principal Operations

Pottsville, Pennsylvania
Richmond, Virginia  (technical center) 
(leased)

Flexible Packaging Films

   Guangzhou, China

   Production of plastic films 

Locations in the U.S.

   Locations Outside the U.S.

   Principal Operations

Bloomfield, New York  (technical center 
and production facility)

Item 3. 

LEGAL PROCEEDINGS

   Cabo de Santo Agostinho, Brazil 

   Production of PET-based films 

The information required by this Item 3 is set forth in Note 18 "Contingencies" to the Consolidated Financial Statements  

in Item 15 and is hereby incorporated herein by reference.

Item 4. 

MINE SAFETY DISCLOSURES

None.

11

  
  
PART II

Item 5. 

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND 
ISSUER PURCHASES OF EQUITY SECURITIES

Tredegar’s common stock is traded on the New York Stock Exchange (“NYSE”) under the ticker symbol “TG”. There 

were 33,743,617 shares of common stock held by 1,677 shareholders of record on March 4, 2022.

Dividend Information

Tredegar has paid a regular cash dividend every quarter since becoming a public company in July 1989 and expects that 
comparable regular cash dividends will continue to be paid in the future.  In addition, Tredegar has paid special cash dividends 
from time to time.  On December 1, 2020, the Board declared a special dividend of $200 million, or $5.97 per share, on the 
Company’s common stock (the “Special Dividend”).  The Special Dividend was paid in December 2020.  

All decisions with respect to the declaration and payment of future dividends will be made by the Board in its sole 

discretion based upon earnings, financial condition, anticipated cash needs, restrictions in the Company’s revolving credit 
facility and other such considerations as the Board deems relevant.  See Note 7 "Debt and Credit Agreements" to the 
Consolidated Financial Statements in Item 15 for the restrictions on the payment of dividends contained in the Company’s 
credit agreement related to aggregate dividends permitted.

Issuer Purchases of Equity Securities

On January 7, 2008, Tredegar announced that the Board approved a share repurchase program whereby management is 

authorized at its discretion to purchase, in the open market or in privately negotiated transactions, up to 5 million shares of the 
Company’s outstanding common stock.  The authorization has no time limit.  Tredegar did not repurchase any shares in the 
open market or otherwise in 2021, 2020 or 2019 under this standing authorization.  The maximum number of shares remaining 
under this standing authorization was 1,732,003 at December 31, 2021.

Stock Performance Graph

The following graph compares cumulative total shareholder returns for Tredegar, the S&P SmallCap 600 Stock Index (an 

index comprised of companies with market capitalizations similar to Tredegar) and the Russell 2000 Index for the five years 
ended December 31, 2021.  Tredegar is part of both the S&P SmallCap 600 Index and Russell 2000 Index. 

COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*
Among Tredegar Corporation, the S&P SmallCap 600 Index, and the Russell 2000 Index

$200

$150

$100

$50

$0

12/16

12/17

12/18

12/19

12/20

12/21

Tredegar Corporation

S&P SmallCap 600

Russell 2000

*$100 invested on 12/31/15 in stock or index, including reinvestment of dividends. 
Fiscal year ending December 31.

Copyright© 2021 Standard & Poor's, a division of S&P Global. All rights reserved.
Copyright© 2021 Russell Investment Group. All rights reserved.

12

Item 6.

[RESERVED]

Item 7. 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF 
OPERATIONS

The following discussion and analysis of our financial condition and results of operations focuses on and is intended to 

clarify the results of our operations, certain changes in our financial position, liquidity, capital structure and business 
developments for the periods covered by the consolidated financial statements included in this Form 10-K. This discussion 
should be read in conjunction with, and is qualified by reference to, the other related information including, but not limited to, 
the audited consolidated financial statements (including the notes thereto) and the description of our business, all as set forth in 
this Form 10-K, as well as the risk factors discussed above in Item 1A.

This section provides discussion and a year-to-year comparison for the years ended December 31, 2021 and 2020. 
Discussion regarding our results of operations for the year ended December 31, 2019 and a year-to-year comparison between 
the years ended December 31, 2020 and 2019 can be found in Item 7 of our Annual Report on Form 10-K for the year ended 
December 31, 2020. 

General

Executive Summary

Tredegar Corporation is an industrial manufacturer with three primary businesses: custom aluminum extrusions for the 
North American building & construction, automotive and specialty end-use markets through its Aluminum Extrusions segment; 
surface protection films for high-technology applications in the global electronics industry through its PE Films segment; and 
specialized polyester films primarily for the Latin American flexible packaging market through its Flexible Packaging Films 
segment.  With approximately 2,400 employees, the Company operates manufacturing facilities in North America, South 
America, and Asia.    

On October 30, 2020, the Company completed the sale of Personal Care Films. The transaction excluded the packaging 
film lines and related operations located at Pottsville Packaging, which are now being reported within the Surface Protection 
component of PE Films. Commencing in the third quarter of 2020, all historical results for Personal Care Films have been 
presented as discontinued operations.  For more information on these transactions, see Note 17 to the Consolidated Financial 
Statements in Item 15.

Sales were $826.5 million in 2021 compared to $755.3 million in 2020.  Net income from continuing operations was 
$57.9 million ($1.72 per diluted share) in 2021, compared with net loss from continuing operations of $16.8 million ($0.51 per 
diluted share) in 2020.  

The 2021 results include:

An after-tax gain of $10.0 million ($0.30 per diluted share) on the sale of the Company’s investment in kaléo on 
December 27, 2021 resulting in total cash proceeds of $47.1 million (see Note 9 to the Consolidated Financial 
Statements in Item 15 for more details).

The 2020 results include:

An after-tax loss on the Company’s investment in kaléo of $47.6 million ($1.42 per diluted share), which was 
accounted for under the fair value method (see Note 9 to the Consolidated Financial Statements in Item 15 for more 
details); and

An impairment of the total goodwill balance of Aluminum Extrusions' reporting unit acquired in the AACOA 
acquisition in 2012 was recorded in the after-tax amount of $10.5 million ($0.32 per diluted share).

•

•

•

Other losses related to asset impairments and costs associated with exit and disposal activities for continuing operations 

were not material for the years ended December 31, 2021 and 2020, respectively. Losses associated with plant shutdowns, asset 
impairments, restructurings and other items are described in Results of Operations. EBITDA from ongoing operations is the 
measure of profit and loss used by Tredegar’s chief operating decision maker (“CODM”) for purposes of assessing financial 
performance. The Company uses net sales from continuing operations as its measure of revenues from external customers at the 
segment level. This measure is separately included in the financial information regularly provided to the CODM.

Earnings before interest and taxes (“EBIT”) from ongoing operations is a non-GAAP financial measure included in the 

reconciliation of segment financial information to consolidated results for the Company. It is not intended to represent the 
stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income 
as defined by GAAP.  We believe EBIT is a widely understood and utilized metric that is meaningful to certain investors and 
that including this financial metric in the reconciliation of management’s performance metric, EBITDA from ongoing 
operations, provides useful information to those investors that primarily utilize EBIT to analyze the Company’s core operations.  

13

See the table in Note 13 to the Consolidated Financial Statements in Item 15 for a reconciliation of this non-GAAP measure to 
GAAP. 

THE IMPACT OF COVID-19 AND RELATED FINANCIAL CONSIDERATIONS

Essential Business and Employee Considerations

The Company’s priorities during the COVID-19 pandemic continue to be to protect the health and safety of employees 

while keeping its manufacturing sites open due to the essential nature of many of its products.  The Company has continued to 
manufacture the full range of products at its facilities.

The Company’s protocols to protect the health and well-being of its employees from COVID-19 continue to evolve as the 

Centers for Disease Control, the Office of the Surgeon General and other state and local health departments learn more about 
the virus and its variants.  Consistent with recommendations and mandates from government agencies and health authorities, 
the Company has implemented multiple layers of COVID-19 protections and interventions. 

The Company has engaged in an education campaign that provides employees with the most accurate and up-to-date 
information related to COVID-19 vaccines and has offered different monetary and/or time-away-from-work incentives to 
encourage employees to get vaccinated with the primary dose(s) and to get a booster shot once eligible. The Company will 
continue to monitor available information to assess safeguards that may be taken to try to prevent a COVID-19 outbreak in the 
workplace. 

  Aluminum Extrusions, also known as Bonnell Aluminum, continues to experience higher than normal absenteeism and 

hiring difficulties, which it attributes to COVID-19-related factors, including high COVID-19 transmission rates in the 
geographic areas where its plants are located.  While the average number of direct labor employees at Bonnell Aluminum 
facilities increased approximately 9% in the fourth quarter of 2021, compared with the abnormally low levels related to the 
pandemic in the second and third quarters of 2020, there continues to be a shortage of labor to meet existing demand and 
desired shipment levels.  Moreover, onboarding new employees has resulted in higher hiring and training costs and labor 
inefficiencies in 2021 versus last year.

All three of the Company's business segments are managing through supply chain disruptions and escalating costs, 
including raw material cost increases, shortages, transportation cost increases and delays.  To offset growing cost pressures, 
Bonnell Aluminum implemented a selling price increase effective January 3, 2022, which followed two price increases in 2021.  
In response to unprecedented cost increases and supply issues for polyethylene and polypropylene resin, PE Films implemented 
a quarterly resin cost pass-through mechanism, effective July 1, 2021, for all products and customers not previously covered by 
such arrangements.  Flexible Packaging Films, which is also known as Terphane, which is headquartered in Brazil, continues to 
monitor cost escalations to adjust selling prices as market dynamics permit. 

Financial Considerations

 Approximately 58% of Bonnell Aluminum’s sales volume in 2021 was related to building and construction (“B&C”) 
markets (non-residential B&C of 51% and residential B&C of 7%).  Non-residential B&C volume started to decline in the 
fourth quarter of 2020 after the fulfillment of contracts that existed at the start of the COVID-19 pandemic.  Market demand in 
this sector has recently been strong but not fully realized in Bonnell Aluminum's fourth quarter and full year 2021 results due to 
pandemic-related labor shortages and resulting production inefficiencies. Non-residential B&C volume declined 4% versus the 
fourth quarter of 2020 and 11% versus full year 2020.  However, current bookings and backlog remain at record high levels 
which the Company believes will bode well for future results when production constraints are alleviated. 

The Surface Protection component of PE Films had record EBITDA from ongoing operations in 2020 but experienced a 

decline in volume in 2021, primarily related to a previously disclosed customer product transition unrelated to the pandemic.  In 
addition, the lag in the pass-through of significant pandemic-related increases in resin costs, and some of such cost increases 
incurred prior to mid-year that will not be recovered even on a lagging basis, have adversely impacted PE Films’ profitability in 
2021.

At Terphane, the Company believes that the pandemic-related surge in demand for flexible packaging films that began in 

early 2020 returned to lower pre-pandemic levels during the second quarter of 2021.

14

Segment Analysis.  A summary of results for 2021 versus 2020 for each of the Company’s reporting segments is shown below.

OPERATIONS REVIEW

Aluminum Extrusions

A summary of results for Aluminum Extrusions is provided below: 

(In thousands, except percentages)
Sales volume (lbs)

Net sales
Ongoing operations:
EBITDA
Depreciation & amortization
EBIT

Capital expenditures

Year Ended
December 31,

2020
2021
  183,367 
  186,391 
$  539,325  $  455,711 

(16,272)   

$  55,948  $  55,137 
(17,403) 
$  39,676  $  37,734 
$  18,914  $  10,260 

Favorable/
(Unfavorable)

% Change

 (1.6) %
 18.3 %

 1.5 %
 6.5 %
 5.1 %

Net sales in 2021 increased by 18.3% versus 2020. The annual increase in net sales was primarily due to an increase in 

average selling prices to cover significantly higher aluminum raw material costs and higher operating costs, partially offset by 
lower sales volume. Sales volume in 2021 decreased by 1.6% versus 2020.  Increased shipments in the specialty sector were 
offset by declines in B&C and automotive markets.  All end markets served within the specialty sector experienced growth.  
The Company believes that declines in the non-residential B&C market resulted mainly from COVID-19-related labor 
shortages, with a portion of the decline in automotive sales volume associated with supply chain issues in the automotive 
industry.   

EBITDA from ongoing operations in 2021 increased by $0.8 million versus 2020 due to higher pricing ($13.6 million net 
of the pass-through of aluminum raw materials costs), partially offset by higher labor and employee-related costs ($7.2 million) 
and other inflationary operating costs such as higher supply expenses ($6.4 million), lower labor productivity ($1.6 million), 
higher freight expenses ($3.2 million) and higher selling, general and administrative costs ($3.2 million). In addition, the timing 
of the flow through under the first-in first-out method of aluminum raw material costs passed through to customers, previously 
acquired at lower prices in a quickly rising commodity pricing environment, resulted in a benefit of $6.9 million in 2021 versus 
a charge of $1.3 million in 2020.

Projected Capital Expenditures and Depreciation & Amortization

Capital expenditures are projected to be $30 million in 2022, including $15 million for new ERP/MES, $6 million for 

infrastructure upgrades at the facilities located in Niles, Michigan, Carthage, Tennessee and Newnan, Georgia, and $3 million 
for other strategic projects.  The ERP/MES project is expected to cost $28 million over a two-year time span.  In addition to 
strategic projects, approximately $6 million will be required to support continuity of current operations.  Depreciation expense 
is projected to be $14 million in 2022.  Amortization expense is projected to be $3 million in 2022.

PE Films

A summary of results for PE Films is provided below: 

(In thousands, except percentages)
Sales volume (lbs)

Net sales
Ongoing operations:
EBITDA
Depreciation & amortization
EBIT

Capital expenditures

Year Ended
December 31,

2021
39,429 

2020
45,175 
$  118,920  $  139,288 

(6,263)   

$  27,694  $  45,107 
(6,762) 
$  21,431  $  38,345 
6,024 
$ 

2,997  $ 

Favorable/
(Unfavorable)

% Change

 (12.7) %
 (14.6) %

 (38.6) %
 7.4 %
 (44.1) %

Net sales in 2021 decreased by $20.4 million versus 2020, primarily due to lower volume and unfavorable mix associated 

with the previously disclosed customer product transitions in Surface Protection, partially offset by higher pricing associated 
with the pass-through of increased resin costs. 

15

 
 
 
 
EBITDA from ongoing operations in 2021 decreased by $17.4 million versus 2020 primarily due to:

A $19.4 million decrease from Surface Protection primarily related to lower sales and unfavorable mix associated with 
the customer product transitions ($14.8 million), lower sales and unfavorable mix for products unrelated to customer 
product transitions ($3.4 million), margin erosion associated with higher resin costs that occurred before the resin 
index pricing plan was fully implemented ($1.4 million), the pass-through lag associated with higher resin costs ($1.4 
million), and higher freight expense ($1.0 million), partially offset by production efficiencies and cost savings ($1.9 
million) and lower research and development spend ($0.4 million); 

A $0.1 million increase from Pottsville Packaging; and

A $2.7 million favorable variance associated with the divestiture of Bright View Technologies at the end of 2020.

•

•

•

Customer Product Transitions and Other Factors in Surface Protection

The Surface Protection component of PE Films supports manufacturers of optical and other specialty substrates used in 

flat panel display products. These films are primarily used by customers to protect components of displays in the manufacturing 
and transportation processes and then discarded.

The Company previously reported the risk that a portion of its film products used in surface protection applications would 
be made obsolete by customer product transitions to less costly alternative processes or materials. The Company estimates that 
these transitions, which principally relate to one customer, adversely impacted EBITDA from ongoing operations for PE Films 
by $14.8 million during 2021 versus 2020.  A further decline of $7 million in EBITDA from ongoing operations due to the 
transitions is expected in 2022 versus 2021, at which time the transitions are expected to be complete. 

The Surface Protection business is also experiencing competitive pricing pressures, unrelated to the customer product 
transitions, that are expected to adversely impact EBITDA from ongoing operations by approximately $6 million in 2022 versus 
2021.  To offset the expected adverse impact of the customer transitions and pricing pressures, the Company is aggressively 
pursuing and making progress in generating contribution from sales of new surface protection products, applications and 
customers and driving production efficiencies and cost savings.  Annual contribution to EBITDA from ongoing operations for 
PE Films from sales of products unrelated to previously disclosed customer product transitions increased $7 million for the two-
year period ended December 31, 2021, which excludes the impact of resin pass-through lag but includes the adverse impact of 
customer inventory corrections, customer production slowdowns associated with COVID-19-related factors, and a slowdown in 
the television market in the fourth quarter of 2021.

Projected Capital Expenditures and Depreciation & Amortization

Capital expenditures are projected to be $5 million in 2022, including: $3 million for productivity projects and $2 million 
for capital expenditures required to support continuity of current operations.  Depreciation expense is projected to be $7 million 
in 2022.  There is no amortization expense for PE Films.

Flexible Packaging Films

A summary of results for Flexible Packaging Films is provided below:

(In thousands, except percentages)
Sales volume (lbs)

Net sales
Ongoing operations:
EBITDA
Depreciation & amortization
EBIT

Capital expenditures

Year Ended
December 31,

2020
2021
  113,115 
  104,569 
$ 139,978  $ 134,605 

(1,988)   

$  31,684  $  30,645 
(1,761) 
$  29,696  $  28,884 
4,959 
$ 

5,603  $ 

Favorable/
(Unfavorable)
% Change

 (7.6) %
 4.0 %

 3.4 %
 (12.9) %
 2.8 %

Sales volume declined by 7.6% in 2021 versus 2020, primarily due to lower demand, resin supply issues, and an 
equipment failure impacting production.  Net sales in 2021 increased 4.0% compared to 2020, primarily due to higher selling 
prices from the pass-through of higher resin costs and favorable product mix, partially offset by lower sales volume.

EBITDA from ongoing operations in 2021 increased by $1.0 million versus 2020 primarily due to:

16

 
• Higher selling prices from the pass-through of higher resin costs ($11.2 million), favorable product mix ($2.0 million) 
and lower selling, general, and administration expenses ($0.7 million), partially offset by higher raw material costs 
($12.8 million), lower sales volume ($4.9 million) and higher variable costs ($1.7 million);

• Net favorable currency translation of Real-denominated operating costs ($5.9 million);

• Higher foreign currency transaction gains ($1.2 million) in 2021 versus 2020; and

• Lower value-added tax credits received in 2021 ($0.5 million) versus 2020.

Projected Capital Expenditures and Depreciation & Amortization

Capital expenditures are projected to be $8 million in 2022, including $4 million for new capacity for value-added 
products and productivity projects and $4 million for capital expenditures required to support continuity of current operations.  
Depreciation expense is projected to be $2 million in 2022.  Amortization expense is projected to be $0.4 million in 2022. 

Corporate Expenses, Interest and Income Taxes

Corporate expenses, net, decreased $1.1 million in 2021 versus 2020, primarily due to higher transition service fees, net of 

corporate costs associated with the 2020 divestiture of the Personal Care Films business ($1.1 million).

Interest expense increased to $3.4 million in 2021 from $2.6 million in 2020, primarily due to higher average debt levels.

The effective tax rate used to compute income taxes for continuing operations in 2021 was 13.8% compared to 32.8% in 
2020. The differences between the U.S. federal statutory rate and the effective tax rate for 2021 and 2020 are shown in Note 12 
to the Consolidated Financial Statements in Item 15.

Pension expense was $14.1 million in 2021, a favorable change of $0.5 million from 2020.  The impact on earnings from 
pension expense is reflected in “Corporate expenses, net” in the net sales and operating profit by segment statements in Note 13 
to the Consolidated Financial Statements in Item 15.  On February 10, 2022, Tredegar announced the initiation of a process to 
terminate and settle its frozen defined benefit pension plan, which could take up to 24 months to complete.  In connection 
therewith, the Company borrowed funds under its revolving credit agreement and made a $50 million Special Contribution to 
reduce its underfunding and as part of a program within the pension plan to hedge or fix the expected future contributions that 
will be needed by the Company through the settlement process.  The Company expects to realize income tax benefits on the 
Special Contribution of approximately $11 million.  Administrative costs for the pension plan through the settlement process 
are estimated at $4 to $5 million.

As of December 31, 2021 (and before the Special Contribution), the estimated pension plan underfunding under GAAP 

was $69 million, comprised of investments at fair value of $245 million and a projected benefit obligation (“PBO”) of $314 
million.  The ultimate settlement benefit obligation may differ from the PBO, depending on market factors for buyers of 
pension obligations at the time of settlement.  Pension expense is projected to be approximately $14 million under GAAP in 
2022 and zero for calculating earnings before interest, taxes, depreciation and amortization as defined in the Company’s 
revolving credit agreement (“Credit EBITDA”), which is used to compute certain borrowing ratios. The Company estimates 
that, with the Special Contribution, there will be no required minimum contributions to the pension plan until final settlement.

Total debt was $73.0 million at December 31, 2021, compared to $134.0 million at December 31, 2020.  Net debt (debt in 

excess of cash and cash equivalents), a non-GAAP financial measure, was $42.5 million at December 31, 2021, compared to 
$122.2 million at December 31, 2020.  The year-over-year decline in net debt of $79.7 million includes proceeds of $47.1 
million from the sale of the Company’s investment in kaleo, Inc (“kaléo”). on December 27, 2021.  The Company’s revolving 
credit agreement allows borrowings of up to $375 million and matures in June 2024.  The Company believes that its most 
restrictive covenant (computed quarterly) is the leverage ratio, which permits maximum borrowings of up to 4x Credit 
EBITDA.   The Company had Credit EBITDA and a leverage ratio (calculated in the “Liquidity and Capital Resources” below) 
of $90.0 million and 0.81x, respectively, at December 31, 2021. 

Net capitalization and other credit measures are provided in Liquidity and Capital Resources, below.

Forward-looking and Cautionary Statements

Some of the information contained in this Form 10-K may constitute “forward-looking statements” within the meaning of 

the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995.  When using the words “believe,” 
“estimate,” “anticipate,” “expect,” “project,” “plan,” “likely,” “may” and similar expressions, Tredegar does so to identify 
forward-looking statements.  Such statements are based on Tredegar’s then current expectations and are subject to a number of 
risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking 
statements.  It is possible that Tredegar’s actual results and financial condition may differ, possibly materially, from the 
anticipated results and financial condition indicated in or implied by these forward-looking statements.  In addition, the 
Company's current projections for its businesses could be materially affected by the highly uncertain impact of the COVID-19 
pandemic. As a consequence, the Company's results could differ significantly from its projections, depending on, among other 

17

things, the ultimate impact of the pandemic on employees, supply chains, customers and the U.S. and world economies. 
Accordingly, you should not place undue reliance on these forward-looking statements.  For risks and important factors that 
could cause actual results to differ from expectations, refer to the reports that Tredegar files with or furnishes the SEC from 
time-to-time, including the risks and important factors set forth in Item 1A.  Readers are urged to review and consider carefully 
the disclosures Tredegar makes in the reports Tredegar files with or furnishes to the SEC.  Tredegar does not undertake, and 
expressly disclaims any duty, to update any forward-looking statement to reflect any change in management’s expectations or 
any change in conditions, assumptions or circumstances on which such statements are based, except as required by applicable 
law. 

Critical Accounting Policies and Estimates

The preparation of financial statements in accordance with GAAP requires the Company to make estimates and 
assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures.  Certain 
accounting policies, as described below, are considered "critical accounting policies" because they are particularly dependent on 
estimates made by management about matters that are inherently uncertain and could have a material impact on the Company’s 
consolidated financial statements.  Estimates and judgments are based on historical experience, forecasted events and various 
other assumptions that management believes are reasonable under the circumstances.  Actual results could differ significantly 
from those estimates under different assumptions and conditions.  A summary of all of our significant accounting policies is 
included in Note 1 to the Consolidated Financial Statements in Item 15.

Impairment of Goodwill

The Company assesses goodwill for impairment when events or circumstances indicate that the carrying value may not be 

recoverable, or, at a minimum, on an annual basis (December 1st of each year).  When assessing goodwill for impairment, 
accounting guidance allows the Company to first perform a qualitative assessment about the likelihood of the carrying value of 
a reporting unit exceeding its fair value, referred to as the Step 0 assessment. The Step 0 assessment requires the evaluation of 
certain qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors and overall 
financial performance, as well as company and reporting unit factors. If the Company's Step 0 analysis indicates that it is more 
likely than not that the fair value of a reporting unit is less than the carrying amount, then the Company would perform a 
quantitative impairment test.

As of December 1, 2021, the Company’s reporting units with goodwill were Surface Protection in PE Films and Futura in 

Aluminum Extrusions.  Both of these reporting units have separately identifiable operating net assets (operating assets 
including goodwill and identifiable intangible assets net of operating liabilities).  In addition, 2021 the Company applied the 
Step 0 goodwill assessment to Surface Protection and Futura; both had fair values significantly in excess of their carrying 
amounts when last tested using the quantitative impairment test.  The Company's Step 0 analyses in 2021 of these reporting 
units concluded that it is not more likely than not that the fair values of each reporting unit was less than its carrying amount. 
Therefore, the quantitative goodwill impairment tests for these reporting units were not necessary in 2021.  The Surface 
Protection and Futura reporting units had goodwill in the amounts of $57.3 million and $13.3 million, respectively, at 
December 31, 2021.

Pension Benefits

Tredegar sponsors noncontributory defined benefit (pension) plans that have resulted in varying amounts of net pension 

income or expense, as developed from actuarial valuations.  Inherent in these valuations are key assumptions including discount 
rates and the expected return on plan assets.  The Company is required to consider current market conditions, including changes 
in interest rates and plan asset investment returns, in determining these assumptions.  Actuarial assumptions may differ 
materially from actual results due to changing market and economic conditions, higher or lower withdrawal rates or longer or 
shorter life spans of participants.  These differences may result in a significant impact to the amount of net pension income or 
expense recorded in future periods.

The discount rate is used to determine the present value of future payments.  The discount rate is the single rate that, when 

applied to expected benefit payments, provides a present value equal to the present value of expected benefit payments 
determined by using the AA-rated bond yield curve.  In general, the pension liability increases as the discount rate decreases 
and vice versa.  The weighted average discount rate utilized was 2.90%, 2.57% and 3.27% at the end of 2021, 2020 and 2019, 
respectively, with changes between periods due to changes in market interest rates.  Pay for active participants of the plan was 
frozen as of December 31, 2007.  As of January 31, 2018, the plan no longer accrued benefits associated with crediting 
employees for service, thereby freezing all future benefits under the plan.  On February 10, 2022, Tredegar announced the 
initiation of a process to terminate and settle its frozen defined benefit pension plan, which could take up to 24 months to 
complete.  As the settlement process occurs, the Company expects to recognize a non-cash reclassification adjustment to net 
income or loss of other comprehensive net actuarial losses associated with the pension plan currently reflected directly in 
shareholders’ equity.  Other comprehensive net actuarial losses associated with the pension plan were approximately $109 
million on a pretax basis as of December 31, 2021. 

18

A lower expected return on plan assets increases the amount of expense and vice versa.  Decreases in the level of actual 

plan assets will also serve to increase the amount of pension expense.  The total return on plan assets (net of fees and plan 
expenses), which is primarily affected by the change in fair value of plan assets, current year contributions and current year 
payments to participants, was approximately 10.4% in 2021, 10.9% in 2020 and 11.8% in 2019.  The expected long-term rate 
return of 3.05%, 5.00% and 6.00% in 2021, 2020 and 2019 was developed through consultation with the Company’s investment 
advisors. Several factors were considered, including prevailing and planned strategic asset allocations, current and expected 
future market conditions, inflation-adjusted historical returns, volatilities, risk premiums and managed asset premiums.  The 
Company anticipates that its expected long-term return on plan assets will be 3.05% for 2022.  See Note 8 to the Consolidated 
Financial Statements in Item 15 for more information on expected long-term return on plan assets and asset mix.

See the Executive Summary section above for further discussion regarding the financial impact of the Company’s pension 

plans.

Income Taxes

Current tax liabilities and assets are recognized for the estimated taxes payable or refundable, respectively, on the tax 
returns for the current year. Deferred tax assets and liabilities are determined based on differences between financial reporting 
and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the 
differences are expected to reverse. Accordingly, accounting for income taxes represents the Company’s best estimate of 
various events and transactions. Tax laws are often complex and may be subject to differing interpretations by the taxpayer and 
the relevant governmental taxing authorities. In establishing a provision for income tax expense, Tredegar must make 
judgments and interpretations about the application of tax laws. The Company must also make estimates about when in the 
future certain items will affect taxable income in the various taxing jurisdictions.

A valuation allowance is recorded in the period when the Company determines that it is more likely than not that all or a 
portion of deferred income tax assets may not be realized. The establishment and removal of a valuation allowance requires the 
Company to consider all positive and negative evidence and make a judgmental decision regarding the amount of valuation 
allowance required as of a reporting date.

Tredegar may be required to change its provision for income taxes when estimates used in determining valuation 

allowances on deferred tax assets significantly change, or when new information indicates the need for adjustment in valuation 
allowances. Additionally, future events, such as changes in tax laws, tax regulations, or interpretations of such laws or 
regulations, could have an impact on the provision for income tax and the effective tax rate. Any such changes could 
significantly affect the amounts reported in the financial statements in the year these changes occur.

See Note 12 to the Consolidated Financial Statements in Item 15 for additional information on income taxes.

2021 versus 2020

Results of Operations

Revenues. Sales in 2021 increased by 9.4% compared with 2020.  Net sales increased 18.3% in Aluminum Extrusions primarily 
due to an increase in average selling prices to cover significantly higher aluminum raw material costs and higher operating 
costs, partially offset by lower sales volume.  Net sales decreased 14.6% in PE Films primarily due to lower volume and 
unfavorable mix associated with the previously disclosed customer product transitions in Surface Protection, partially offset by 
higher pricing associated with the pass-through of increased resin costs.  Net sales increased in Flexible Packaging Films by 
4.0% primarily due to higher selling prices from the pass-through of higher resin costs and favorable product mix, partially 
offset by lower sales volume.  For more information on changes in net sales and volume, see the Executive Summary section 
above.

Operating Costs and Expenses. Consolidated gross profit (sales minus cost of goods sold and freight) as a percentage of sales 
(gross profit margin) was 18.0% in 2021 versus 22.6% in 2020.  The gross profit margin in Aluminum Extrusions decreased 
primarily due to higher labor and employee-related costs and other inflationary operating costs such as higher supply expenses, 
partially offset by higher pricing.  The gross profit margin in PE Films decreased primarily due to Surface Protection lower 
sales and unfavorable mix associated with the customer product transitions, lower sales and unfavorable mix for products 
unrelated to customer product transitions, and margin erosion associated with higher resin costs that occurred before the resin 
index pricing plan was fully implemented.  The gross profit margin in Flexible Packaging Films decreased due to lower sales 
volume and higher raw material costs, partially offset by favorable product mix and higher selling prices from the pass-through 
of higher resin costs.  For more information on changes in operating costs and expenses, see the Executive Summary section 
above.

Selling, General and Administrative. As a percentage of sales, selling, general and administrative (“SG&A”) and R&D 
expenses were 9.8% in 2021 compared with 12.3% in 2020.  SG&A and R&D expenses were down year-over-year, while net 
sales increased. Decreased spending is primarily due to non-recurring corporate costs associated with the divested Personal 

19

Care Films business, lower R&D spending in PE Films, lower stock-based compensation, and nonrecurring SG&A expenses 
related to the Bright View Technologies divestiture at the end of 2020.

Plant shutdowns, asset impairments, restructurings and other.  Pre-tax losses associated with plant shutdowns, asset 
impairments, restructurings and other items for continuing operations in 2021 detailed below are shown in the statements of net 
sales and EBITDA from ongoing operations by segment table in Note 13 to the Consolidated Financial Statements in Item 15 
and are included in “Asset impairments and costs associated with exit and disposal activities, net of adjustments” in the 
consolidated statements of income, unless otherwise noted.  A discussion of unrealized gains and losses on investments can also 
be found in Note 16 to the Financial Statements in Item 15 and additional information on restructuring costs can be found in 
Note 17 to the Consolidated Financial Statements in Item 15.

20

($ in millions)
Aluminum Extrusions:

(Gains) losses from sale of assets, investment writedowns and other items:
Consulting expenses for ERP feasibility study1
Futura intangible amortization out-of-period adjustment6
Vacation accrual policy change5
Environmental charges at Newnan, Georgia plant3
COVID-19-related expenses, net of relief 2

Total for Aluminum Extrusions
PE Films:

(Gains) losses associated with plant shutdowns, asset impairments and 
restructurings:

Q1

Q2

Q3

Q4

2021

$  —  $  —  $  —  $  0.3  $  0.3 
(0.9) 
  —    —    —   
(2.9) 
  —    —    —   
0.2 
0.1   
  —    —   
0.1 
0.1   
0.3   
$  (0.2) $  0.3  $  0.2  $  (3.5) $  (3.2) 

(0.9)  
(2.9)  
0.1   
(0.1)  

(0.2)  

Other restructuring costs - severance

$  —  $  —  $  0.1  $  0.3  $  0.4 

(Gains) losses from sale of assets, investment writedowns and other items:
Vacation accrual policy change5
COVID-19-related expenses2

Total for PE Films
Flexible Packaging Films:

(Gains) losses from sale of assets, investment writedowns and other items:

One-time tax credit in Brazil for unemployment/social security insurance non-
income taxes resulting from a favorable decision by Brazil’s Supreme Court 
regarding the calculation of such taxes 2,4
COVID-19-related expenses2
Total for Flexible Packaging Films
Corporate:

(Gains) losses associated with plant shutdowns, asset impairments and 
restructurings:

Costs, net of gain associated with the sale of the Lake Zurich manufacturing 
facility assets
Other restructuring costs - severance

(Gains) losses from sale of assets, investment writedowns and other items:
Professional fees associated with business development activities and other2
Professional fees associated with internal control over financial reporting2
Write-down of investment in Harbinger Capital Partners Special Situations 
Fund2
Stock compensation expense associated with the fair value remeasurement of 
awards granted at the time of the 2020 Special Dividend1
Transition service fees, net of corporate costs associated with the divested 
Personal Care Films business2
Vacation accrual policy change5

  —    —    —   
0.1   

(0.5) 
0.5 
$  0.2  $  0.1  $  0.2  $  (0.1) $  0.4 

(0.5)  
0.1   

0.2   

0.1   

$  —  $  (8.5) $  —  $  —  $  (8.5) 
  —    —    —   
0.1 
$  —  $  (8.5) $  —  $  0.1  $  (8.4) 

0.1   

$  0.2  $  0.2  $  (0.2) $  (0.1) $  0.1 
0.2 
  —    —    —   

0.2   

0.8   
0.2

0.8   
0.9

0.7   
0.8

1.6   
1.2  

3.9 
3.1 

0.1   

0.4    —    —   

0.5 

0.4   

0.1   

(0.1)   —   

0.4 

(0.3)  

(0.3)  

(0.3) 
0.1   
  —    —    —   
(0.4) 
$  1.4  $  2.1  $  1.3  $  2.7  $  7.5 

0.2   
(0.4)  

Total for Corporate
1. Included in “Selling, general and administrative expenses” in the consolidated statements of income.
2. Included in “Other income (expense), net” in the consolidated statements of income.
3. Included in "Costs of goods sold" in the consolidated statements of income.
4. For more information, see Note 9 to the consolidated financial statements in Item 15.
5. For more information, see Note 6 to the consolidated financial statements in Item 15.
6. Included in “Amortization of identifiable intangibles” in the consolidated statements of income.

Interest Expense.  Interest expense, which is net of amounts capitalized and included in property, plant and equipment ($0.1 
million and $0.1 million capitalized in 2021 and 2020, respectively), was $3.4 million in 2021, compared to $2.6 million for 
2020.  Average debt outstanding and interest rates were as follows: 

21

 
 
 
 
 
 
(In millions, except percentages)
Floating-rate debt with interest charged on a rollover basis at one-month LIBOR plus a credit 
spread:

2021

2020

Average outstanding debt balance
Average interest rate

$ 

128.8 

$ 

 1.8 %

33.5 
 2.3 %

Liquidity and Capital Resources

The Company continuously focuses on working capital management.  Measures such as days sales outstanding (“DSO”), 
days inventory outstanding (“DIO”) and days payables outstanding (“DPO”) are used to evaluate changes in working capital.  
Changes in operating assets and liabilities from continuing operations from December 31, 2020 to December 31, 2021 are 
summarized below. Cash flows for discontinued operations have not been separately disclosed in the consolidated statements of 
cash flows.

•

Accounts and other receivables increased $17.0 million or 19.7%.

◦

◦

◦

Accounts and other receivables in Aluminum Extrusions increased by $17.1 million primarily due to an increase in 
average selling prices to cover significantly higher aluminum raw material costs and higher operating costs, partially 
offset by lower sales volume and improved collection efforts in 2021.  DSO (computed using trailing 12 months net 
sales and a rolling 12-month average of accounts and other receivables balances) was approximately 47.6 days in 
2021 and 47.5 days in 2020.

Accounts and other receivables in PE Films decreased by $0.6 million primarily due to lower volume and unfavorable 
mix associated with the previously disclosed customer product transitions in Surface Protection, partially offset by 
higher pricing associated with the pass-through of increased resin costs.  DSO was approximately 28.5 days in 2021 
and 30.2 days in 2020. 

Accounts and other receivables in Flexible Packaging Films increased by $1.3 million primarily due to higher selling 
prices from the pass-through of higher resin costs and favorable product mix, partially offset by lower sales volume.  
DSO was approximately 40.0 days in 2021 and 41.0 days in 2020.

•

Inventories increased $22.1 million or 33.3%.

◦

◦

◦

Inventories in Aluminum Extrusions increased by $17.4 million primarily due to higher average aluminum prices and 
COVID-19-related operational and production inefficiencies.  DIO (computed using trailing 12 months costs of goods 
sold calculated on a first in, first out basis and a rolling 12-month average of inventory balances calculated on the 
first-in, first-out basis) was approximately 41.4 days in 2021 and 39.3 days in 2020.

Inventories in PE Films decreased by $2.1 million primarily due to lower planned raw material levels as a result of 
lower sales volume in 2021 compared to 2020.  DIO was approximately 62.8 days in 2021 and 59.2 days in 2020.

Inventories in Flexible Packaging Films increased by $6.8 million primarily related to higher average resin prices, 
higher finished good levels due to lower than anticipated sales demand and higher planned raw material levels due to 
resin supply issues.  DIO was approximately 93.1 days in 2021 and 89.4 days in 2020. 

• Net property, plant and equipment increased by $3.8 million (2.3%) primarily due to capital expenditures of $27.8 million, 

partially offset by depreciation expense of $22.1 million and a reduction from the effect of changes in foreign exchange rates 
of $0.8 million.

• Goodwill and identifiable intangible assets, net decreased by $1.8 million (2.0%) primarily due to amortization expense.

• Accounts payable increased by $34.1 million or 38.0%.

◦

◦

◦

Accounts payable in Aluminum Extrusions increased by $23.7 million, primarily due to higher average aluminum 
prices and favorable payment terms with certain vendors.  DPO (computed using trailing 12 months costs of goods 
sold calculated on a first in, first out basis and a rolling 12-month average of accounts payable balances) was 
approximately 60.1 days in 2021 and 53.1 days in 2020.

Accounts payable in PE Films increased by $4.4 million primarily due to higher resin costs related to raw material 
purchases in 2021.  DPO was approximately 44.0 days in 2021 and 36.8 days in 2020.

Accounts payable in Flexible Packaging Films increased by $6.7 million, primarily due to higher resin costs related to 
raw material purchases in 2021 and favorable payment terms with certain vendors.  DPO was approximately 68.2 
days in 2021 and 61.7 days in 2020.

22

Net cash provided by operating activities was $70.6 million in 2021 compared to $74.4 million in 2020.  The decrease was 

primarily due to higher net working capital ($13.8 million), partially offset by lower pension and postretirement benefit plan 
contributions ($7.0 million) and lower operating lease payments ($1.1 million) in 2021 compared to 2020.

Net cash provided by investing activities was $24.5 million in 2021 compared to $32.9 million in 2020.  The decrease was 

primarily due to higher capital expenditure spending of $4.0 million in 2021 and cash proceeds from the sale of Personal Care 
Films ($55.1 million) and Bright View Technologies ($1.1 million) in 2020, partially offset by cash proceeds received in 2021 
in connection with the sale of the Company’s investment in kaléo ($47.1 million) and the sale of the Lake Zurich manufacturing 
facility assets ($4.7 million).

Net cash used in financing activities was $76.8 million in 2021 compared to $125.6 million in 2020.  The decrease was 

primarily due to a special dividend of $200 million paid to shareholders in 2020, partially offset by higher net borrowings 
($153.0 million) in 2020 under the Credit Agreement (as defined below).

The Company believes that existing borrowing availability, current cash balances and cash flow from operations will be 
sufficient to satisfy short term material cash requirements related to working capital, capital expenditure, debt repayments and 
dividend requirements for at least the next twelve months. In the longer term, liquidity will depend on many factors, including 
results of operations, the timing and extent of capital expenditures, changes in operating plans, or other events that would cause 
the Company to seek additional financing in future periods.

At December 31, 2021, Tredegar had cash and cash equivalents of $30.5 million, including funds held in locations outside 

the U.S. of $16.4 million.   

Tredegar has a five-year secured revolving credit agreement (the “Credit Agreement”) providing for aggregate borrowings 

in an amount of $375 million, which matures in June 2024. 

Net capitalization and indebtedness as defined under the Credit Agreement as of December 31, 2021 were as follows: 

Net Capitalization and Indebtedness as of December 31, 2021
(In thousands)

Net capitalization:

Cash and cash equivalents
Debt:

Credit Agreement

Debt, net of cash and cash equivalents
Shareholders’ equity
Net capitalization

Indebtedness as defined in Credit Agreement:

Total debt
Indebtedness

$ 

30,521 

73,000 
42,479 
184,722 
227,201 

73,000 
73,000 

$ 

$ 
$ 

The credit spread and commitment fees charged on the unused amount under the Credit Agreement at various 

indebtedness-to-Credit EBITDA levels are as follows:

Pricing Under Credit Agreement (Basis Points)

Indebtedness-to-Credit EBITDA Ratio
> 3.5x but <= 4.0x
> 3.0x but <= 3.5x
> 2.0x but <= 3.0x
> 1.0x but <= 2.0x
<= 1.0x

Credit Spread
Over LIBOR
200.0 
187.5 
175.0 
162.5 
150.0 

Commitment
Fee

40 
35 
30 
25 
20 

At December 31, 2021, the interest rate on debt under the Credit Agreement existing at that date was priced at one-month 

LIBOR plus the applicable credit spread of 150.0 basis points.  

The most restrictive covenants in the Credit Agreement include:

• Maximum indebtedness-to-Credit EBITDA (“Leverage Ratio”) of 4.00x;

• Minimum Credit EBITDA-to-interest expense of 3.00x; and

23

 
 
 
 
 
 
 
 
 
 
 
 
 
• Maximum aggregate distributions to shareholders over the remaining term of the Credit Agreement of $75 million; 

provided, that if the Leverage Ratio of equal to or greater than 3.00x, a limitation on such payments for the succeeding 
quarter at the greater of (i) $4.75 million and (ii) 50% of consolidated net income for the most recent fiscal quarter. 

The Credit Agreement is secured by substantially all of the Company’s and its domestic subsidiaries’ assets, including 

equity in certain material first-tier foreign subsidiaries.  At December 31, 2021, based upon the most restrictive covenant within 
the Credit Agreement, available credit under the Credit Agreement was approximately $287 million.  Total debt outstanding 
was $73 million and $134 million as of December 31, 2021 and 2020, respectively.  

The computations of Credit EBITDA, the leverage ratio and interest coverage ratio as defined in the Credit Agreement are 

presented below along with the related most restrictive covenants.  Credit EBITDA as defined in the Credit Agreement is not 
intended to represent net income or cash flow from operations as defined by GAAP and should not be considered as either an 
alternative to net income or to cash flow.

24

Computations of Credit EBITDA, Leverage Ratio and Interest Coverage Ratio as Defined in the Credit Agreement Along 
with Related Most Restrictive Covenants
As of and for the Twelve Months Ended December 31, 2021 (In thousands)

Computations of Credit EBITDA as defined in Credit Agreement for the twelve months ended December 31, 2021

Net income (loss)
Plus:

After-tax losses related to discontinued operations
Total income tax expense for continuing operations
Interest expense
Depreciation and amortization expense for continuing operations
All non-cash losses and expenses, plus cash losses and expenses not to exceed $10,000, for continuing 
operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset 
impairments and/or restructurings (cash-related of $8,999)
Charges related to stock option grants and awards accounted for under the fair value-based method
Losses related to the application of the equity method of accounting
Losses related to adjustments in the estimated fair value of assets accounted for under the fair value 
method of accounting

Minus:

After-tax income related to discontinued operations
Total income tax benefits for continuing operations
Interest income
All non-cash gains and income, plus cash gains and income in excess of $10,000, for continuing 
operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset 
impairments and/or restructurings
Income related to changes in estimates for stock option grants and awards accounted for under the fair 
value-based method
Income related to the application of the equity method of accounting
Income related to adjustments in the estimated fair value of assets accounted for under the fair value 
method of accounting

Plus cash dividends declared on investments in an amount not to exceed $10,000 for such period
Plus or minus, as applicable, pro forma EBITDA adjustments associated with acquisitions and asset 
dispositions
Plus or minus, as applicable, pro forma EBITDA adjustments to pension expense associated with the early 
payment of pension obligations
Credit EBITDA as defined in Credit Agreement

Computations of leverage and interest coverage ratios as defined in Credit Agreement at December 31, 2021:

Leverage ratio (indebtedness-to-Credit EBITDA)
Interest coverage ratio (Credit EBITDA-to-interest expense)

Most restrictive covenants as defined in Credit Agreement:

Available balance of maximum permitted aggregate amount of dividends that can be paid by Tredegar 
during the remaining term of the Credit Agreement ($75,000 minus $20,187 of dividends paid after 
December 1, 2020)
Maximum leverage ratio permitted
Minimum interest coverage ratio permitted

$ 

57,826 

111 
9,284 
3,386 
23,784 

9,553 
2,495 
— 

— 

— 
— 
(73) 

(3,859) 

— 
— 

(12,780) 
318 

— 

— 
90,045 

$ 

0.81x
26.59x

$ 

54,813 
4.00x
3.00x

Tredegar was in compliance with all of its debt covenants as of December 31, 2021.  Noncompliance with any of the debt 
covenants may have a material adverse effect on its financial condition or liquidity, in the event such noncompliance cannot be 
cured or should the Company be unable to obtain a waiver from the lenders.  Renegotiation of the covenant through an 
amendment to the Credit Agreement may effectively cure the noncompliance, but may have an effect on its financial condition 
or liquidity depending upon how the covenant is renegotiated.

25

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Material Cash Requirements for Known Contractual and Other Obligations

The Company’s material cash requirements from known contractual and other obligations as of December 31, 2021 were 

as follows:

Long-term debt and interest payments

As of December 31, 2021, the Company had outstanding debt of $73.0 million with contractual payments due in June 
2024.  Estimated future interest payments associated with outstanding debt total $3.2 million, with $1.3 million payable within 
the next 12 months.

Pension and other postretirement obligations

On February 10, 2022, Tredegar announced the initiation of a process to terminate and settle its frozen defined benefit 

pension plan, which could take up to 24 months to complete.  In connection therewith, on February 9, 2022, the Company 
borrowed funds under its revolving credit agreement and contributed a $50 million Special Contribution to the pension plan to 
reduce its underfunding and as part of a program within the pension plan to hedge or fix the expected future contributions that 
will be needed by the Company through the settlement process.  The Company estimates that, with the Special Contribution, 
there will be no required minimum contributions to the pension plan until final settlement.  Tredegar has determined that it is 
not practicable to estimate additional cash requirements beyond 2022 as the ultimate settlement of the benefit obligation may 
differ from the projected benefit obligation of $314 million as of December 31, 2021.  

In addition to providing pension benefits, the Company provides postretirement life insurance and health care benefits for 

certain groups of employees.  As of December 31, 2021, the aggregate benefit obligation for the Company’s other post 
retirement plans was $7.4 million, of which the Company expects to pay $0.5 million in the next 12 months.

Capital expenditure commitments

See “Projected Capital Expenditures and Depreciation & Amortization” within “Operations Overview” above in this Item 
7 for discussion of the Company’s planned investment in capital expenditures in 2022, a portion of which represents contractual 
commitments that existed as of December 31, 2021. 

Operating Leases

The Company enters into various operating leases primarily for real estate, office equipment and vehicles.  See Note 4 to 

the consolidated financial statements for additional information.

Uncertain Tax Positions

As of December 31, 2021, unrecognized tax benefits on uncertain tax positions were $0.6 million.  Tax payments 
resulting from the successful challenge by the taxing authority on uncertain tax positions taken by Tredegar would possibly 
result in the payment of estimated interest and penalties of $0.1 million if tax payments were made as a result of a successful 
challenge by the taxing authority on uncertain tax positions.  Due to uncertainties in the timing of potential tax audits, the 
timing of the resolution of these positions is uncertain.  Therefore, the Company is unable to make a reasonably reliable 
estimate of the timing of payments beyond 12 months.  See Note 12 to the Consolidated Financial Statements in Item 15 for 
additional information.

Off-Balance Sheet Arrangements

The Company has no material off-balance sheet arrangements that have had or are reasonably likely to have a material 
current or future effect on its financial condition, changes in financial condition, revenues or expenses, results of operations, 
liquidity, capital expenditures or capital resources.

From time to time, the Company enters into transactions with third parties in connection with the sale of assets or 
businesses in which it agrees to indemnify the buyers or third parties involved in the transaction, or the sellers or third parties 
involved in the transaction agree to indemnify Tredegar, for certain liabilities or risks related to the assets or business.  Also, in 
the ordinary course of business, the Company may enter into agreements with third parties for the sale of goods or services that 
may contain indemnification provisions.  In the event that an indemnification claim is asserted, liability for indemnification 
would be subject to an assessment of the underlying facts and circumstances under the terms of the applicable agreement.  
Further, any indemnification payments may be limited or barred by a monetary cap, a time limitation, or a deductible or basket.  
For these reasons, the Company is unable to estimate the maximum potential amount of the potential future liability under the 
indemnity provisions of these agreements.  Tredegar does, however, accrue for losses for any known contingent liability, 
including those that may arise from indemnification provisions, when future payment is probable and the amount is reasonably 
estimable.  The Company discloses contingent liabilities if the probability of loss is reasonably possible and material.

26

Quantitative and Qualitative Disclosures about Market Risk

Tredegar has exposure to the volatility of interest rates, polyethylene and polypropylene resin prices, PTA and MEG 

prices, aluminum ingot and scrap prices, energy prices, foreign currencies and emerging markets. See Liquidity and Capital 
Resources regarding interest rate exposures related to borrowings under the Credit Agreement.

Profit margins in Aluminum Extrusions are sensitive to fluctuations in aluminum ingot and scrap prices as well as natural 
gas prices (natural gas is the principal energy source used to operate its casting furnaces). Changes in polyethylene resin prices 
and the timing of those changes could have a significant impact on profit margins in PE Films. Changes in polyester resin, PTA 
and MEG prices, and the timing of those changes, could have a significant impact on profit margins in Flexible Packaging 
Films. There is no assurance of the Company’s ability to pass through higher raw material and energy costs to its customers.

In the normal course of business, Aluminum Extrusions enters into fixed-price forward sales contracts with certain 
customers for the sale of fixed quantities of aluminum extrusions at scheduled intervals. In order to hedge its exposure to 
aluminum price volatility (see the chart below) under these fixed-price arrangements, which generally have a duration of not 
more than 12 months, the Company enters into a combination of forward purchase commitments and futures contracts to 
acquire or hedge aluminum, based on the scheduled deliveries. See Note 10 to the Consolidated Financial Statements in Item 15 
for additional information.

The volatility of quarterly average aluminum prices is shown in the chart below.

Quarterly Average Price of Aluminum
(U.S. Midwest Transaction Price - Cents Per Pound)

94

96

105

99

124

112

114

109

104

100

98

95

90

100

90

77

77

79

80

85

153

155

135

111

1st Qtr. 2016

2nd Qtr. 2016

3rd Qtr. 2016

4th Qtr 2016

1st Qtr. 2017

2nd Qtr. 2017

3rd Qtr. 2017

4th Qtr 2017

1st Qtr. 2018

2nd Qtr. 2018

3rd Qtr. 2018

4th Qtr 2018

1st Qtr. 2019

2nd Qtr. 2019

3rd Qtr. 2019

4th Qtr 2019

1st Qtr. 2020

2nd Qtr. 2020

3rd Qtr. 2020

4th Qtr 2020

1st Qtr. 2021

2nd Qtr. 2021

3rd Qtr. 2021

4th Qtr 2021

   Source:  Quarterly averages computed by the Company using daily Midwest average prices provided by Platts.

27

The volatility of quarterly average natural gas prices is shown in the chart below.

Quarterly Average Price of Natural Gas
(NYMEX Settlement Prices - $ Per mmBtu)

2.81

2.98

3.32 3.18

3.00

2.93

3.00

2.80

2.90

3.64

3.15

2.09

1.95

2.64

2.23

2.50

1.95

1.72 1.98

2.66

2.69

2.83

5.83

4.01

1st Qtr. 2016

2nd Qtr. 2016

3rd Qtr. 2016

4th Qtr 2016

1st Qtr. 2017

2nd Qtr. 2017

3rd Qtr. 2017

4th Qtr 2017

1st Qtr. 2018

2nd Qtr. 2018

3rd Qtr. 2018

4th Qtr 2018

1st Qtr. 2019

2nd Qtr. 2019

3rd Qtr. 2019

4th Qtr 2019

1st Qtr. 2020

2nd Qtr. 2020

3rd Qtr. 2020

4th Qtr 2020

1st Qtr. 2021

2nd Qtr. 2021

3rd Qtr. 2021

4th Qtr 2021

    Source:  Quarterly averages computed by Tredegar using monthly NYMEX settlement prices.

The volatility of average quarterly prices of polyethylene resin in the U.S. (a primary raw material for PE Films products) 

is shown in the chart below:

Quarterly Average U.S. Large Buyer Price for Polyethylene Resin
(Cents Per Pound)

119

109

109

77

77

79

81

83

75

68

90

90

91

90

89

88

85

84

83

88

73

66

55

53

51

1st Qtr. 2016

2nd Qtr. 2016

3rd Qtr. 2016

4th Qtr 2016

1st Qtr. 2017

2nd Qtr. 2017

3rd Qtr. 2017

4th Qtr 2017

1st Qtr. 2018

2nd Qtr. 2018

3rd Qtr. 2018

4th Qtr 2018

1st Qtr. 2019

2nd Qtr. 2019

3rd Qtr. 2019

4th Qtr 2019

1st Qtr. 2020

2nd Qtr. 2020

3rd Qtr. 2020

4th Qtr 2020

1st Qtr. 2021

2nd Qtr. 2021

3rd Qtr. 2021

4th Qtr 2021

Source: Quarterly averages computed by Tredegar using monthly data provided by IHS, Inc. In February 2020, IHS reflected a 32 cents per pound non-market adjustment based 
on their estimate of the growth of discounts in prior periods. The 4th quarter 2019 average rate of $0.51 per pound is shown on a pro forma basis as if the non-market adjustment 
was made in the fourth quarter of 2019.

The price of resin is driven by several factors, including supply and demand and the price of oil, ethylene and natural gas. 

Selling prices to customers are set considering numerous factors, including the expected volatility of resin prices. In certain 
situations, PE Films has index-based pass-through raw material cost arrangements with customers. However, under certain 
agreements, changes in resin prices are not passed through for a period of 90 days or more. In response to unprecedented cost 
increases and supply issues for polyethylene and polypropylene resin, Tredegar Surface Protection implemented a quarterly 
resin cost pass-through mechanism, effective July 1, 2021, for all products and customers not previously covered by such 
arrangements.  Pricing on the remainder of the business is based upon raw material costs and supply/demand dynamics within 
the markets that the Company competes.

Polyester resins, MEG and PTA used in flexible packaging films produced in Brazil are primarily purchased domestically, 

with other sources available mostly from Asia and the U.S. Given the nature of these products as commodities, pricing is 

28

derived from Asian pricing indexes. The volatility of the average quarterly prices for polyester fibers in Asia, which is 
representative of polyester resin (a primary raw material for Flexible Packaging Films) pricing trends, is shown in the chart 
below:

Quarterly Average Asian Buyer Price for Polyester Fiber
(Cents per Pound)

45

43

44

46

49

51

54

53

47

45

37

39

38

39

40

36

34

26

26

28

40

37

42

43

1st Qtr. 2016

2nd Qtr. 2016

3rd Qtr. 2016

4th Qtr 2016

1st Qtr. 2017

2nd Qtr. 2017

3rd Qtr. 2017

4th Qtr 2017

1st Qtr. 2018

2nd Qtr. 2018

3rd Qtr. 2018

4th Qtr 2018

1st Qtr. 2019

2nd Qtr. 2019

3rd Qtr. 2019

4th Qtr 2019

1st Qtr. 2020

2nd Qtr. 2020

3rd Qtr. 2020

4th Qtr 2020

1st Qtr. 2021

2nd Qtr. 2021

3rd Qtr. 2021

4th Qtr 2021

   Source:  Quarterly averages computed by Tredegar using monthly data from CMAI Global Index data.

The volatility of average quarterly prices of PTA and MEG in Asia (raw materials used in the production of polyester 

resins produced by Flexible Packaging Films) is shown in the chart below:

Quarterly Average Asian Buyer Price for Terephthalic Acid and Monoethlyene Glycol
(Cents Per Pound)

70
65
60
55
50
45
40
35
30
25
20

1st Qtr. 2016

2nd Qtr. 2016

3rd Qtr. 2016

4th Qtr 2016

1st Qtr. 2017

2nd Qtr. 2017

3rd Qtr. 2017

4th Qtr 2017

1st Qtr. 2018

2nd Qtr. 2018

3rd Qtr. 2018

4th Qtr 2018

1st Qtr. 2019

2nd Qtr. 2019

3rd Qtr. 2019

4th Qtr 2019

1st Qtr. 2020

2nd Qtr. 2020

3rd Qtr. 2020

4th Qtr 2020

1st Qtr. 2021

2nd Qtr. 2021

3rd Qtr. 2021

4th Qtr 2021

Monoethylene Glycol Fiber Grade (Cents/Lb)

Terephthalic Acid (Cents/Lb)

  Source:  Quarterly averages computed by Tredegar using monthly data from CMAI Global Index data.

29

The Company sells to customers in foreign markets through its foreign operations and through exports from U.S. plants.  
The percentage of sales and total assets for manufacturing operations related to foreign markets for 2021, 2020 and 2019 are as 
follows:

Tredegar Corporation
Percentage of Net Sales and Total Assets Related to Foreign Markets*

2021

% of Total
Net Sales

Exports
From
U.S.

2 
1 
1 
7 
11 

Foreign 
Operations
— 
— 
12 
— 
12 

2020

% of Total
Net Sales

Exports
From
U.S.

2 
1 
  — 
11 
14 

Foreign 
Operations
— 
— 
13 
— 
13 

% Total
Assets - 
Foreign 
Operations
— 
— 
10 
3 
13 

2019

% of Total
Net Sales

Exports
From
U.S.

2 
1 
1 
10 
14 

Foreign 
Operations
— 
— 
12 
— 
12 

% Total
Assets - 
Foreign
Operations
— 
— 
10 
4 
14 

% Total
Assets -
Foreign
Operations
— 
— 
7 
3 
10 

Canada
Europe
Latin America
Asia

Total

*

The percentages for foreign markets are relative to Tredegar’s consolidated net sales and total assets .

Tredegar attempts to match the pricing and cost of its products in the same currency and generally views the volatility of 

foreign currencies and the corresponding impact on earnings and cash flow as part of the overall risk of operating in a global 
environment (for additional information, see trends for the Brazilian Real and Chinese Yuan in the charts on the following 
page). Exports from the U.S. are generally denominated in U.S. Dollars. The Company’s foreign currency exposure on income 
from continuing foreign operations relates to the Chinese Yuan and the Brazilian Real.

PE Films is generally able to match the currency of its sales and costs for its product lines. For flexible packaging films 
produced in Brazil, selling prices and key raw material costs are principally determined in U.S. Dollars and are impacted by 
local economic conditions and local and global competitive dynamics. Flexible Packaging Films is exposed to foreign exchange 
translation risk (its functional currency is the Brazilian Real) because almost 90% of the sales of Flexible Packaging Films 
business unit in Brazil (“Terphane Ltda.”) and substantially all of its related raw material costs are quoted or priced in U.S. 
Dollars while its variable conversion, fixed conversion and sales, general and administrative costs before depreciation & 
amortization (collectively “Terphane Ltda. Operating Costs”) are quoted or priced in Brazilian Real. This mismatch, together 
with a variety of economic variables impacting currency exchange rates, causes volatility that could negatively or positively 
impact EBITDA from ongoing operations for Flexible Packaging Films.

The Company estimates annual net costs of R$150 million for the net mismatch translation exposure between Terphane 

Ltda.’s U.S. Dollar quoted or priced sales and raw material costs and underlying Brazilian Real quoted or priced Terphane Ltda. 
Operating Costs. Terphane Ltda. has outstanding foreign exchange average forward rate contracts to purchase Brazilian Real 
and sell U.S. Dollars to hedge its exposure. See Note 10 to the Consolidated Financial Statements in Item 15 for more 
information on outstanding hedging contracts and this hedging program.

Tredegar estimates that the change in the value of foreign currencies relative to the U.S. Dollar on PE Films had a 

favorable impact on EBITDA from ongoing operations in PE Films of $0.3 million in 2021 compared to 2020 and an 
unfavorable impact on EBITDA from ongoing operations of $0.7 million in 2020 compared with 2019.

30

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trends for the Brazilian Real and Chinese Yuan are shown in the chart below: 

Quarterly Avg. Exchange Rates of Brazilian Real & Chinese Yuan Relative to the U.S.
Dollar

0.80

0.60

0.40

0.20

0.1700

0.1600

0.1500

0.1400

0.1300

0.1200

0.1100

1st Qtr. 2016
2nd Qtr. 2016

3rd Qtr. 2016

4th Qtr 2016

1st Qtr. 2017
2nd Qtr. 2017

3rd Qtr. 2017

4th Qtr 2017

1st Qtr. 2018
2nd Qtr. 2018

3rd Qtr. 2018

4th Qtr 2018

1st Qtr. 2019
2nd Qtr. 2019

3rd Qtr. 2019

4th Qtr 2019

1st Qtr. 2020
2nd Qtr. 2020

3rd Qtr. 2020

4th Qtr 2020

1st Qtr. 2021
2nd Qtr. 2021

3rd Qtr. 2021

4th Qtr 2021

Quarterly Average of U.S. Dollar Equivalent of 1 Brazilian Real (Left Axis)
Quarterly Average of U.S. Dollar Equivalent of 1 Chinese Yuan (Right Axis)

    Source:  Quarterly averages computed by Tredegar using daily closing data provided by Bloomberg.

31

Item 7A.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

See discussion of Quantitative and Qualitative Disclosures about Market Risk in Item 7.

Item 8. 

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The information required by this Item 8 is set forth in Item 15 and is hereby incorporated herein by reference.

Item 9. 

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND 
FINANCIAL DISCLOSURE 

None.

Item 9A.

CONTROLS AND PROCEDURES

On November 1, 2018, the Company filed a Current Report on Form 8-K (the “November 2018 Form 8-K”) to disclose 

deficiencies in internal control over financial reporting. For further information, see the November 2018 Form 8-K and Item 4. 
“Controls and Procedures” of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 
2018.  See Item 1A. “Risk Factors” of this Form 10-K for risks and uncertainties associated with management’s report on 
internal control over financial reporting as of and for the year ended December 31, 2021.

Evaluation of Disclosure Controls and Procedures

In connection with the preparation of this Form 10-K, pursuant to Rule 13a-15(b) under the Securities Exchange Act of 

1934, as amended (the “Exchange Act”), the Company carried out an evaluation with the participation of its management, 
including its Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer), of 
the effectiveness of the design and operation of our disclosure controls and procedures (as defined under Rule 13a-15(e) and 
15d-15(e) under the Exchange Act) as of December 31, 2021.

Based on this evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that, because of 

the material weaknesses in internal control over financial reporting discussed below, the Company’s disclosure controls and 
procedures were not effective as of December 31, 2021, to ensure: (i) that information required to be disclosed by the Company 
in the reports that it files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time 
periods specified in the SEC’s rules and forms, and (ii) that such information is accumulated and communicated to 
management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions 
regarding required disclosure.

Management’s Report on Internal Control Over Financial Reporting

The Company’s management is responsible for establishing and maintaining adequate internal control over financial 

reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. The Company’s internal control 
over financial reporting is a process designed by or under the supervision of the Company’s Chief Executive Officer and Chief 
Financial Officer, and overseen by the Board of Directors, to provide reasonable assurance regarding the reliability of financial 
reporting and the preparation of financial statements for external purposes in accordance with GAAP and includes policies and 
procedures that:

•

•

•

Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and 
dispositions of the Company’s assets;

Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements 
in accordance with GAAP, and that the Company’s receipts and expenditures are being made only in accordance with 
the authorization of its management and directors; and

Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition 
of the Company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting is not intended to provide absolute assurance 

that a misstatement of the Company’s consolidated financial statements would be prevented or detected. Also, projections of 
any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes 
in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that 
there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented 
or detected on a timely basis.

32

Management conducted an evaluation of the effectiveness of the Company’s internal control over financial reporting 
using the criteria in Internal Control - Integrated Framework 2013 issued by the Committee of Sponsoring Organizations of the 
Treadway Commission (the “2013 COSO Framework”). As a result of this evaluation, management concluded that the 
Company’s internal control over financial reporting was not effective as of December 31, 2021, because of the material 
weaknesses in internal control over financial reporting discussed below.

•

•

•

Control Environment: The Company did not have a sufficient number of trained resources with assigned 
responsibility and accountability for the design, operation and documentation of internal control over financial 
reporting in accordance with the 2013 COSO Framework.

Risk Assessment: The Company did not have an effective risk assessment process to identify and evaluate at a 
sufficient level of detail all relevant risks of material misstatement, including fraud risks.

Information and Communication: The Company did not have an effective information and communication process 
that identified and assessed the source of and controls necessary to ensure the reliability of information used in 
financial reporting and that communicates relevant information about roles and responsibilities for internal control 
over financial reporting.

• Monitoring Activities: The Company did not have effective monitoring activities to assess the operation of internal 

control over financial reporting, including the continued appropriateness of control design and level of documentation 
maintained to support control effectiveness.

•

Control Activities: As a consequence of the material weaknesses described above, internal control deficiencies related 
to the design and operation of process-level controls and general information technology controls were determined to 
be pervasive throughout the Company’s financial reporting processes.

While these material weaknesses did not result in material misstatements of the Company’s consolidated financial 
statements as of and for the year ended December 31, 2021, these material weaknesses create a reasonable possibility that a 
material misstatement of account balances or disclosures in annual or interim consolidated financial statements may not be 
prevented or detected in a timely manner. Accordingly, the Company concluded that the deficiencies represent material 
weaknesses in its internal control over financial reporting and its internal control over financial reporting was not effective as of 
December 31, 2021.

The Company’s independent registered public accounting firm, KPMG LLP, which audited the 2021 consolidated 
financial statements included in this Form 10-K, has expressed an adverse opinion on the operating effectiveness of the 
Company's internal control over financial reporting.  KPMG LLP’s report appears on page 40 of this Form 10-K.

Remediation Plan and Efforts to Address the Previously Identified Material Weaknesses

To remediate the material weaknesses described above, the Company, with the oversight of the Audit Committee of the 

Board of Directors (the “Audit Committee”), has been pursuing the six remediation steps as originally identified in the 
Company’s Annual Report on Form 10-K for the year ended December 31, 2018. The Company’s remediation plan was 
designed with the assistance of management’s outside consultant, an internationally recognized accounting firm. The Company 
continues to work with its outside consultant to assist in completing the remediation plan and believes that its remediation plan 
will be sufficient to remediate the identified material weaknesses and strengthen its internal control over financial reporting. As 
the Company continues to evaluate, and works to improve, its internal control over financial reporting, management may 
determine that additional measures to address control deficiencies or modifications to the remediation plan are necessary.

Through the fourth quarter of 2021, the Company has completed certain steps in its remediation plan, including:

for certain processes, developed new and revised existing process narratives and identified risks of material 
misstatement inherent to those processes;

developed new controls and revised the design of existing controls for a significant number of relevant key controls to 
mitigate the aforementioned risks, inclusive of general information technology controls and entity-level controls;  

conducted initial organization-wide training sessions with all control owners;

increased resources in the Company’s internal audit function and created and staffed a controls compliance group 
charged with monitoring and facilitating compliance with the Company’s responsibilities under the Sarbanes Oxley 
Act of 2002 (“SOX”); and

implemented a software solution to assist in monitoring and documenting compliance with SOX.

•

•

•

•

•

The following remaining activities are scheduled for completion in the first half of 2022 in anticipation of conducting 
management’s testing that will begin in the first half of 2022 in support of issuing management’s assessment of internal control 
over financial reporting as of December 31, 2022:

•

completion of the identification of risks arising from inappropriate segregation of duties and fraud risks;

33

•

•

•

•

completion of risk assessment and control design for the remaining populations of processes and controls;

implementation of controls across all financial reporting processes and information technology environments;

ongoing training with control owners, as necessary; and

ongoing migration of certain components of a legacy information technology system onto a common information 
technology environment, including risk assessment, control design and implementation of new and revised controls.

The Company continues to monitor the impact of employee turnover, the COVID-19 pandemic and other external factors 

on its remediation plan and its assessment of internal control over financial reporting. The material weaknesses cannot be 
considered remediated until the applicable controls have operated for a sufficient period of time and management has 
concluded, through testing, that these controls are operating effectively. The Company cannot assure you when it will remediate 
the identified material weaknesses, nor can it be certain whether additional actions will be required. Moreover, the Company 
cannot assure you that additional material weaknesses will not arise in the future.

Changes in Internal Control Over Financial Reporting

The Company is in the process of making certain changes in its internal controls to remediate the material weaknesses as 
described above. The execution of the material aspects of this plan began in the second quarter of 2019. Except as noted above 
with respect to the completion of certain steps in the remediation plan, there has been no change in the Company’s internal 
control over financial reporting during the quarter ended December 31, 2021, that has materially affected, or is reasonably 
likely to materially affect, its internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the 
Exchange Act).

Item 9B.  OTHER INFORMATION

None.

Item 9C.  DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

None.

34

PART III

Item 10. 

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The information concerning directors and persons nominated to become directors of Tredegar to be included in the Proxy 
Statement under the headings “Proposal 1: Election of Directors” and “Tredegar’s Board of Directors” is incorporated herein by 
reference. 

The information concerning corporate governance to be included in the Proxy Statement under the headings “Board 
Meetings, Meetings of Non-Management Directors and the Board Committees” and “Corporate Governance” is incorporated 
herein by reference.

Set forth below are the names, ages and titles of the Company’s executive officers:

Name
John M. Steitz
D. Andrew Edwards
Kevin C. Donnelly

Age Title
  63  President and Chief Executive Officer
  63  Executive Vice President and Chief Financial Officer
  47  Vice President, General Counsel and Corporate Secretary

John M. Steitz.  Mr. Steitz was elected President and Chief Executive Officer effective March 19, 2019.  He previously served 
as President and Chief Executive Officer of Addivant Corporation, a leading global supplier of antioxidants, intermediates, 
inhibitors, modifiers, UV stabilizers and other additives to the plastic and rubber industries, from March 2015 until January 
2019, as President and Chief Operating Officer of PQ Corporation, a leading worldwide producer of specialty inorganic 
performance chemicals and catalysts, from October 2013 until March 2015, as President and Chief Executive Officer of 
Avantor Performance Materials, a global supplier of ultra-high-purity life sciences materials with strict regulatory and 
performance specifications, from September 2012 until September 2013, as President and Chief Operating Officer of Albemarle 
Corporation, a global specialty chemicals company, from March 2012 until August 2012, and as Chief Operating Officer and 
Executive Vice President of Albemarle from April 2007 until March 2012.

D. Andrew Edwards.  Mr. Edwards was named Executive Vice President and Chief Financial Officer effective August 6, 
2020. Mr. Edwards served as Vice President and Chief Financial Officer from July 20, 2015 until August 2020.  He previously 
served as the Chief Financial Officer of United Sporting Companies, Inc., a wholesale distributor of outdoor sporting goods, 
from February 2013 until July 2015 and as Vice President, Controller and Chief Accounting Officer of Owens & Minor, Inc., a 
distributor of acute medical products, from April 2010 to February 2013 and as Acting Chief Financial Officer of Owens & 
Minor, Inc. from March 2012 to February 2013.  Mr. Edwards also served as Vice President, Finance, of Owens & Minor, Inc. 
from December 2009 until April 2010.  Mr. Edwards previously served as the Company’s Vice President, Chief Financial 
Officer and Treasurer from August 2003 to December 2009 and as the Company’s Vice President, Finance from November 
1998 to August 2003. Mr. Edwards also served as the Company’s Treasurer from May 1997 to December 2009 and as the 
Company’s Controller from October 1992 until July 2000.  

Kevin C. Donnelly.  Mr. Donnelly was elected Vice President, General Counsel and Corporate Secretary effective January 1, 
2021.  He joined Tredegar in 2010 and served as its Associate General Counsel from 2013 to 2020.  Prior to joining Tredegar, 
Mr. Donnelly was an associate at Hunton & Williams LLP (now Hunton Andrews Kurth LLP).  He received a B.A. degree 
from the University of Richmond and a J.D. from the University of Virginia.

Tredegar has adopted a Code of Conduct that applies to all of its directors, officers and employees (including its chief executive 
officer, chief financial officer and principal accounting officer) and has posted the Code of Conduct on its website.  All 
amendments to or waivers from any provision of the Company’s Code of Conduct applicable to the chief executive officer, 
chief financial officer and principal accounting officer will be disclosed on the Company’s website.  The Company’s internet 
address is www.tredegar.com. 

Item 11. 

EXECUTIVE COMPENSATION

The information to be included in the Proxy Statement under the headings “Compensation of Directors,” “Board 
Meetings, Meetings of Non-Management Directors and Board Committees - Executive Compensation Committee Interlocks 
and Insider Participation,” “Compensation Discussion and Analysis,” “Executive Compensation Committee Report” and 
“Compensation of Executive Officers” is incorporated herein by reference.

Item 12. 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND 
RELATED STOCKHOLDER MATTERS

The information to be included in the Proxy Statement under the heading “Equity Compensation Plan Information” is 

incorporated herein by reference.

35

Item 13. 

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The information to be included in the Proxy Statement under the headings “Certain Relationships and Related 
Transactions,” “Tredegar’s Board of Directors” and “Board Meetings, Meetings of Non-Management Directors and Board 
Committees” is incorporated herein by reference.

Item 14. 

PRINCIPAL ACCOUNTING FEES AND SERVICES

Our independent registered public accounting firm is KPMG LLP, Richmond, Virginia, Audit Firm ID: 185.

The following is incorporated herein by reference:

•

•

Information on accounting fees and services to be included in the Proxy Statement under the heading “Audit and 
Non-Audit Fees;” and

Information on the Audit Committee’s procedures for pre-approving certain audit and non-audit services to be 
included in the Proxy Statement under the heading “Board Meetings, Meetings of Non-Management Directors and 
Board Committees—Audit Committee Matters.”

36

PART IV

Item 15. 

EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a)

List of documents filed as a part of the report:

(1)

Financial statements:

Tredegar Corporation

Index to Financial Statements and Supplementary Data

Page

Auditors’ Opinions:

Report of Independent Registered Public Accounting Firm

Opinion on Internal Control Over Financial Reporting

Financial Statements:

Consolidated Balance Sheets

Consolidated Statements of Income

Consolidated Statements of Comprehensive Income (Loss)

Consolidated Statements of Cash Flows

Consolidated Statements of Shareholders' Equity

Notes to Financial Statements

(2)

Financial statement schedules:

None

(3) Exhibit Index

38

40

42

43

44

45

46
47

88

37

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors 
Tredegar Corporation:

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of Tredegar Corporation and subsidiaries (the Company) as of 
December 31, 2021 and 2020, the related consolidated statements of income, comprehensive income (loss), shareholders’ 
equity, and cash flows for each of the years in the three-year period ended December 31, 2021, and the related notes 
(collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all 
material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and 
its cash flows for each of the years in the three-year period ended December 31, 2021, in conformity with U.S. generally 
accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) 
(PCAOB), the Company’s internal control over financial reporting as of December 31, 2021, based on criteria established in 
Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway 
Commission, and our report dated March 11, 2022 expressed an adverse opinion on the effectiveness of the Company’s internal 
control over financial reporting.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express 
an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the 
PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and 
the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the 
audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, 
whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the 
consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such 
procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial 
statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, 
as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a 
reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial 
statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or 
disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or 
complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated 
financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate 
opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Fair value of investments measured at net asset value

As discussed in Note 8 to the consolidated financial statements, the fair value of pension plan assets at December 31, 2021 
was $244.6 million. Of this amount, $49.0 million represents the fair value of private equity, hedge funds and certain 
international equity securities measured at net asset value (NAV).

We identified the assessment of the fair value of investments measured at NAV as a critical audit matter. Subjective auditor 
judgment was required in the application and performance of procedures to assess the fair value of the investments 
measured at NAV because the determination involved the use of unobservable inputs.  Additionally, specialized skills and 

38

knowledge were required to assess the fair value of the investments measured at NAV and to assess the sufficiency of audit 
evidence obtained.

The following are the primary procedures we performed to address this critical audit matter.  For a selection of the 
investments measured at NAV, we compared:

•
•
•

the Company’s previous estimates of fair value to the NAVs subsequently audited by third parties
the rates of return to relevant, publicly available market indices
the estimated fair values to external confirmations received directly from the third-party investment managers.

We involved valuation professionals with specialized skills and knowledge, who assisted in our risk assessment and the 
design of procedures performed for the investments measured at NAV. With respect to the selection of investments tested, 
the valuation professionals assisted in assessing the sufficiency of audit evidence obtained by assessing the results of the 
procedures performed.

/s/ KPMG LLP

We have served as the Company’s auditor since 2018.

Richmond, Virginia
March 11, 2022 

39

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors 
Tredegar Corporation:

Opinion on Internal Control Over Financial Reporting

We have audited Tredegar Corporation and subsidiaries' (the Company) internal control over financial reporting as of 
December 31, 2021, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee 
of Sponsoring Organizations of the Treadway Commission. In our opinion, because of the effect of the material weaknesses, 
described below, on the achievement of the objectives of the control criteria, the Company has not maintained effective internal 
control over financial reporting as of December 31, 2021, based on criteria established in Internal Control – Integrated 
Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.   

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) 
(PCAOB), the consolidated balance sheets of the Company as of December 31, 2021 and 2020, the related consolidated 
statements of income, comprehensive income (loss), shareholders’ equity, and cash flows for each of the years in the three-year 
period ended December 31, 2021, and the related notes (collectively, the consolidated financial statements), and our report 
dated March 11, 2022 expressed an unqualified opinion on those consolidated financial statements.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that 
there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be 
prevented or detected on a timely basis. The material weaknesses related to an ineffective control environment resulting from an 
insufficient number of trained resources, ineffective risk assessment, ineffective information and communication, and 
ineffective monitoring activities resulting in ineffective control activities related to the design and operation of process-level 
controls and general information technology controls across all financial reporting processes have been identified and included 
in management’s assessment. The material weaknesses were considered in determining the nature, timing, and extent of audit 
tests applied in our audit of the 2021 consolidated financial statements, and this report does not affect our report on those 
consolidated financial statements.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its 
assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report 
on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control 
over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be 
independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and 
regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the 
audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all 
material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control 
over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating 
effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we 
considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the 
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally 
accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures 
that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and 
dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit 
preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and 
expenditures of the company are being made only in accordance with authorizations of management and directors of the 
company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or 
disposition of the company’s assets that could have a material effect on the financial statements.

40

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, 
projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate 
because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ KPMG LLP

Richmond, Virginia
March 11, 2022 

41

CONSOLIDATED BALANCE SHEETS
Tredegar Corporation and Subsidiaries

(In thousands, except share data)
Assets
Current assets:

Cash and cash equivalents
Accounts and other receivables, net
Income taxes recoverable
Inventories
Prepaid expenses and other
Current assets of discontinued operations

Total current assets
Property, plant and equipment, at cost:
Land and land improvements
Buildings
Machinery and equipment

Total property, plant and equipment

Less accumulated depreciation

Net property, plant and equipment

Right-of-use leased assets
Investment in kaléo (cost basis of $7,500)
Identifiable intangible assets, net
Goodwill
Deferred income tax assets
Other assets
Non-current assets of discontinued operations

Total assets

Liabilities and Shareholders’ Equity
Current liabilities:

Accounts payable
Accrued expenses
Lease liability, short-term
Income taxes payable
Current liabilities of discontinued operations

Total current liabilities

Lease liability, long-term
Long-term debt
Pension and other postretirement benefit obligations, net
Other non-current liabilities

Total liabilities
Shareholders’ equity:

Common stock (no par value):

Authorized 150,000,000 shares;

Issued and outstanding— 33,736,629 shares in 2021 and 33,457,176 in 2020 (including restricted 
stock)

Common stock held in trust for savings restoration plan (108,433 shares in 2021 and 105,067 in 2020)

Accumulated other comprehensive income (loss):

Foreign currency translation adjustment
Gain (loss) on derivative financial instruments
Pension and other postretirement benefit adjustments

Retained earnings

Total shareholders’ equity
Total liabilities and shareholders’ equity

See accompanying notes to financial statements.

42

December 31

2021

2020

30,521  $ 
103,312 
2,558 
88,569 
11,275 
178 
236,413 

4,537 
69,406 
424,368 
498,311 
(327,930)   
170,381 
13,847 
— 
14,152 
70,608 
15,723 
2,460 
— 
523,584  $ 

123,760  $ 
33,104 
2,158 
9,333 
193 
168,548 
12,831 
73,000 
78,265 
6,218 
338,862 

11,846 
86,327 
2,807 
66,437 
19,679 
1,339 
188,435 

4,544 
66,406 
404,669 
475,619 
(309,074) 
166,545 
16,037 
34,600 
18,820 
67,708 
19,068 
3,506 
151 
514,870 

89,702 
40,741 
2,082 
706 
7,521 
140,752 
14,949 
134,000 
110,585 
5,529 
405,815 

55,174 
(2,135)   

(85,792)   
901 
(64,613)   
281,187 
184,722 
523,584  $ 

50,066 
(2,087) 

(84,149) 
2,264 
(96,519) 
239,480 
109,055 
514,870 

$ 

$ 

$ 

$ 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Years Ended December 31
2020

2019

2021

$ 

826,455  $ 
20,376 
846,831 

755,290  $ 
(67,294)   
687,996 

826,324 
28,371 
854,695 

641,140 
28,980 
76,598 
7,893 
13,601 
9,642 
4,051 

784 
— 
782,689 
72,006 
13,545 
58,461 
(10,202) 
48,259 

649,690 
28,232 
74,964 
6,347 
1,704 
14,160 
3,386 

1,127 
— 
779,610 
67,221 
9,284 
57,937 

(111)   
57,826  $ 

558,967 
25,686 
84,246 
8,398 
3,017 
14,720 
2,587 

1,725 
13,696 
713,042 
(25,046)   
(8,213)   
(16,833)   
(58,611)   
(75,444)  $ 

1.72  $ 
— 
1.72  $ 

1.72  $ 
— 
1.72  $ 

(0.51)  $ 
(1.75)   
(2.26)  $ 

(0.51)  $ 
(1.75)   
(2.26)  $ 

1.76 
(0.31) 
1.45 

1.76 
(0.31) 
1.45 

33,563
33,670

33,402
33,402

33,236
33,258

CONSOLIDATED STATEMENTS OF INCOME
Tredegar Corporation and Subsidiaries

(In thousands, except per-share data)
Revenues and other:

Sales
Other income (expense), net

Costs and expenses:

Cost of goods sold
Freight
Selling, general and administrative
Research and development
Amortization of identifiable intangibles
Pension and postretirement benefits
Interest expense
Asset impairments and costs associated with exit and disposal activities, 
net of adjustments
Goodwill impairment

Total

Income (loss) from continuing operations before income taxes
Income tax expense (benefit)
Net income (loss) from continuing operations
Income (loss) from discontinued operations, net of tax
Net income (loss)

Earnings (loss) per share:

Basic:

Continuing operations
Discontinued operations
Basic earnings (loss) per share

Diluted:

Continuing operations
Discontinued operations
Diluted earnings (loss) per share

Shares used to compute earnings (loss) per share:

Basic
Diluted

See accompanying notes to financial statements.

43

$ 

$ 

$ 

$ 

$ 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
Tredegar Corporation and Subsidiaries

(In thousands)
Net income (loss)
Other comprehensive income (loss):

Unrealized foreign currency translation adjustment (net of tax benefit 
of $365 in 2021, net of tax benefit of $897 in 2020 and net of tax 
benefit of $623 in 2019)
Reclassification of foreign currency translation loss realized on the 
sale of Personal Care Films
Derivative financial instruments adjustment (net of tax benefit of 
$351 in 2021, net of tax of $790 in 2020 and net of tax of $71 in 
2019)
Pension & other postretirement benefit adjustments:

Net gains (losses) and prior service costs (net of tax of $5,212 in 
2021, net of tax benefit of $4,228 in 2020 and net of tax benefit of 
$6,417 in 2019)
Amortization of prior service costs and net gains or losses (net of 
tax of $3,676 in 2021, net of tax of $3,937 in 2020 and net of tax 
of $2,359 in 2019)

Other comprehensive income (loss)

Comprehensive income (loss)

See accompanying notes to financial statements.

Years Ended December 31
2020

2019

2021

$ 

57,826  $ 

(75,444)  $ 

48,259 

(1,643)   

(8,781)   

(3,723) 

— 

25,295 

(1,363)   

3,571 

— 

294 

18,720 

(12,197)   

(22,508) 

13,186 
28,900 
86,726  $ 

11,359 
19,247 
(56,197)  $ 

8,273 
(17,664) 
30,595 

$ 

44

 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONSOLIDATED STATEMENTS OF CASH FLOWS
Tredegar Corporation and Subsidiaries

Cash flows from operating activities:

Net income (loss)
Adjustments for noncash items:

Depreciation
Amortization of identifiable intangibles
Goodwill impairment
Reduction of right-of-use lease asset
Deferred income taxes
Accrued pension and postretirement benefits
Stock-based compensation expense
(Gain) loss on investment in kaléo
Loss on sale of divested businesses
Net gain on disposal of assets

Changes in assets and liabilities:

Accounts and other receivables
Inventories
Income taxes recoverable/payable
Prepaid expenses and other
Accounts payable and accrued expenses
Lease liability

Pension and postretirement benefit plan contributions
Other, net

Net cash provided by operating activities

Cash flows from investing activities:

Capital expenditures
Proceeds from the sale of kaléo
Net proceeds on sale of divested businesses
Proceeds from the sale of assets and other

Net cash provided by (used in) investing activities

Cash flows from financing activities:

Borrowings
Debt principal payments
Dividends paid
Debt financing costs
Other

Net cash used in financing activities:

Effect of exchange rate changes on cash
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental cash flow information:

Interest payments
Income tax payments (refunds), net

See accompanying notes to financial statements.

2021

Years Ended December 31
2020
(In thousands)

2019

$ 

57,826  $ 

(75,444)  $ 

48,259 

22,080 
1,704 
— 
2,086 
(4,944)   
14,160 
5,167 
(12,462)   

— 
— 

(16,993)   
(23,132)   
8,956 
3,612 
19,835 
(1,935)   
(5,687)   
310 
70,583 

(27,361)   
47,062 
— 
4,749 
24,450 

28,940 
3,017 
13,696 
2,753 
(16,892)   
14,720 
5,402 
60,900 
52,326 
— 

(335)   
(4,366)   
1,617 
(2,203)   
4,045 
(3,049)   
(12,681)   
1,927 
74,373 

(23,355)   

— 
56,236 
— 
32,881 

75,500 
(136,500)   
(16,167)   

325 
(76,842)   
484 
18,675 
11,846 
30,521  $ 

162,250 
(70,250)   
(216,049)   
(693)   
(850)   
(125,592)   
(1,238)   
(19,576)   
31,422 
11,846  $ 

30,683 
13,601 
— 
2,588 
5,856 
9,642 
7,293 
(10,900) 
— 
(6,334) 

16,471 
11,315 
2,644 
795 
(2,937) 
(2,723) 
(8,614) 
(1,776) 
115,863 

(50,864) 
— 
— 
10,936 
(39,928) 

65,500 
(125,000) 
(15,325) 
(1,817) 
(670) 
(77,312) 
(1,598) 
(2,975) 
34,397 
31,422 

2,923  $ 
4,706  $ 

1,679  $ 
1,670  $ 

4,358 
2,595 

$ 

$ 
$ 

45

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
Tredegar Corporation and Subsidiaries

Common Stock

Shares

Amount

Retained
Earnings

Trust for 
Savings 
Restoration 
Plan

Accumulated Other Comprehensive Income 
(Loss)
Gain 
(Loss) on 
Derivative 
Financial 
Instruments

Pension & 
Other 
Postretirement 
Benefit Adjust

Foreign 
Currency 
Translation

Total 
Shareholders’ 
Equity

(1,559)  $ 
— 

(96,940)  $ 
— 

(1,601)  $ 
— 

(81,446)  $ 
— 

354,857 
48,259 

(In thousands, except share and per-
share data)
Balance at January 1, 2019
Net income (loss)
Foreign currency translation 
adjustment
Derivative financial instruments 
adjustment
Net gains or (losses) and prior service 
costs
Amortization of prior service costs and 
net gains or losses
Cash dividends declared ($0.46 per 
share)
Stock-based compensation expense
Repurchase of employee common 
stock for tax withholdings
Issued upon exercise of stock options
Tredegar common stock purchased by 
trust for savings restoration plan
Balance at December 31, 2019
Net income (loss)
Foreign currency translation 
adjustment
Foreign currency translation loss 
realized on the sale of Personal Care 
Films
Derivative financial instruments 
adjustment
Net gains or (losses) and prior service 
costs
Amortization of prior service costs and 
net gains or losses
Cash dividends declared ($6.45 per 
share)
Stock-based compensation expense
Repurchase of employee common 
stock for tax withholdings
Tredegar common stock purchased by 
trust for savings restoration plan
Balance at December 31, 2020
Net income (loss)
Foreign currency translation 
adjustment
Derivative financial instruments 
adjustment
Net gains or (losses) and prior service 
costs
Amortization of prior service costs and 
net gains or losses
Cash dividends declared ($0.48 per 
share)
Stock-based compensation expense
Issued upon exercise of stock options
Repurchase of employee common 
stock for tax withholdings
Tredegar common stock purchased by 
trust for savings restoration plan
Balance at December 31, 2021

 33,176,024  $  38,892  $ 497,511  $ 

— 

— 

— 

— 

— 

— 

  48,259 

— 

— 

— 

— 

— 

— 

— 

— 

— 
228,959 

— 
7,292 

  (15,325) 
— 

(49,444) 
9,500 

(854) 
184 

— 
— 

— 

— 

— 

— 

— 
— 

— 
— 

— 
 33,365,039 
— 

— 
  45,514 
— 

33 
  530,478 
  (75,444) 

(33) 
(1,592) 
— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 
131,354 

— 
5,402 

 (216,049) 
— 

(39,217) 

(850) 

— 

— 

— 

— 

— 

— 

— 
— 

— 

(3,723) 

— 

— 

— 

— 
— 

— 
— 

— 
(100,663) 
— 

(8,781) 

25,295 

— 

— 

— 

— 
— 

— 

— 

294 

— 

— 

— 
— 

— 
— 

— 
(1,307) 
— 

— 

— 

3,571 

— 

— 

— 
— 

— 

— 
 33,457,176 
— 

— 
  50,066 
— 

495 
  239,480 
  57,826 

(495) 
(2,087) 
— 

— 
(84,149) 
— 

— 
2,264 
— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 
229,014 
67,705 

— 
4,783 
915 

  (16,167) 
— 
— 

(17,266) 

(590) 

— 

— 

— 

48 

 33,736,629  $  55,174  $ 281,187  $ 

— 

— 

— 

— 

— 
— 
— 

— 

(1,643) 

— 

— 

— 

— 

— 
— 
— 

— 

(1,363) 

— 

— 

— 
— 
— 

— 

See accompanying notes to financial statements.

46

— 

— 

(3,723) 

294 

(22,508) 

(22,508) 

8,273 

8,273 

— 
— 

— 
— 

— 
(95,681) 
— 

— 

— 

— 

(15,325) 
7,292 

(854) 
184 

— 
376,749 
(75,444) 

(8,781) 

25,295 

3,571 

(12,197) 

(12,197) 

11,359 

11,359 

— 
— 

— 

— 
(96,519) 
— 

— 

— 

18,720 

13,186 

— 
— 
— 

— 

(216,049) 
5,402 

(850) 

— 
109,055 
57,826 

(1,643) 

(1,363) 

18,720 

13,186 

(16,167) 
4,783 
915 

(590) 

(48) 
(2,135)  $ 

— 
(85,792)  $ 

— 
901  $ 

— 
(64,613)  $ 

— 
184,722 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTES TO FINANCIAL STATEMENTS
Tredegar Corporation and Subsidiaries

 1.     NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations. Tredegar Corporation and subsidiaries (collectively “Tredegar,” “the Company,” “we,” “us” or “our”) is 
an industrial manufacturer with three primary businesses: custom aluminum extrusions for the North American building & 
construction, automotive and specialty end-use markets; surface protection films for high-technology applications in the global 
electronics industry and polyethylene overwrap films used in bathroom tissue and paper towels; and polyester-based films for 
use in packaging applications that have specialized properties primarily for the Latin American and the United States (“U.S.”) 
flexible packaging markets.  The Company’s business segments are Aluminum Extrusions (also referred to as Bonnell 
Aluminum), PE Films, and Flexible Packaging Films (also referred to as Terphane).  More information on the Company’s 
business segments is provided in Note 13.

On October 30, 2020, the Company completed the sale of its personal care films business (“Personal Care Films”), which 

was part of its PE Films segment. The transaction excluded the packaging film lines and related operations located at the 
Pottsville, Pennsylvania manufacturing site (“Pottsville Packaging”), which are now being reported within the Surface 
Protection component of PE Films. Commencing in the third quarter of 2020, all historical results for Personal Care Films have 
been presented as discontinued operations.  

In December 2020, the Company entered into a definitive agreement to sell Bright View Technologies (“Bright View”).  

The sale did not represent a strategic shift nor did it have a major effect on the Company’s historical and ongoing operations, 
thus all financial information for Bright View has been presented as continuing operations in the PE Films segment.

For more information on these transactions, see Note 15 in the Notes to Financial Statements

Basis of Presentation and Principles of Consolidation. The consolidated financial statements include the accounts and 
operations of the Company and have been prepared in accordance with U.S. generally accepted accounting principles 
(“GAAP”).  Intercompany balances and transactions have been eliminated in consolidation.  Certain amounts for the prior years 
have been reclassified to conform to current year presentation. 

Fiscal Year End.  The Company operates on a calendar fiscal year except for the Aluminum Extrusions segment, which 
operates on a 52/53-week fiscal year basis.  References to Aluminum Extrusions for 2021, 2020 and 2019 relate to the 52-week 
fiscal year ended December 26, 2021, the 52-week fiscal year ended December 27, 2020 and the 52-week fiscal year ended 
December 29, 2019, respectively. The Company does not believe the impact of reporting the results of this segment in this 
manner is material to the consolidated financial results.  The Company may fund or receive cash from the Aluminum 
Extrusions segment based on Aluminum Extrusion’s cash flows from operations during the intervening period from Aluminum 
Extrusion’s fiscal year end to the Company’s calendar year end.  There was no intercompany funding with Aluminum 
Extrusions between December 27, 2021 and December 31, 2021.  As of December 31, 2020, the Company’s cash and cash 
equivalents declined by $3.8 million since the Company made payments to the Aluminum Extrusions segment to fund its 
working capital during the intervening period.  

Use of Estimates.  The preparation of financial statements in conformity with GAAP requires management to make estimates 
and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and disclosure of contingent assets and 
liabilities (if any). On an ongoing basis, the Company evaluates its estimates, including those related to provisions for 
transaction and credit losses, income taxes, pension, and the valuation of goodwill and intangible assets, among others. 
Tredegar bases its estimates on historical experience and various other assumptions which the Company believes to be 
reasonable under the circumstances.  Actual results could differ from those estimates.

Risk and Uncertainties.  While it is not possible to estimate the impact that the coronavirus pandemic (“COVID-19”) may have 
on the Company’s business, estimates related to the accounting for impairment of long-lived assets and goodwill, pension 
benefits and income taxes could be materially adversely affected in future periods. Due to the uncertainty with respect to the 
magnitude of the impact and duration of COVID-19, future developments associated with COVID-19 may adversely affect the 
Company's financial condition, results of operations and cash flows. The Company continues to monitor the impact of 
COVID-19 on the business and its effect on the consolidated financial statements.

Foreign Currency Translation. The financial statements of subsidiaries located outside the U.S., where the local currency is 
the functional currency, are translated into U.S. Dollars using exchange rates in effect at the period end for assets and liabilities 
and average exchange rates during each reporting period for results of operations.  Adjustments resulting from the translation of 
these financial statements are reflected as a separate component of shareholders’ equity.  There are no operating subsidiaries 
located outside the U.S. where the U.S. Dollar is the functional currency.  Transaction and remeasurement gains or losses 
included in income were losses of $0.5 million, gains of $0.6 million and losses of $0.6 million in 2021, 2020 and 2019, 
respectively.  These amounts do not include the effects between reporting periods that exchange rate changes have on income of 
the locations outside the U.S. that result from translation into U.S. Dollars.

47

Cash and Cash Equivalents. Cash and cash equivalents consist of cash on hand in excess of daily operating requirements and 
highly liquid investments with original maturities of three months or less.  At December 31, 2021 and 2020, Tredegar had cash 
and cash equivalents of $30.5 million and $11.8 million, respectively, including funds held in locations outside the U.S. of 
$16.4 million and $9.4 million, respectively.  

The Company’s policy permits investment of excess cash in marketable securities that have the highest credit ratings and 

maturities of less than one year.  The primary objectives of the policy are safety of principal and liquidity.  

Accounts and Other Receivables, net. Accounts receivable are stated at the amount invoiced to customers less allowances for 
doubtful accounts.  Accounts receivable are non-interest bearing and arise from the sale of product to customers under typical 
industry trade terms. Notes receivable are immaterial. Past due amounts are determined based on established terms and charged-
off when deemed uncollectible. The allowance for doubtful accounts is determined based on an assessment of probable losses 
taking into account past due amounts, customer credit profile, historical experience and current economic conditions. For 
receivables that do not have a specific allowance, the loss rate is computed by segment to apply to the remaining receivables 
balance, using each segment’s historic loss rate. Other receivables include value-added taxes related to certain foreign 
subsidiaries and other miscellaneous receivables due within one year. For certain customers, the Company has arrangements in 
place with financial institutions whereby certain customer receivables are sold to the financial institution at a discount and 
without recourse.  Upon sale, the associated receivable is unrecognized and the discount is recognized as a reduction of sales. 
For more information on accounts receivable and other receivables, net, see Note 2. 

Inventories. Inventories are stated at the lower of cost or market, with cost determined using the last in, first out (“LIFO”), the 
weighted average cost or the first in, first out method.  Cost elements included in work-in-process and finished goods 
inventories are raw materials, direct labor and manufacturing overhead.  Finished goods, work-in-process, raw materials and 
supplies, stores and other inventory are reviewed to determine if inventory quantities are in excess of forecasted usage or if they 
have become obsolete. 

Property, Plant and Equipment. Accounts include costs of assets constructed or purchased, related delivery and installation 
costs and interest incurred on significant capital projects during their construction periods.  Expenditures for renewals and 
betterments also are capitalized, but expenditures for repairs and maintenance are expensed as incurred.  The cost and 
accumulated depreciation applicable to assets retired or sold are removed from the respective accounts, and gains or losses 
thereon are included in income.  Capital expenditures for property, plant and equipment include capitalized interest.  
Capitalized interest included in capital expenditures for property, plant and equipment was $0.1 million, $0.1 million and $0.3 
million in 2021, 2020 and 2019, respectively.  Depreciation is computed primarily by the straight-line method based on the 
estimated useful lives of the assets that generally range from 5 to 40 years for buildings and land improvements and 2 to 20 
years for machinery and equipment.

Goodwill and Identifiable Intangibles. The excess of the purchase price over the fair value of identifiable net assets of acquired 
companies is allocated to goodwill.  The Company assesses goodwill for impairment when events or circumstances indicate that 
the carrying value may not be recoverable or, at a minimum, on an annual basis (December 1st of each year).  When assessing 
goodwill for impairment, accounting guidance allows the Company to first perform a qualitative assessment about the 
likelihood of the carrying value of a reporting unit exceeding its fair value, referred to as the "Step 0" assessment. The Step 0 
assessment requires the evaluation of certain qualitative factors, including macroeconomic conditions, industry and market 
considerations, cost factors and overall financial performance, as well as company and reporting unit factors. If the Company's 
Step 0 analysis indicates that it is more likely than not that the fair value of a reporting unit is less than the carrying amount, 
then the Company would perform a quantitative impairment test that estimates the fair value of its reporting units using 
discounted cash flow analyses and comparative enterprise value-to-EBITDA (earnings before interest, taxes, depreciation and 
amortization) multiples. 

During the first three months of 2020, the Company performed goodwill impairment tests and recognized a goodwill 
impairment charge of $13.7 million ($10.5 million after taxes), which represented the entire amount of goodwill associated with 
Aluminum Extrusions’ AACOA reporting unit. The operations of the AACOA reporting unit, which includes the Niles, 
Michigan and Elkhart, Indiana facilities, were expected to be severely impacted by COVID-19, with over 80% of the aluminum 
extrusions manufactured at these facilities sold to customers that make consumer durable products, such as recreational boating 
and power sports vehicles, and to customers serving the building and construction and automotive markets.

As of December 1, 2021, the Company’s reporting units with goodwill were Surface Protection in PE Films and Futura in 

Aluminum Extrusions.  Both of these reporting units have separately identifiable operating net assets (operating assets 
including goodwill and identifiable intangible assets net of operating liabilities).  In addition, the Company applied the Step 0 
goodwill assessment to Surface Protection and Futura; both had fair values significantly in excess of their carrying amounts 
when last tested using the quantitative impairment test.  The Company's Step 0 analyses in 2021 of these reporting units 
concluded that it is not more likely than not that the fair values of each reporting unit was less than its carrying amount. 
Therefore, the quantitative goodwill impairment tests for these reporting units were not necessary in 2021.  The Surface 

48

Protection and Futura reporting units had goodwill in the amounts of $57.3 million and $13.3 million, respectively, at 
December 31, 2021.  For more information on goodwill and identifiable intangibles, see Note 5.

Impairment of Long-Lived Assets. The Company reviews long-lived assets for possible impairment when events indicate that 
an impairment may exist.  For assets that are held and used in operations, if events indicate that an asset may be impaired, the 
Company estimates the future unlevered pre-tax cash flows expected to result from the use of the asset and its eventual 
disposition.  Assets are grouped for this purpose at the lowest level for which there are identifiable and independent cash flows.  
If the sum of these undiscounted pre-tax cash flows is less than the carrying amount of the asset group, an impairment loss is 
calculated.  Measurement of the impairment loss is the amount by which the carrying amount exceeds the estimated fair value 
of the asset group.  As of December 31, 2021 and 2020, no events were identified that indicated long-lived assets may be 
impaired.

Assets that are held for sale are reported at the lower of their carrying amount or estimated fair value less cost to sell, with 

an impairment loss recognized for any write-down required.

Pension Costs and Postretirement Benefit Costs Other than Pensions. Pension costs and postretirement benefit costs other 
than pensions have been accrued over the period employees provided service to Tredegar.  Liabilities and expenses for pension 
plans and other postretirement benefits are determined using actuarial methodologies and incorporate significant assumptions, 
including the rate used to discount the future estimated liability, the long-term rate of return on plan assets, and several 
assumptions relating to the employee workforce.  The Company recognizes the funded status of its pension and other 
postretirement plans in the accompanying consolidated balance sheets.  Tredegar’s policy is to fund its pension plans at 
amounts not less than the minimum requirements of the Employee Retirement Income Security Act (“ERISA”) of 1974 and to 
fund postretirement benefits other than pensions when claims are incurred.

On February 10, 2022, Tredegar announced the initiation of a process to terminate and settle its frozen defined benefit 

pension plan, which could take up to 24 months to complete.  In connection therewith, on February 9, 2022, the Company 
contributed $50 million to the pension plan (the “Special Contribution”).  The Company estimates that, with the Special 
Contribution, there will be no required minimum contributions to the pension plan until final settlement.  As of December 31, 
2021, no adjustment to the consolidated financial statements has been recognized as a result of this announcement and Special 
Contribution made in 2022.  As the settlement process occurs, the Company expects to recognize a non-cash reclassification 
adjustment to net income or loss of other comprehensive net actuarial losses associated with the pension plan currently reflected 
directly in shareholders’ equity.  Other comprehensive net actuarial losses associated with the pension plan were approximately 
$109 million on a pretax basis as of December 31, 2021.  

Additional disclosure regarding Tredegar’s pension costs and postretirement benefit costs other than pensions is included 

in Note 8.

Revenue Recognition. The Company’s revenue is primarily generated from the sale of finished products to customers. Those 
sales predominantly contain a single performance obligation and revenue is recognized at the point in time when control of the 
product is transferred to customers, along with the title, risk of loss and rewards of ownership. Depending on the arrangement 
with the customer, these criteria are met either at the time the product is shipped or when the product is made available or 
delivered at the destination specified in the agreement with the customer.

Sales revenue is recognized in an amount that reflects the consideration the Company expects to be entitled to in exchange 

for that finished product.  The Company offers various discounts, rebates and allowances to customers, (collectively, 
“allowances”), all of which are considered when determining the transaction price. Certain allowances are fixed and 
determinable at the time of sale and are recorded at the time of sale as a reduction to revenues. Other allowances can vary 
depending on future outcomes such as sales returns and customer sales volume, thus represents variable consideration. 

Amounts billed to customers related to freight are classified as sales revenue and the cost of freight is classified as a 
separate line in the accompanying consolidated statements of income. Taxes assessed by a governmental authority that are both 
imposed on and concurrent with a specific revenue-producing transaction between Tredegar and its customers (such as value-
added taxes) are accounted for on a net basis and therefore excluded from revenues.  See Note 13 for disaggregation of revenue 
by segment and type.  See Note 2 for a table showing accounts and other receivables, net of allowance for bad debts.

Revenue expected to be recognized in any future period related to remaining performance obligations, excluding i) 
revenue pertaining to contracts that have an original expected duration of one year or less, ii) contracts where revenue is 
recognized as invoiced and iii) variable consideration related to unsatisfied performance obligations, is not expected to 
materially impact the Company’s financial results. 

Research & Development (“R&D”) Costs. R&D costs are expensed as incurred and include primarily salaries, wages, 
employee benefits, equipment depreciation, facility costs and the cost of materials consumed relating to R&D efforts.  R&D 
costs include a reasonable allocation of indirect costs.

49

Leases.  At inception, the Company determines if an arrangement contains a lease and whether that lease meets the 
classification criteria of a finance or operating lease. The Company has elected to not record short-term leases with an original 
lease term of one year or less in the consolidated balance sheet. To the extent such leases contain renewal options that the 
Company intends to exercise, the related Right-of-Use (“ROU”) asset and lease liability are included in the consolidated 
balance sheet.  Some of the Company’s lease arrangements contain lease components (e.g., minimum rent payments) and non-
lease components (e.g., maintenance, labor charges, etc.).  The Company generally accounts for the lease and non-lease 
components as a single lease component. 

Certain of the Company’s lease agreements include rental payments that are adjusted periodically for an index or rate. The 

leases are initially measured using the projected payments adjusted for the index or rate in effect at the commencement date.  
The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.

Operating leases are included in “Right-of-use lease assets”, “Lease liabilities - short-term” and “Lease liabilities - long-
term” on the consolidated balance sheets. These assets and liabilities are recognized at the commencement date based on the 
present value of remaining lease payments over the lease term using the Company’s secured incremental borrowing rates, 
adjusted for term and geographic location using country-based swap rates.  As a result of the Company’s review of new and 
existing lease contracts, there were no instances where the Company could readily determine a rate implicit in the lease.

Lease expense for operating leases is recognized on a straight-line basis over the lease term. Variable lease expense is 

recognized in the period in which the obligation for those payments is incurred.  Depending upon the specific use of the ROU 
asset, lease expense is included in the “Cost of goods sold”, “Freight”, “Selling, general and administrative”, and “Research and 
development” line items on the consolidated statements of income. Lease income is not material to the results of operations for 
the years ended December 31, 2021 and 2020, respectively.  Additional disclosure regarding Tredegar’s leases is included in 
Note 4. 

Income Taxes. Income taxes are recognized during the period in which transactions enter into the determination of income for 
financial reporting purposes, with deferred income taxes being provided at enacted statutory tax rates on the differences 
between the financial reporting and tax bases of assets and liabilities (see Note 12).  Tredegar’s policy is to accrue U.S. federal 
income taxes to the extent required under GAAP on unremitted earnings of all foreign subsidiaries where required. However, 
due to changes in the taxation of dividends under the Tax Cuts and Jobs Act (the “TCJA”) enacted by the U.S. government in 
December 2017, Tredegar only records U.S. federal income taxes on unremitted earnings of its foreign subsidiaries where 
Tredegar cannot take steps to eliminate any potential tax on future distributions from its foreign subsidiaries.  Because of the 
accumulation of significant losses related to foreign currency translations at Terphane Limitada, there were no unrecorded 
deferred income tax liabilities associated with U.S. federal income taxes and foreign withholding taxes on Terphane Limitada’s 
undistributed earnings as of December 31, 2021 and December 31, 2020. 

A valuation allowance is recorded in the period when the Company determines that it is more likely than not that all or a 

portion of deferred income tax assets may not be realized.  The establishment and removal of a valuation allowance requires the 
Company to consider all positive and negative evidence and make a judgmental decision regarding the amount of valuation 
allowance required as of a reporting date.  The benefit of an uncertain tax position is included in the accompanying financial 
statements when the Company determines that it is more likely than not that the position will be sustained, based on the 
technical merits of the position, if the taxing authority examines the position and the dispute is litigated.  This determination is 
made on the basis of all the facts, circumstances and information available as of the reporting date.

Earnings Per Share. Basic earnings per share is computed using the weighted average number of shares of common stock 
outstanding.  Diluted earnings per share is computed using the weighted average common and potentially dilutive common 
equivalent shares outstanding, determined as follows:

Weighted average shares outstanding used to compute basic earnings 
per share
Incremental shares attributable to stock options and restricted stock

Shares used to compute diluted earnings per share

2021

2020

2019

33,562,684 
107,566 
33,670,250 

33,402,147 
— 
33,402,147 

33,236,115 
22,022 
33,258,137 

Incremental shares attributable to stock options and restricted stock are computed using the average market price during 

the related period.  For the year ended December 31, 2021, average out-of-the-money options to purchase shares that were 
excluded from the calculation of incremental shares attributable to stock options and restricted stock were 1,582,222. The 
Company had a net loss from continuing operations for the year ended December 31, 2020, so there is no dilutive impact for 
such shares.  If the Company had reported net income from continuing operations for the year ended December 31, 2020, 
average out-of-the-money options to purchase shares that were excluded from the calculation of incremental shares attributable 
to stock options and restricted stock were 1,212,375.  For the year ended December 31, 2019, average out-of-the-money options 

50

 
 
 
 
 
 
 
 
 
to purchase shares that were excluded from the calculation of incremental shares attributable to stock options and restricted 
stock were 209,592.

Stock-Based Employee Compensation Plans.  The cost of all share-based payments is recognized using the calculated fair 
value at the grant date, or the date of any later modification, over the requisite service period under the graded-vesting method.  
See Note 11 for additional information.

Financial Instruments. Tredegar uses derivative financial instruments for the purpose of hedging aluminum price volatility and 
currency exchange rate exposures that exist as part of transactions associated with ongoing business operations.  The 
Company’s derivative financial instruments are designated as and qualify as cash flow hedges and are recognized in the 
accompanying balance sheet at fair value.  A change in the fair value of the derivative that is highly effective and that is 
designated and qualifies as a cash flow hedge is recorded in other comprehensive income.  Gains and losses reported in other 
comprehensive income (loss) are reclassified to earnings in the periods in which earnings are affected by the variability of cash 
flows of the hedged transaction.  Such gains and losses are reported in the same line as the underlying hedged item, and the 
cash flows related to financial instruments are classified in the consolidated statements of cash flows in a manner consistent 
with those of the transactions being hedged.  

The Company’s policy requires that it formally document all relationships between hedging instruments and hedged 

items, as well as its risk management objective and strategy for undertaking various hedge transactions.  The Company also 
uses regression analysis, unless the hedge qualifies for other methods of assessing effectiveness, to formally assess (both at the 
hedge’s inception and on an ongoing basis) whether the derivatives that are used in hedging transactions have been highly 
effective in offsetting changes in the fair value or cash flows of hedged items and whether those derivatives may be expected to 
remain highly effective in future periods.  When it is determined that a derivative is not (or has ceased to be) highly effective as 
a hedge, the Company discontinues hedge accounting prospectively.

As a policy, Tredegar does not engage in speculative or leveraged transactions, nor does it hold or issue financial 

instruments for trading purposes.  Additional disclosure of the utilization of derivative hedging instruments is included in 
Note 10.

Comprehensive Income (Loss). Comprehensive income (loss) is defined as net income or loss as adjusted by other 
comprehensive income or loss items.  Other comprehensive income (loss) includes changes in foreign currency translation 
adjustments, unrealized gains and losses on derivative financial instruments, prior service costs and net gains or losses from 
pension and other postretirement benefit plans arising during the period and amortization of these prior service costs and net 
gain or loss adjustments, all recorded net of deferred income taxes.

51

The changes in accumulated other comprehensive income (loss) by component are summarized as follows:

Foreign 
Currency 
Translation

Gain (Loss) on 
Derivative Financial 
Instruments

Pension & Other 
Postretirement 
Benefit Adjust

Total Accumulated 
Other Comprehensive 
Income (Loss)

Balance at January 1, 2019
Other comprehensive income (loss)
Income tax (expense) benefit

$ 

(96,940)  $ 
(4,346)   
623 

(1,601)  $ 
(3,214)   
528 

(81,446)  $ 
(28,925)   
6,417 

(179,987) 
(36,485) 
7,568 

Other comprehensive income (loss), net 
of tax

Reclassification adjustment to net 
income (loss)
Income tax (expense) benefit

Reclassification adjustment to net 
income (loss), net of tax

Other comprehensive income (loss), 
net of tax

Balance at December 31, 2019
Other comprehensive income (loss)
Income tax (expense) benefit

Other comprehensive income (loss), net 
of tax

Reclassification adjustment to net 
income (loss)
Income tax (expense) benefit

Reclassification adjustment to net 
income (loss), net of tax

Other comprehensive income (loss), 
net of tax

Balance at December 31, 2020
Other comprehensive income (loss)
Income tax (expense) benefit

Other comprehensive income (loss), net 
of tax

Reclassification adjustment to net 
income (loss)
Income tax (expense) benefit

Reclassification adjustment to net 
income (loss), net of tax

(3,723)   

(2,686)   

(22,508)   

(28,917) 

— 
— 

— 

(3,723)   
(100,663)   
(9,678)   
897 

3,578 
(598)   

2,980 

294 
(1,307)   
(4,362)   
1,077 

10,632 
(2,359)   

8,273 

(14,235)   
(95,681)   
(16,425)   
4,228 

14,210 
(2,957) 

11,253 

(17,664) 
(197,651) 
(30,465) 
6,202 

(8,781)   

(3,285)   

(12,197)   

(24,263) 

25,295 
— 

25,295  

16,514  
(84,149)  
(2,008)  
365  

(1,643)  

—  
—  

—  

8,724 
(1,868)   

15,296 
(3,937)   

6,856  

3,571  
2,264  
3,800  
(842)  

2,958  

(5,513)  
1,192  

(4,321)  

11,359  

(838)  
(96,519)  
23,932  
(5,212)  

18,720  

16,862  
(3,676)  

13,186  

49,315 
(5,805) 

43,510 

19,247 
(178,404) 
25,724 
(5,689) 

20,035 

11,349 
(2,484) 

8,865 

Other comprehensive income (loss), 
net of tax

Balance at December 31, 2021

$ 

(1,643)  
(85,792)  $ 

(1,363)  

901  $ 

31,906  
(64,613)  $ 

28,900 
(149,504) 

The amounts reclassified out of accumulated other comprehensive income (loss) related to pension and other 

postretirement benefits is included in the computation of net periodic pension costs, see Note 8 for additional details. 

52

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accounting Standards Adopted.  

In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 

2019-12, which simplifies the accounting for income taxes by eliminating certain exceptions related to the approach for 
intraperiod tax allocation, the methodology for calculating income taxes in an interim period, hybrid taxes and the recognition 
of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the accounting for income 
taxes.  In the first quarter of 2021, the Company adopted ASU 2019-12, which did not have a material impact on the 
Company’s consolidated financial statements. 

Accounting Standards Not Yet Adopted.

In March 2020, the FASB issued ASU 2020-04, which provides optional expedients and exceptions for applying GAAP to 
contracts, hedging relationships and other transactions affected by the discontinuation of the London Interbank Offered Rate or 
by another reference rate expected to be discontinued because of reference rate reform. The guidance was effective beginning 
March 12, 2020 and can be applied prospectively through December 31, 2022. In January 2021, the FASB issued ASU 
2021-01, which clarified the scope and application of the original guidance.  The Company is currently evaluating the potential 
impact of adopting this guidance, but does not expect it to have a material impact on the consolidated financial statements.

 2.     ACCOUNTS AND OTHER RECEIVABLES

As of December 31, 2021 and 2020, accounts receivable and other receivables, net, were $103.3 million and 

$86.3 million, respectively, made up of the following:

(In thousands)
Customer receivables
Other accounts and notes receivable

Total accounts and other receivables

Less: Allowance for bad debts(a)

Total accounts and other receivables, net

2021

2020

$ 

$ 

102,090  $ 
2,958 
105,048 

(1,736)   
103,312  $ 

85,274 
3,850 
89,124 
(2,797) 
86,327 

(a) As of December 31, 2021, the Company recorded a reclassification of $0.8 million from accounts receivable, net to 

accrued expenses to account for the Company’s estimated obligation to customers for product returns that may result in 
either a customer credit or refund.  Prior to December 31, 2021, the Company presented estimated sales returns as a 
reduction to accounts receivable.

A reconciliation of the beginning and ending balances of the allowance for doubtful accounts for the three years ended 

December 31, 2021 is as follows: 

(In thousands)
Balance, beginning of year
Charges to expense
Recoveries

Write-offs and settlements
Foreign exchange and other
Reclassification to accrued expenses for estimated sales returns
Balance, end of year

2021

2020

2019

$ 

$ 

2,797  $ 
1,440 
35 
(1,246)   
(515)   
(775)   
1,736  $ 

1,904  $ 
1,901 

(90)   
(709)   
(209)   
— 
2,797  $ 

2,054 
715 
(38) 
(756) 
(71) 
— 
1,904 

53

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3.     INVENTORIES

Inventories consist of the following:

(In thousands)
Finished goods
Work-in-process
Raw materials
Stores, supplies and other

Total

2021

2020

25,199  $ 
11,955 
32,958 
18,457 
88,569  $ 

15,251 
9,098 
25,913 
16,175 
66,437 

$ 

$ 

Inventories stated on the LIFO basis amounted to $18.8 million at December 31, 2021 and $14.4 million at December 31, 

2020, which were below replacement costs by $27.5 million at December 31, 2021 and $12.1 million at December 31, 2020.  
Inventories stated on the weighted average cost basis were $30.9 million and $33.6 million at December 31, 2021 and 2020, 
respectively, while inventories stated on the first in, first out method amounted to $38.9 million and $18.4 million at December 
31, 2021 and 2020, respectively.

 4.     LEASES

Tredegar has various operating lease agreements with remaining terms up to 9 years, including leases of real estate, office 

equipment and vehicles. As of December 31, 2021 and 2020, the Company had no finance lease agreements.  Some leases 
include options to purchase the leased asset, terminate the agreement or extend the term of the agreement for one or more years. 
These options are included in the lease term when it is reasonably certain that the option will be exercised. 

The following table presents information about the amount, timing and uncertainty of cash flows arising from the 

Company’s operating leases as of December 31, 2021:

(In thousands)

2022
2023
2024
2025
2026
Thereafter

Future Lease Payments
$ 

2,594 
2,478 
2,417 
2,417 
2,079 
5,326 
17,311 
2,322 
14,989 

Total undiscounted operating lease payments

Less: Imputed interest

Present value of operating lease liabilities

$ 

The following table summarizes lease costs, related cash flow and other information for the years ended December 31, 
2021 and 2020. These costs are primarily related to long-term operating leases, but also include amounts for variable leases and 
short-term leases. 

(In thousands)
Operating lease expense

Right-of-use assets recognized as non-cash additions from the execution 
of new operating leases
Other Information:
Weighted-average remaining lease term for operating leases
Weighted-average discount rate for operating leases

$ 

$ 

2021

2020

2,752 

— 

$ 

$ 

7 years
 4.22 %

3,260 

529 

8 years
 4.21 %

54

 
 
 
 
 
 
 
 
 
 
 
 
 
 5.     GOODWILL AND IDENTIFIABLE INTANGIBLE ASSETS

The components of goodwill and identifiable intangibles at December 31, 2021 and 2020, and related amortization 

periods are as follows:

(In thousands)
Goodwill
Identifiable intangible assets, net:

2021

2020

Amortization Periods

$ 

70,608  $ 

67,708  Not amortized

Customer relationships (cost basis of $26,526 in 2021 and 
$29,450 in 2020)
Proprietary technology (cost basis of $3,721 in 2021 and 
$3,726 in 2020)
Trade names (cost basis of $13,338 in 2021 and $13,397 in 
2020)

Total carrying value of identifiable intangibles

13,259 

17,551  10-12 years

118 

194  Not more than 15 years

775 
14,152 

1,075  5 - 13 years
18,820 

Total carrying value of goodwill and identifiable intangible 
assets

$ 

84,760  $ 

86,528 

A reconciliation of goodwill at December 31, 2021 and 2020 is as follows: 

(In thousands)
Net carrying value of goodwill at December 31, 2019

Goodwill impairment charge

Net carrying value of goodwill at December 31, 2020

Out-of-period adjustment

Aluminum 
Extrusions(a) PE Films(a)
$ 

24,066  $ 
(13,696)   
10,370 
2,900 
13,270  $ 

57,338  $ 
— 
57,338 
— 
57,338  $ 

Total

81,404 
(13,696) 
67,708 
2,900 
70,608 

Net carrying value of goodwill at December 31, 2021
(a) The goodwill of Aluminum Extrusions and PE Films is carried by the Futura and Surface Protection reporting units, respectively.

$ 

During the fourth quarter of 2021, the Company recorded an out-of-period adjustment in connection with the original 
valuation of intangible assets and goodwill related to the acquisition of Futura in February 2017.  This adjustment resulted in a 
reclassification of $2.9 million from acquired customer relationship intangible assets to goodwill and a $0.9 million decrease to 
accumulated amortization and amortization expense as of and for the period ended December 31, 2021. 

55

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A reconciliation of identifiable intangibles at December 31, 2021 and 2020 is as follows:

(In thousands)
Aluminum Extrusions:

Net carrying value at December 31, 2019

Amortization expense

Net carrying value at December 31, 2020
Amortization expense(a)
Out-of-period Adjustment(b)
Net carrying value at December 31, 2021

PE Films:

Net carrying value at December 31, 2019

Amortization expense
Bright View disposal

Net carrying value at December 31, 2020

Amortization expense

Net carrying value at December 31, 2021

Flexible Packaging Films:

Net carrying value at December 31, 2019

Amortization expense
Increase (decrease) due to foreign currency translation

Net carrying value at December 31, 2020

Amortization expense
Increase (decrease) due to foreign currency translation

Net carrying value at December 31, 2021
Total net carrying value of identifiable intangibles at 
December 31, 2021

 Customer 
Relationships

 Proprietary 
Technology

 Trade Names

 Total

$ 

$ 

$ 

$ 

$ 

$ 

$ 

19,644  $ 
(2,480)   
17,164 
(2,239)   
(1,953)   
12,972  $ 

—  $ 
— 
— 
— 
— 
—  $ 

554  $ 
(84)   
(83)   
387 
(82)   
(18)   
287  $ 

55  $ 
(20)   
35 
(20)   
— 
15  $ 

610  $ 
(120)   
(490)   
— 
— 
—  $ 

230  $ 
(53)   
(18)   
159 
(53)   
(3)   
103  $ 

—  $ 
— 
— 
— 
— 
—  $ 

—  $ 
— 
— 
— 
— 
—  $ 

1,543  $ 
(260)   
(208)   
1,075 
(257)   
(43)   
775  $ 

19,699 
(2,500) 
17,199 
(2,259) 
(1,953) 
12,987 

610 
(120) 
(490) 
— 
— 
— 

2,327 
(397) 
(309) 
1,621 
(392) 
(64) 
1,165 

13,259  $ 

118  $ 

775  $ 

14,152 

(a) Excludes a reduction of $0.9 million to amortization expense related to the out-of-period adjustment.
(b) Represents a $2.9 million gross reclassification from customer relationship intangible assets to goodwill offset by a 

$0.9 million decrease to accumulated amortization as a result of the out-of-period adjustment.

Amortization expense over the next five years is expected to be as follows:

Year
2022
2023
2024
2025
2026

Amount
(In thousands)
2,579 
$ 
1,953 
1,913 
1,913 
1,913 

56

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 6.     ACCRUED EXPENSES

Accrued expenses consist of the following:

(In thousands)
Incentive compensation
Payrolls, related taxes and medical and other benefits
Vacation
Workers’ compensation and disabilities
Accrued freight
Accrued utilities
Customer rebates
Environmental liabilities (current)
Derivative contract liability
Accrued severance
Other

Total

2021

2020

7,016  $ 
6,903 
3,452 
2,422 
2,337 
1,938 
1,857 
1,634 
1,254 
445 
3,846 
33,104  $ 

8,138 
9,571 
7,283 
2,986 
1,397 
1,460 
1,398 
2,066 
487 
1,894 
4,061 
40,741 

$ 

$ 

In the fourth quarter of 2021, the Company changed its vacation policy such that effective January 1, 2022 substantially 

all U.S. employees earn their vacation for the current year on a monthly basis throughout the year and forfeit any unused 
vacation at the end of the year, with the exception of a partial rollover allowance subject to a cap or where forfeiture is 
prohibited by applicable state or local law or a collective bargaining agreement.  Under the previous policy, vacation was 
granted at the beginning of the year in advance of work being performed for the subsequent year.  As a result of this policy 
change, the Company recorded in the fourth quarter of 2021 a reduction of $3.9 million to accrued expenses and a decrease to 
selling, general, and administrative expense ($1.3 million) and cost of goods sold ($2.6 million) within the consolidated 
statements of income.

 7.     DEBT AND CREDIT AGREEMENTS  

Tredegar has a five-year secured revolving credit agreement (the “Credit Agreement”) providing for aggregate borrowings 

in an amount of $375 million, which matures in June 2024. 

Borrowings under the Credit Agreement bear an interest rate of LIBOR plus a credit spread and commitment fees charged 

on the unused amount under the Credit Agreement at various indebtedness-to-Credit EBITDA levels as follows:

Pricing Under Credit Agreement (Basis Points)

Indebtedness-to-Credit EBITDA Ratio
> 3.5x but <= 4.0x
> 3.0x but <= 3.5x
> 2.0x but <= 3.0x
> 1.0x but <= 2.0x
<= 1.0x

Credit Spread
Over LIBOR
200.0 
187.5 
175.0 
162.5 
150.0 

Commitment
Fee

40 
35 
30 
25 
20 

At December 31, 2021, the interest cost on debt borrowed under the Credit Agreement was priced at one-month LIBOR 

plus the applicable credit spread of 150.0 basis points.

The most restrictive covenants in the Credit Agreement include:

•

•

•

Maximum indebtedness-to-Credit EBITDA (“Leverage Ratio”) of 4.00x;

Minimum Credit EBITDA-to-interest expense of 3.00x; and

Maximum aggregate distributions to shareholders over the remaining term of the Credit Agreement of $75 million; 
provided, that if the Leverage Ratio of equal to or greater than 3.00x, a limitation on such payments for the 
succeeding quarter at the greater of (i) $4.75 million and (ii) 50% of consolidated net income for the most recent 
fiscal quarter.

The Credit Agreement is secured by substantially all of the Company’s and its domestic subsidiaries’ assets, including 
equity in certain material first-tier foreign subsidiaries.  At December 31, 2021, based upon the most restrictive covenant within 
the Credit Agreement, available credit under the Credit Agreement was approximately $287 million.  Total debt outstanding 
was $73 million and $134 million as of December 31, 2021 and 2020, respectively. 

57

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tredegar was in compliance with all of its debt covenants as of December 31, 2021.  Noncompliance with any of the debt 
covenants may have a material adverse effect on its financial condition or liquidity, in the event such noncompliance cannot be 
cured or should the Company be unable to obtain a waiver from the lenders.  Renegotiation of the covenant through an 
amendment to the Credit Agreement may effectively cure the noncompliance, but may have an effect on its financial condition 
or liquidity depending upon how the covenant is renegotiated.

 8.     RETIREMENT PLANS AND OTHER POSTRETIREMENT BENEFITS

Tredegar sponsors a noncontributory defined benefit (pension) plan covering certain current and former U.S. employees. 
The plan for salaried and hourly employees currently in effect is based on a formula using the participant’s years of service and 
compensation or using the participant’s years of service and a dollar amount.  The plan is closed to new participants and pay for 
active plan participants for benefit calculations was frozen as of December 31, 2007.  As of January 31, 2018, the plan no 
longer accrued benefits associated with crediting employees for service, thereby freezing all future benefits under the plan.

Tredegar also has a non-qualified supplemental pension plan covering certain employees.  Effective December 31, 2005, 

further participation in this plan was terminated and benefit accruals for existing participants were frozen.  The plan was 
designed to restore all or a part of the pension benefits that would have been payable to designated participants from the 
principal pension plans if it were not for limitations imposed by income tax regulations.  The projected benefit obligation 
relating to this unfunded plan was $2.1 million and $2.2 million at December 31, 2021 and December 31, 2020, respectively.  
Pension expense recognized for this plan was $0.1 million in 2021, 2020, and 2019.  This information has been included in the 
pension benefit tables below.

In addition to providing pension benefits, the Company provides postretirement life insurance and health care benefits for 

certain groups of employees.  Tredegar and retirees share in the cost of postretirement health care benefits, with employees 
hired on or before January 1, 1993, receiving a fixed subsidy to cover a portion of their health care premiums.  The Company 
eliminated prescription drug coverage for Medicare-eligible retirees as of January 1, 2006.  Consequently, Tredegar is not 
eligible for any federal subsidies.

Pension and other postretirement benefit liabilities related to Personal Care Films have been retained by the Company.  
Pension expense recognized for participation by these former employees in the Company’s plans is not material for the years 
ended December 31, 2021, 2020, and 2019.

58

The following tables reconcile the changes in benefit obligations and plan assets in 2021 and 2020, and reconcile the 

funded status to prepaid or accrued cost at December 31, 2021 and 2020:

(In thousands)
Change in benefit obligation:

Benefit obligation, beginning of year
Service cost
Interest cost
Effect of actuarial (gains) losses related to the following:

$ 

Discount rate change
Retirement rate assumptions and mortality table 
adjustments
Other

Plan participant contributions
Benefits paid
Benefit obligation, end of year

Change in plan assets:

Plan assets at fair value, beginning of year
Actual return on plan assets
Employer contributions

Plan participant contributions
Benefits paid
Plan assets at fair value, end of year
Funded status of the plans

Amounts recognized in the consolidated balance sheets:

Accrued expenses (current)
Pension and other postretirement benefit obligations, net

Net amount recognized

$ 

$ 

$ 
$ 

$ 

$ 

Pension Benefits

2021

2020

Other Post-
Retirement Benefits
2020
2021

336,159  $ 
— 
8,398 

318,763 
— 
10,156 

$ 

8,164  $ 
21 
195 

7,650 
29 
243 

(12,512)   

26,887 

(272)   

644 

1,028 
(101)   
— 

(16,803)   
316,169  $ 

233,075  $ 
23,131 
5,209 
— 

(16,803)   
244,612  $ 
(71,557)  $ 

(3,446) 
69 
— 
(16,270) 
336,159 

$ 

$ 

218,329 
18,800 
12,216 
— 
(16,270) 
233,075 
$ 
(103,084)  $ 

(1)   
(274)   
613 
(1,076)   
7,370  $ 

—  $ 
— 
463 
613 
(1,076)   
—  $ 
(7,370)  $ 

181  $ 

71,376 
71,557  $ 

181 
102,903 
103,084 

$ 

$ 

478  $ 

6,892 
7,370  $ 

13 
55 
606 
(1,076) 
8,164 

— 
— 
470 
606 
(1,076) 
— 
(8,164) 

481 
7,683 
8,164 

The following table sets forth the assumptions used in accounting for the pension and other post-retirement benefits, and 

the components of net periodic benefit cost: 

(In thousands, except percentages)

Weighted-average assumptions used to 
determine benefit obligations:

Discount rate
Expected long-term return on plan assets

Weighted-average assumptions used to 
determine net periodic benefit cost:

Discount rate
Expected long-term return on plan assets

Components of net periodic benefit cost:

Service cost
Interest cost
Expected return on plan assets
Amortization of prior service costs and 
gains or losses
Net periodic benefit cost

Pension Benefits
2020

2021

2019

2021

Other Post-
Retirement Benefits
2020

2019

 2.90 %
 3.05 %

 2.57 %
 5.00 %

 3.27 %
 5.00 %

 2.86 %
n/a

 2.54 %
n/a

 3.25 %
n/a

 2.57 %
 5.00 %

 3.27 %
 5.00 %

 4.40 %
 6.00 %

 2.54 %
n/a

 3.25 %
n/a

 4.37 %
n/a

$  — 
  8,398 
 (11,316) 

$  — 
  10,156 
 (11,004) 

$  — 
  12,222 
 (13,528) 

$ 

21 
195 
  — 

$ 

29 
243 
— 

$ 

26 
290 
— 

  17,003 
$ 14,085 

  15,494 
$ 14,646 

  10,891 
$  9,585 

(141) 
75 

$ 

(198) 
74 

$ 

(258) 
58 

$ 

59

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net periodic benefit cost is determined using assumptions at the beginning of each year.  Funded status is determined 

using assumptions at the end of each year.  The amount of the accumulated benefit obligation is the same as the projected 
benefit obligation.  At December 31, 2021, the effect of a 1% change in the health care cost trend rate assumptions would not 
impact the post-retirement obligation.

Expected benefit payments over the next five years and in the aggregate for 2027—2031 are as follows:

(In thousands)
2022
2023
2024
2025
2026
2027—2031

$ 

Pension
Benefits

Other Post-
Retirement
Benefits

18,256  $ 
18,380 
18,591 
18,615 
18,574 
89,722 

478 
472 
465 
456 
447 
2,081 

The average remaining duration of benefit payments for the pension plan is about 11.1 years.  

The pre-tax amounts recorded in 2021, 2020 and 2019 in accumulated other comprehensive income consist of:

(In thousands)
Net actuarial (gain) loss

2021

Pension
2020

2019

Other Post-Retirement
2020

2019

2021

$  109,893  $  150,267  $  150,047  $ 

(320)  $ 

86  $ 

(824) 

Pension expense is expected to be $13.9 million in 2022.  The amounts in accumulated other comprehensive income, 
before related deferred income taxes, that are expected to be recognized as components of net periodic cost during 2022 are 
$13.2 million of cost for the pension plan and $0.1 million of benefit for other post-retirement plans. 

The percentage composition of assets held by pension plans at December 31, 2021, 2020 and 2019 are as follows:

% Composition of Plan Assets
at December 31,
2020

2021

2019

Pension plans:

Fixed income securities
Large/mid-capitalization equity securities
Small-capitalization equity securities
International and emerging market equity securities
Total equity securities
Private equity and hedge funds
Cash and cash equivalents
Other assets

Total

 25.3 %
 28.1 
 6.8 
 19.9 
 54.8 
 10.4 
 2.8 
 6.7 
 100.0 %

 7.7 %
 27.1 
 8.6 
 20.6 
 56.3 
 12.1 
 17.5 
 6.4 
 100.0 %

 8.7 %
 21.3 
 7.8 
 19.7 
 48.8 
 35.0 
 1.4 
 6.1 
 100.0 %

Prior to commencing plans to terminate and settle the frozen defined benefit pension plan, the Company’s primary 
investment objective was to maximize total return with a strong emphasis on the preservation of capital, which it expected to 
achieve through a diversified portfolio with both a higher risk profile and anticipated long-term returns via fixed income 
securities, equity securities, hedge funds and private equity funds.  Concurrent with the Company’s decision to commence the 
termination and settlement of the plan, the Company began transitioning to a liability-driven investment strategy aimed at 
reducing funded status volatility.  The new strategy contemplates an increase of the fixed income securities allocation from 
25.3% as of December 31, 2021 to an ultimate target of 100% and decreases to the asset allocations currently invested in equity 
securities, commodity funds, private equity and hedge funds, from 71.9% to zero over the next 18 months.

The expected long-term rate of return developed through consultation with the Company’s investment advisors as of 

December 31, 2021 contemplates the impact of this strategy which included consideration of several factors, including 
prevailing and planned strategic asset allocations, current and expected future market conditions, inflation-adjusted historical 
returns, volatilities, risk premiums and managed asset premiums.

60

 
 
 
 
 
 
 
 
 
 
 
 
 
Estimates of the fair value of assets held by the Company’s pension plan are provided by unaffiliated third parties. 
Investments in private equity, hedge funds and certain international equity securities are measured at net asset value, which is a 
practical expedient for measuring fair value.  These assets are therefore excluded from the fair value hierarchy for each of the 
years presented.  At December 31, 2021 and 2020, the pension plan assets are categorized by level within the fair value 
measurement hierarchy as follows: 

(In thousands)
Balances at December 31, 2021
Cash and cash equivalents
Large/mid-capitalization equity securities
Small-capitalization equity securities
International and emerging market equity securities
Fixed income securities
Contracts with insurance companies
Other assets(a)

Total plan assets at fair value

Investments measured at net asset value
Total plan assets, December 31, 2021

Balances at December 31, 2020
Cash and cash equivalents
Large/mid-capitalization equity securities
Small-capitalization equity securities
International and emerging market equity securities
Fixed income securities
Contracts with insurance companies
Other assets(a)

Total plan assets at fair value

Investments measured at net asset value
Total plan assets, December 31, 2020

Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)

Significant
Other
Observable
Inputs
(Level 2)

Significant
Unobservable
Inputs
(Level 3)

Total

$ 

$ 

$ 

$ 

$ 

$ 

6,943  $ 
68,739 
16,588 
25,174 
61,845 
9,438 
6,868 
195,595  $ 
49,017 
244,612 

40,890  $ 
63,146 
19,932 
24,325 
18,008 
9,118 
5,629 
181,048  $ 
52,027 
233,075 

6,943  $ 
68,739 
16,588 
25,174 
9,306 
— 
6,868 
133,618  $ 

40,890  $ 
63,146 
19,932 
24,325 
6,690 
— 
5,629 
160,612  $ 

—  $ 
— 
— 
— 
52,539 
— 
— 
52,539  $ 

—  $ 
— 
— 
— 
11,318 
— 
— 
11,318  $ 

— 
— 
— 
— 
— 
9,438 
— 
9,438 

— 
— 
— 
— 
— 
9,118 
— 
9,118 

(a) Represents investments in certain commodity funds measured using quoted market prices.

61

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 9.     OTHER INCOME (EXPENSE), NET

Other income (expense), net consists of the following:

$ 

2021

2020

2019

12,780  $ 

(60,900)  $ 

(In thousands)
Gain (loss) on investment in kaléo(a)
One-time tax credit in Brazil for unemployment/social security insurance 
non-income taxes resulting from a favorable decision by Brazil’s Supreme 
Court regarding the calculation of such tax
Transition service fees, net of corporate costs associated with the divested 
Personal Care business
COVID-19-related expenses(b)
Loss on sale of Bright View Technologies
Write-down of investment in Harbinger Capital Partners Special Situations 
Fund(c)
Gain associated with the sale of Lake Zurich manufacturing facility assets
Other
Total
(a)   The gain in 2021 includes a $0.3 million dividend received from kaléo in the first quarter of 2021.  The gain in 2019 includes a $17.6 

— 
— 
(1,013)   
(67,294)  $ 

(517)   
378 
(424)   
20,376  $ 

(851)   
(2,231)   
(2,299)   

297 
(624)   
— 

8,486 

— 

$ 

— 
— 
(111) 
28,371 

— 

— 
— 
— 

28,482 

million dividend received from kaléo.  

(b)   Costs associated with operating under COVID-19 conditions include employee overtime expenses associated with absenteeism, 

personal protective equipment supplies and facility maintenance. 

(c)    Represents the unrealized loss on the Company’s investment in Harbinger Capital Partners Special Situations Funds L.P. that had a fair 

value of $0.2 million, $0.7 million and $1.1 million as of December 31, 2021, 2020 and 2019, respectively, reported in “Other assets” 
in the consolidated balance sheet. 

In May 2021, the Brazil Supreme Court ruled in a leading case related to the amount of Brazilian value-added tax to 
exclude from the calculation of unemployment/social security insurance non-income taxes (“PIS/COFINS”).  As a result, in the 
second quarter of 2021, the Company recorded a pre-tax gain of $8.5 million for certain excess PIS/COFINS paid from 2003 to 
2021, that included applicable interest, which the Company applied to required Brazilian federal tax payments during 2021. The 
pre-tax gain was recorded in “Other income (expense), net” in the consolidated statements of income.

 10.   DERIVATIVES

Tredegar uses derivative financial instruments for the purpose of hedging margin exposure from fixed-price forward sales 

contracts in Aluminum Extrusions and exposure from currency volatility that exist as part of ongoing business operations 
(primarily in Flexible Packaging Films).  These derivative financial instruments are designated as and qualify as cash flow 
hedges and are recognized in the consolidated balance sheet at fair value.  The fair value of derivative instruments recorded on 
the consolidated balance sheets are based upon Level 2 inputs.  If individual derivative instruments with the same counterparty 
can be settled on a net basis, the Company records the corresponding derivative fair values as a net asset or net liability.

In the normal course of business, Aluminum Extrusions enters into fixed-price forward sales contracts with certain 
customers for the future sale of fixed quantities of aluminum extrusions at scheduled intervals.  In order to hedge margin 
exposure created from the fixing of future sales prices relative to volatile raw material (aluminum) costs, Aluminum Extrusions 
enters into a combination of forward purchase commitments and futures contracts to acquire or hedge aluminum, based on the 
scheduled purchases for the firm sales commitments.  The fixed-price firm sales commitments and related hedging instruments 
generally have durations of not more than 12 months, and the notional amount of aluminum futures contracts that hedged future 
purchases of aluminum to meet fixed-price forward sales contract obligations was $22.1 million (14.9 million pounds of 
aluminum) at December 31, 2021 and $12.1 million (13.0 million pounds of aluminum) at December 31, 2020.

62

 
 
 
 
 
 
 
 
 
 
 
 
 
 
The table below summarizes the location and gross amounts of aluminum derivative contract fair values (Level 2) in the 

consolidated balance sheets as of December 31, 2021 and 2020:

(In thousands)
Derivatives Designated as Hedging Instruments

Asset derivatives:
Aluminum futures contracts

Liability derivatives:

Liability derivatives:
Aluminum futures contracts
Net asset (liability)

December 31, 2021

December 31, 2020

Balance Sheet
Account

Fair
Value

Balance Sheet
Account

Fair
Value

Prepaid expenses 
& other

$ 

2,085 

Prepaid expenses 
& other

$ 

1,560 

Accrued 
expenses

Accrued 
expenses

(119) 
1,966 

$ 

(22) 
1,538 

$ 

In the event that a counterparty to an aluminum fixed-price forward sales contract chooses not to take delivery of its 
aluminum extrusions, the customer is contractually obligated to compensate Aluminum Extrusions for any losses on the related 
aluminum futures and/or forward contracts through the date of cancellation.

The Company's earnings are exposed to foreign currency exchange risk primarily through the translation of the financial 

statements of subsidiaries that have a functional currency other than the U.S. Dollar. The Company estimates that the net 
mismatch translation exposure for the Flexible Packaging Film's business unit in Brazil (“Terphane Ltda.”) of its sales and raw 
materials quoted or priced in U.S. Dollars and its variable conversion, fixed conversion and sales, general and administrative 
costs (before depreciation and amortization) quoted or priced in Brazilian Real is annual net costs of R$150 million Brazilian 
Real ("R$").

Terphane Ltda. has the following outstanding foreign exchange average forward rate contracts to purchase Brazilian Real 

and sell U.S. Dollars:

USD Notional Amount 
(000s)
$1,677
$1,751
$1,662
$1,615
$1,647
$1,596
$1,719
$1,708
$1,780
$1,793
$1,784
$1,659
$20,391

Average Forward Rate 
Contracted on USD/
BRL
5.3360
5.3631
5.3905
5.4247
5.4545
5.4890
5.5200
5.5560
5.5915
5.6264
5.6597
5.6962
5.5108

R$ Equivalent Amount 
(000s)
R$8,948
R$9,391
R$8,959
R$8,761
R$8,984
R$8,760
R$9,489
R$9,490
R$9,953
R$10,088
R$10,097
R$9,450
R$112,370

Applicable Month
Jan-22
Feb-22
Mar-22
Apr-22
May-22
Jun-22
Jul-22
Aug-22
Sep-22
Oct-22
Nov-22
Dec-22

Estimated % of 
Terphane Ltda. R$ 
Operating Cost 
Exposure Hedged
72%
75%
72%
70%
72%
70%
76%
76%
80%
81%
81%
76%
75%

These foreign currency exchange contracts have been designated and qualify as cash flow hedges of Terphane Ltda.’s 

forecasted sales to customers quoted or priced in U.S. Dollars over that period. By changing the currency risk associated with 
these U.S. Dollar sales, the derivatives have the effect of offsetting operating costs quoted or priced in Brazilian Real and 
decreasing the net exposure to Brazilian Real in the consolidated statements of income. 

63

 
 
 
The table below summarizes the location and gross amounts of foreign currency forward contract fair values (Level 2) in 

the consolidated balance sheets as of December 31, 2021 and 2020:

(In thousands)
Derivatives Designated as Hedging Instruments

Asset derivatives:
Foreign currency forward contracts
Liability derivatives:
Foreign currency forward contracts
Net asset (liability)

December 31, 2021

December 31, 2020

Balance Sheet
Account

Fair
Value

Balance Sheet
Account

Fair
Value

Prepaid expenses 
and other
Accrued 
expenses

Prepaid expenses 
and other
Accrued 
expenses

$ 

— 

(1,255) 

$ 

(1,255) 

$ 

853 

(466) 

387 

$ 

These derivative contracts involve elements of market risk that are not reflected on the consolidated balance sheet, 
including the risk of dealing with counterparties and their ability to meet the terms of the contracts. The counterparties to any 
forward purchase commitments are major aluminum brokers and suppliers, and the counterparties to any aluminum futures 
contracts are major financial institutions. Fixed-price forward sales contracts are only made available to the best and most 
credit-worthy customers. The counterparties to the Company’s foreign currency cash flow hedge contracts are major financial 
institutions.

The pretax effect on net income (loss) from continuing operations and other comprehensive income (loss) of derivative 

instruments classified as cash flow hedges and described in the previous paragraphs for years ended December 31, 2021, 2020, 
and 2019 is summarized in the tables below:

(In thousands)

Years Ended December 31,
Amount of pre-tax gain (loss) recognized in other comprehensive income
Location of gain (loss) reclassified from accumulated other comprehensive income 
into net income (effective portion)
Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive 
income to net income (effective portion)

Cash Flow Derivative Hedges
Aluminum Futures Contracts
2020

2019

2021

$ 

6,215  $ 

74  $ 

(2,359) 

Cost of
goods sold

Cost of
goods sold

Cost of
goods sold

$ 

5,787  $ 

(2,717)  $ 

(2,736) 

(In thousands)

Years Ended December 31,
Amount of pre-tax gain (loss) recognized in other 
comprehensive income
Location of gain (loss) reclassified from 
accumulated other comprehensive income into 
net income (effective portion)
Amount of pre-tax gain (loss) reclassified from 
accumulated other comprehensive income to net 
income (effective portion)

Cash Flow Derivative Hedges
Foreign Currency Forward Contracts
2020

2021

2019

$ 

—  $ 

(2,415)  $ 

—  $ 

(4,437)  $ 

—  $ 

(856) 

Cost of
goods sold

Selling, 
general & 
admin

Cost of
goods sold

Selling, 
general & 
admin

Cost of
goods sold

Selling, 
general & 
admin

$ 

63  $ 

(337)  $ 

62  $ 

(6,069)  $ 

62  $ 

(904) 

As of December 31, 2021, the Company expects $0.7 million of unrealized after-tax net gains on aluminum and foreign 
currency derivative contracts reported in accumulated other comprehensive income (loss) to be reclassified to earnings within 
the next 12 months. For the years ended December 31, 2021, 2020 and 2019, net gains or losses realized, from previously 
unrealized net gains or losses on hedges that had been discontinued, were not material.

 11.   STOCK OPTION AND STOCK AWARD PLANS  

As of December 31, 2021, the Company had one stock-based compensation plan that permits the grants of stock options, 
stock appreciation rights (“SARs”), stock, restricted stock, and stock unit awards.  Awards available for grant totaled 910,420 
shares at December 31, 2021. Stock options may be granted to purchase a specified number of shares of common stock at a 
price no lower than the fair market value on the date of grant and for a term not to exceed 10 years.  Stock options granted by 
the Company in 2021, 2020 and 2019 vest after 2 years and have a 7-year life or vest after 3 years and have a 5-year life.  Stock 
options exercisable totaled 1,762,190 and 1,287,792 shares at December 31, 2021 and 2020, respectively.  

On December 1, 2020, Tredegar’s Board of Directors declared a special cash dividend of $200 million, or $5.97 per share, 
on the Company’s common stock (the “Special Dividend”).  The Special Dividend was payable on December 18, 2020 and had 

64

 
 
 
 
 
an ex-dividend date of December 21, 2020.  All stock option awards that were outstanding at the time of the Special Dividend 
were modified pursuant to the nondiscretionary anti-dilution provisions in the related stock-based compensation plan.  SARs 
that were outstanding at the time of the Special Dividend were also modified pursuant to the nondiscretionary anti-dilution 
provisions in the related SARs grant agreements.  The modifications included increasing the number of outstanding stock 
options and SARs as well as reducing the exercise prices of all outstanding stock options and SARS. The modification did not 
result in additional stock-based compensation expense.  No other terms or conditions of outstanding awards were modified.   

A summary of stock options outstanding at December 31, 2021, 2020 and 2019, and changes during those years, is 

presented below: 

Outstanding at January 1, 2019

Granted

Forfeited and expired

Exercised

Outstanding at December 31, 2019

Granted
Modification for special cash dividend(a)
Forfeited and expired(a)
Outstanding at December 31, 2020(a)
Granted

Forfeited and expired

Exercised

Number of
Options

890,116  $ 

758,287 

(10,000)   

(9,500)   

  1,628,903 

638,074 

701,535 

(141,074)   

  2,827,438 

388,822 

(22,611)   

(67,705)   

Option Exercise Price/Share

Range

Weighted
Average

15.65 

18.48 

19.40 

19.40 

15.65 

10.75 

10.75 

10.75 

10.75 

16.37 

14.47 

10.75 

to

to

to

to

to

to

to

to

to

to

to

to

$ 

24.84  $ 

18.48 

19.40 

19.40 

24.84 

14.62 

14.62 

24.84 

22.49 

16.37 

19.64 

17.29 

19.69 

18.48 

19.40 

19.40 

19.13 

11.90 

11.90 

11.87 

13.55 

16.37 

18.14 

13.51 

Outstanding at December 31, 2021

13.82 
(a) The option exercise price per share reflects the reduction to the exercise prices of outstanding stock options impacted by the modification 

  3,125,944  $ 

22.49  $ 

10.75 

to

$ 

due to the anti-dilution provisions in the stock-based compensation plan.

The assumptions used in the Black-Scholes options-pricing model for valuing Tredegar stock options originally granted in 

2021, 2020 and 2019, and the related estimated fair values at the date of grant, were as follows:

2021

2020

2019

Dividend yield
Weighted average volatility percentage
Weighted average risk-free interest rate
Holding period (years)
Weighted average exercise price at date of grant (also weighted average 
market price at date of grant)(a)
18.48 
Estimated weighted average fair value of options per share at date of grant
5.43 
Total estimated fair value of stock options granted (in thousands)
4,117 
(a) In December 2020, the weighted average exercise price for outstanding stock option awards granted in 2020 and 2019 were modified to 
$10.75 and $13.78, respectively.  As the anti-dilution provisions in the stock-based compensation plan were structured to equitably 
adjust the award’s fair value before and after the modification, there is no resulting incremental fair value.

 2.6 %
 48.3 %
 0.9 %
5

 2.5 %
 43.8 %
 0.8 %
5

14.41 
4.44 
2,833 

16.37 
5.57 
2,165 

 2.4 %
 38.3 %
 2.4 %
5

$ 
$ 
$ 

$ 
$ 
$ 

$ 
$ 
$ 

The dividend yield is the actual dividend yield on Tredegar’s common stock at the date of grant, which the Company 

believes is a reasonable estimate of the expected yield during the holding period.  The expected volatility is based on the 
historical volatility of Tredegar’s common stock using a sequential period of historical data equal to the expected holding 
period of the option.  The Company has no reason to believe that future volatility for this period is likely to differ from the past.  
The assumed risk-free interest rate is based on observed interest rates for U.S. Treasury debt securities appropriate for the 
expected holding period.

65

 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The following table summarizes additional information about stock options outstanding and exercisable at December 31, 

2021:

Options Outstanding at December 31, 2021
Weighted Average

Options Exercisable at December 31, 2021

Range of
Exercise Prices

$  10.75 
  17.29 
Total

to $  16.37 
to   25.94 

Shares
 2,953,052 
  172,892 
 3,125,944 

Remaining 
Contractual 
Life
4.4 years $ 
1.6 years
4.2 years $ 

Exercise
Price

Aggregate 
Intrinsic 
Value

Shares

Weighted 
Average 
Exercise Price

Aggregate 
Intrinsic 
Value

13.48  $  792,082 
19.71 
— 
13.82  $  792,082 

 1,589,298  $ 
  172,892 
 1,762,190  $ 

13.78  $  41,076 
19.71 
— 
14.36  $  41,076 

The total intrinsic value of stock options exercised is $0.2 million in 2021 and $0.1 million in 2019.  There were no stock 

options exercised in 2020.  The grant-date fair value of stock option-based awards vested was $3.5 million, $3.0 million, and 
$0.5 million in 2021, 2020, and 2019, respectively.  As of December 31, 2021, the unrecognized compensation cost for 
continuing operations related to stock option-based awards was $1.7 million.  This cost is expected to be recognized over the 
remaining weighted average period of 0.6 years.  Commencing in 2019, stock option award grants include a retirement 
provision that allow for the immediate vesting of options held by a participant that ceases to provide service, including service 
as a member of the board of directors, with the Company, subsequent to reaching the age of 65.  As a result of this provision, 
the Company recognized accelerated stock compensation expense for continuing operations of $0.1 million and $1.3 million in 
2020 and 2019, respectively.  There was no accelerated stock compensation expense in 2021. 

Restricted stock grants ordinarily vest three years from the date of grant based upon continued employment.  The fair 

value of restricted stock awards is estimated as of the grant date using the closing stock price on that date.  Stock unit awards 
vest upon the achievement of certain performance targets.  The following table summarizes additional information about 
unvested restricted stock outstanding at December 31, 2021, 2020 and 2019:

Unvested Restricted Stock

Weighted Avg. 
Grant Date 
Fair Value/
Share

Maximum Unvested Restricted Stock Units 
Issuable Upon Satisfaction of Certain 
Performance Criteria
Weighted Avg. 
Grant Date 
Fair Value/
Share

Grant Date
Fair Value
(In thousands)
3,134 
1,053 
(766) 
(283) 

16.97  $ 
18.34 
10.96 
11.51 

Grant Date
Fair Value
(In thousands)
3,965 
3,423 
(1,739)    (69,926)   
(425)    (24,562)   

Number
of Shares
  184,709  $ 
  57,442 

16.20  $ 
18.46 
14.76 
16.11 

Number
of Shares
  244,736  $ 
  185,422 
 (117,834)   
  (26,389)   

  285,935 
  155,138 
 (148,709)   
  (57,385)   

  234,979 
  200,073 
  (87,636)   
  (11,616)   

18.27 
14.55 
17.39 
17.00 

16.68 
15.63 
15.78 
16.38 

  147,663 
  34,275 

5,224 
2,257 
(2,586)    (37,370)   
(976)    (32,066)   

  112,502 
  14,669 

3,919 
3,127 
(1,383)    (73,930)   
(2,523)   

(190)   

21.25 
15.25 
17.38 
17.36 

21.82 
15.24 
17.17 
17.63 

3,138 
523 
(649) 
(557) 

2,455 
224 
(1,269) 
(44) 

  335,800  $ 

16.30  $ 

5,473 

  50,718  $ 

17.63  $ 

1,366 

Outstanding at January 1, 2019
Granted
Vested
Forfeited
Outstanding at December 31, 
2019
Granted
Vested
Forfeited
Outstanding at December 31, 
2020
Granted
Vested
Forfeited
Outstanding at December 31, 
2021

As of December 31, 2021, the unrecognized compensation cost for continuing operations related to non-vested restricted 

stock awards was $2.6 million.  This cost is expected to be recognized over the remaining weighted average period of 1.5 years.  

SARs granted by the Company in 2021 and 2020 vest after 2 years and have a 7-year life.  No SARs were granted prior to 

January 1, 2020 since 1992.  SARs may be settled in cash upon exercise and therefore are classified as liabilities and included 
in accrued expenses in the consolidated balance sheet.  The fair value of these liability awards is remeasured at each reporting 
period until the date of settlement.  Increases and decreases in stock-based compensation expense is recognized over the vesting 
period, or immediately, for vested awards.  

66

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A summary of SARs outstanding at December 31, 2021 and 2020, and changes during those years, is presented below: 

Exercise Price/Share

Number of
SARs

Weighted
Average

—  $ 

Outstanding at January 1, 2020
— 
Granted(a)
11.60 
Modification for special cash dividend
11.60 
Forfeited and expired
11.39 
Outstanding at December 31, 2020
11.64 
Granted
16.37 
Forfeited and expired
13.01 
Exercised
13.87 
Outstanding at December 31, 2021
13.55 
(a) The SARs exercise price per share reflects the reduction to the exercise prices of outstanding SARs as a results of the modification to the 

387,252 
71,402 
(82,214)   
376,440 
164,464 
(10,043)   
(9,260)   
521,601  $ 

19.64 
19.64 
19.64 
19.64 
16.37 
16.37 
15.25 
16.37  $ 

— 
10.75 
10.75 
10.75 
10.75 
16.37 
10.75 
10.75 
10.75 

—  $ 

$ 

$ 

awards pursuant to the nondiscretionary anti-dilution provisions in the related SARs grant agreements.

Range
to
to
to
to
to
to
to
to
to

The grant-date fair value of SARs awards vested was $0.1 million and $0.6 million in 2021 and 2020, respectively.  As of 

December 31, 2021, the unrecognized compensation cost for continuing operations was $0.4 million.  This cost is expected to 
be recognized over the remaining weighted average period of 0.6 years.

 12.   INCOME TAXES 

Income (loss) from continuing operations before income taxes and income tax expense (benefit) for continuing operations 

are as follows:

(In thousands)
Income (loss) from continuing operations before income taxes:

2021

2020

2019

Domestic
Foreign

Total

Current income tax expense (benefit):

Federal
State
Foreign

Total

Deferred income tax expense (benefit):

Federal
State
Foreign

Total
Total income tax expense (benefit)

$ 

$ 

$ 

$ 

22,885  $ 
44,336 
67,221  $ 

(58,033)  $ 
32,987 
(25,046)  $ 

1,232  $ 
764 
13,521 
15,517 

(7,862)   
125 
1,504 
(6,233)   
9,284  $ 

4,777  $ 
136 
2,374 
7,287 

(18,191)   
(640)   
3,331 
(15,500)   
(8,213)  $ 

52,536 
19,470 
72,006 

7,551 
1,558 
579 
9,688 

15,298 
187 
(11,628) 
3,857 
13,545 

67

 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The significant differences between the U.S. federal statutory rate and the effective income tax rate related to continuing 

operations are as follows:

2021

2020

2019

(In thousands, except percentages)
Income tax expense (benefit) at federal statutory rate
Foreign rate differences

Amount
$  14,116 
8,269 

%
 21.0  $ 
 12.3 

Amount

(5,260) 
4,554 

Amount

%
 21.0  $  15,121 
2,247 
 (18.2)   

%
 21.0 
 2.9 

Tax on Prodepe tax incentive

2,858 

 4.3 

(801) 

 3.2 

(714) 

 (1.0) 

Foreign currency translation variation on intercompany loans  
Non-deductible other
State taxes, net of federal income tax benefit
Tax contingency accruals and tax settlements
Foreign derived intangible income deduction
Valuation allowance due to foreign losses and impairments
Dividend received deduction net of foreign withholding tax
Changes in estimates related to prior year tax provision
Research and development tax credit
Valuation allowance for capital loss carryforwards
U.S. tax on foreign branch income
Brazilian tax incentive
    Income tax expense (benefit) at effective income tax rate

$ 

1,374 
1,053 
933 
202 
— 
— 
(109) 
(383) 
(928) 
(5,415) 
(5,667) 
(7,019) 
9,284 

 2.0 
 1.6 
 1.4 
 0.3 
 — 
 — 
 (0.2)   
 (0.6)   
 (1.4)   
 (8.1)   
 (8.4)   
 (10.4)   
 13.8  $ 

— 
208 
(373) 
(58) 
— 
— 
(52) 
(2,472) 
(633) 
52 
1,409 
(4,787) 
(8,213) 

— 
 — 
637 
 (0.8)   
1,050 
 1.5 
(2,543) 
 0.2 
(319) 
 — 
(14,350) 
 — 
(1,016) 
 0.2 
(135) 
 9.9 
(523) 
 2.5 
60 
 (0.2)   
16,029 
 (5.6)   
 19.1 
(1,999) 
 32.8  $  13,545 

 — 
 0.9 
 1.5 
 (3.5) 
 (0.4) 
 (19.9) 
 (1.4) 
 (0.2) 
 (0.7) 
 0.1 
 22.3 
 (2.8) 
 18.8 

Income taxes in 2021 are primarily due to the strong earnings of Terphane Ltda, which are included in Tredegar’s U.S. 
consolidated tax return and, the tax impact of the local statutory tax rates of Tredegar’s foreign subsidiaries being higher than 
the current U.S. tax rate of 21%, the benefit of tax incentives in Brazil and the release of the valuation allowance for capital loss 
carryforwards.  

Income taxes in 2020 were primarily impacted by the tax impact of Terphane Ltda. being included in Tredegar’s U.S. 
consolidated tax return as a foreign branch, the tax impact of the local statutory tax rates of Tredegar’s foreign subsidiaries 
being higher than the current US tax rate of 21%, the benefit of tax incentives in Brazil, and by claims for prior years’ U.S. 
research and development tax credits.

During 2019, due to favorable earnings trends, the Company released a $12.4 million valuation allowance on the net 
deferred tax assets of its Brazilian subsidiary Terphane Ltda.  Because Terphane Ltda. is taxed as a foreign branch for U.S. tax 
purposes, Tredegar also recorded a related deferred tax liability of $12.4 million for the reduction in foreign tax credits that 
would result from Terphane Ltda. realizing this net deferred tax asset. 

Tredegar accrues U.S. federal income taxes on unremitted earnings of all foreign subsidiaries where required.  However, 

due to changes in the taxation of dividends under TCJA, Tredegar will only record U.S. federal income taxes on unremitted 
earnings of its foreign subsidiaries where Tredegar cannot take steps to eliminate any potential tax on future distributions from 
its foreign subsidiaries.  Because of the accumulation of significant losses related to foreign currency translations at Terphane 
Ltda., there were no deferred income tax liabilities associated with the U.S. federal income taxes and foreign withholding taxes 
on Terphane Ltda.’s undistributed earnings as of December 31, 2021 and 2020. 

The Brazilian federal statutory income tax rate is a composite of 34.0% (25.0% of income tax and 9.0% of social 
contribution on income).  Terphane’s manufacturing facility in Brazil is the beneficiary of certain income tax incentives that 
allow for a reduction in the statutory Brazilian federal income tax rate levied on the operating profit of its products.  These 
incentives produce a current tax rate of 15.25% for Terphane (6.25% of income tax and 9.0% social contribution on income). 
The incentives were originally granted for a 10-year period commencing January 1, 2015 and expiring at the end of 2024.  
Terphane Brazil has been granted an additional three years of tax incentives through the end of 2027.  The benefit from the tax 
incentives was $7.0 million,  $4.8 million and $2.0 million in 2021, 2020 and 2019, respectively.

68

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Deferred income tax liabilities and deferred income tax assets at December 31, 2021 and 2020, are as follows: 

(In thousands)
Deferred income tax liabilities:

Amortization of goodwill and identifiable intangibles
Depreciation
Foregone tax credits on foreign branch income
Excess of carrying value over tax basis of investment in kaléo
Right-of-use leased assets
Other

Total deferred income tax liabilities

Deferred income tax assets:

Pensions
Employee benefits
Excess capital losses
Inventory
Asset write-offs, divestitures and environmental accruals
Tax benefit on U.S. federal, state and foreign NOL and credit carryforwards
Other
Lease liabilities
Tax basis remaining for installment sale - kaléo
Foreign currency translation gain adjustment

Deferred income tax assets before valuation allowance

Less: Valuation allowance

Total deferred income tax assets
Net deferred income tax (assets) liabilities
Amounts recognized in the consolidated balance sheets:

Deferred income tax assets (noncurrent)
Deferred income tax liabilities (noncurrent)

Net deferred income tax assets (liabilities)

2021

2020

10,215  $ 
12,902 
4,796 
— 
2,767 
520 
31,200 

5,632 
7,791 
1,097 
3,775 
1,173 
33,922 
146 
2,977 
1,092 
1,970 
59,575 
12,652 
46,923 
(15,723)  $ 

9,520 
10,844 
5,714 
4,905 
2,979 
944 
34,906 

25,576 
9,757 
7,462 
2,613 
2,904 
18,305 
275 
3,144 
— 
1,423 
71,459 
17,485 
53,974 
(19,068) 

15,723  $ 
— 
15,723  $ 

19,068 
— 
19,068 

$ 

$ 

$ 

$ 

Except as noted below, the Company believes that it is more likely than not that future taxable income will exceed future 

tax-deductible amounts thereby resulting in the realization of deferred income tax assets.  The Company has estimated gross 
federal, state and foreign tax credits and net operating loss carryforwards of $33.9 million and $18.3 million at December 31, 
2021 and 2020, respectively.  The U.S. federal foreign tax credits will expire between 2027-2031 and the U.S. federal research 
and development tax credits will expire by 2041.  The U.S. state carryforwards expire at different points over the next 20 years.  

Valuation allowances of $9.4 million, $5.5 million and $2.5 million at December 31, 2021, 2020 and 2019, respectively, 
are recorded against the tax benefit on U.S. federal, state and foreign tax credits and net operating loss carryforwards generated 
by certain foreign and domestic subsidiaries that may not be recoverable in the carryforward period.  The valuation allowance 
for excess capital losses from investments and other related items was $0.7 million, $7.1 million and $1.3 million at 
December 31, 2021, 2020 and 2019, respectively.  The 2021 balance decreased primarily due to utilization of capital losses as a 
result of the sale of the Company’s investment in kaléo. The amount of the deferred income tax asset considered realizable, 
however, could be adjusted in the near term if estimates of the fair value of certain investments during the carryforward period 
change.  As circumstances and events warrant, allowances will be reversed when it is more likely than not that future taxable 
income will exceed deductible amounts, thereby resulting in the realization of deferred income tax assets.  Valuation allowances 
of $2.5 million, $4.9 million and $0 million at December 31, 2021, 2020 and 2019, respectively, were recorded against certain 
deferred state tax assets.  In 2019, the Company reversed a $12.4 million valuation allowance on the net deferred tax assets of 
its Brazilian subsidiary Terphane Ltda due to favorable earnings trends.  Since Terphane Ltda. is taxed as a foreign branch for 
US tax purposes, Tredegar also recorded a related deferred tax liability of $12.4 million for the reduction in foreign tax credits 
that would result from Terphane Ltda. realizing this net deferred tax asset. 

69

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A reconciliation of the Company’s unrecognized uncertain tax positions since January 1, 2019, is shown below:

(In thousands)
Balance at beginning of period
Increase (decrease) due to tax positions taken in:

Current period
Prior period

Increase (decrease) due to settlements with taxing authorities
Reductions due to lapse of statute of limitations
Balance at end of period

Years Ended December 31,
2020

2019

2021

$ 

628  $ 

881  $ 

3,361 

— 
40 
— 
(20)   
648  $ 

12 
— 
— 
(265)   
628  $ 

12 
49 
(151) 
(2,390) 
881 

$ 

Additional information related to unrecognized uncertain tax positions since January 1, 2019 is summarized below:

(In thousands)
Gross unrecognized tax benefits on uncertain tax positions (reflected in
current income tax, other noncurrent liability accounts, or deferred tax 
assets in the balance sheet)

Years Ended December 31,
2020

2019

2021

$ 

648  $ 

628  $ 

881 

Deferred income tax assets related to unrecognized tax benefits on 
uncertain tax positions (reflected in deferred income tax accounts in the 
balance sheet)
Net unrecognized tax benefits on uncertain tax positions, which would 
impact the effective tax rate if recognized
Interest and penalties accrued on deductions taken relating to uncertain 
tax positions (approximately $26, $2 and $(144) reflected in income tax 
expense in the income statement in 2021, 2020 and 2019, respectively, 
with the balance shown in current income tax and other noncurrent 
liability accounts in the balance sheet)
Related deferred income tax assets recognized on interest and penalties
Interest and penalties accrued on uncertain tax positions net of related 
deferred income tax benefits, which would impact the effective tax rate if 
recognized
Total net unrecognized tax benefits on uncertain tax positions reflected in 
the balance sheet, which would impact the effective tax rate if recognized $ 

48 

696 

(110)   

(163) 

518 

718 

133 
(31)   

102 
(24)   

102 

78 

798  $ 

596  $ 

100 
(23) 

77 

795 

Tredegar, or one of its subsidiaries, files income tax returns in the U.S. federal jurisdiction, various states and jurisdictions 
outside the U.S.  With few exceptions, Tredegar is no longer subject to U.S. federal, state or non-U.S. income tax examinations 
by tax authorities for years before 2018.  The Company anticipates that it is reasonably possible that Federal and state income 
tax audits or statutes may settle or close within the next 12 months, which could result in the recognition of up to approximately 
$0.5 million of the balance of unrecognized tax positions, including any payments that may be made.

 13.   BUSINESS SEGMENTS

The Company's business segments are Aluminum Extrusions, PE Films and Flexible Packaging Films.  Aluminum 
Extrusions, also referred to as Bonnell Aluminum, produces high-quality, soft-alloy and medium-strength custom fabricated 
and finished aluminum extrusions for the building and construction, automotive and transportation, consumer durables, 
machinery and equipment, electrical and renewable energy, and distribution markets.  PE Films is composed of surface 
protection films, polyethylene overwrap films and films for other markets.  Flexible Packaging Films is comprised of the 
Company’s polyester films business, Terphane Holdings LLC (“Terphane”).   

The Company’s reportable segments are based on its method of internal reporting, which is generally segregated by 
differences in products.  Accounting standards for presentation of segments require an approach based on the way the Company 
organizes the segments for making operating decisions and how the chief operating decision maker (“CODM”) assesses 
performance.  EBITDA from ongoing operations is the key profitability measure used by the CODM (Tredegar’s President and 
Chief Executive Officer) for purposes of assessing financial performance.  The Company uses sales less freight (“net sales”) 
from continuing operations as its measure of revenues from external customers at the segment level.  This measure is separately 
included in the financial information regularly provided to the CODM.  

70

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Information by business segment and geographic area for the last three years is provided in the segment tables below.  

There were no accounting transactions between segments and no allocations to segments.  

Net Sales

(In thousands)
Aluminum Extrusions
PE Films
Flexible Packaging Films
Total net sales

Add back freight
Sales as shown in consolidated statements of income

Refer to Notes to Financial Tables that follow these tables. 

2021

2020

2019

539,325  $ 
118,920 
139,978 
798,223 
28,232 
826,455  $ 

455,711  $ 
139,288 
134,605 
729,604 
25,686 
755,290  $ 

529,602 
133,807 
133,935 
797,344 
28,980 
826,324 

$ 

$ 

EBITDA from Ongoing Operations

2021

2020

2019

(In thousands)
Aluminum Extrusions:

Ongoing operations:
EBITDA
Depreciation & amortization (d)
EBIT

Plant shutdowns, asset impairments, restructurings and other (a)
Goodwill impairment charge
Trade name accelerated amortization (d)

PE Films:

Ongoing operations:
EBITDA
Depreciation & amortization
EBIT

Plant shutdowns, asset impairments, restructurings and other (a)

Flexible Packaging Films:

Ongoing operations:
EBITDA
Depreciation & amortization
EBIT

Plant shutdowns, asset impairments, restructurings and other (a)

Total
Interest income
Interest expense
Gain (loss) on investment in kaléo (a)
Loss on sale of Bright View (f)
Stock option-based compensation expense
Corporate expenses, net (a)
Income (loss) from continuing operations before income taxes
Income tax expense (benefit) (a)
Income (loss) from continuing operations
Income (loss) from discontinued operations, net of tax (a)
Net income (loss)

Refer to Notes to Financial Tables that follow these tables. 

71

$ 

55,948  $ 
(16,272)   
39,676 
3,237 
— 
— 

55,137  $ 
(17,403)   
37,734 
(3,506)   
(13,696)   

— 

27,694 
(6,263)   
21,431 

(371)   

45,107 
(6,762)   
38,345 
(1,974)   

31,684 
(1,988)   
29,696 
8,439 
102,108 
73 
3,386 
12,780 
— 
2,495 
41,859 
67,221 
9,284 
57,937 

(111)   
57,826  $ 

$ 

30,645 
(1,761)   
28,884 

(18)   

85,769 
44 
2,587 
(60,900)   
(2,299)   
2,161 
42,912 
(25,046)   
(8,213)   
(16,833)   
(58,611)   
(75,444)  $ 

65,683 
(16,719) 
48,964 
(561) 
— 
(10,040) 

41,133 
(5,860) 
35,273 
(733) 

14,737 
(1,517) 
13,220 
— 
86,123 
66 
4,051 
28,482 
— 
4,132 
34,482 
72,006 
13,545 
58,461 
(10,202) 
48,259 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
Aluminum Extrusions
PE Films
Flexible Packaging Films

Subtotal
General corporate
Cash and cash equivalents (b)
Discontinued operations

Total

(In thousands)
Aluminum Extrusions
PE Films
Flexible Packaging Films

Subtotal

General corporate (e)
Discontinued operations

Total

(In thousands)
United States
Exports from the United States to:

Asia
Canada
Europe
Latin America

Operations outside the United States:

Brazil
China
Total

(In thousands)
United States
Operations outside the United States:

Brazil
China

General corporate
Cash and cash equivalents (b)
Discontinued operations

Total

Identifiable Assets

2021

2020

280,521  $ 
113,613 
75,269 
469,403 
23,482 
30,521 
178 
523,584  $ 

244,560 
119,013 
66,453 
430,026 
71,508 
11,846 
1,490 
514,870 

$ 

$ 

Depreciation and Amortization
2019
2020
2021

Capital Expenditures
2020

2019

2021

$ 

$ 

15,326  $ 
6,263 
1,988 
23,577 
207 
— 
23,784  $ 

17,403  $ 
6,762 
1,761 
25,926 
520 
5,511 
31,957  $ 

26,759  $ 
5,860 
1,517 
34,136 
186 
9,962 
44,284  $ 

18,914  $ 
2,997 
5,603 
27,514 

(153)   
— 
27,361  $ 

10,260  $ 
6,024 
4,959 
21,243 
200 
1,912 
23,355  $ 

17,855 
8,567 
8,866 
35,288 
223 
15,353 
50,864 

Net Sales by Geographic Area (c)

2021

2020

2019

$ 

614,987  $ 

530,243  $ 

593,599 

59,242 
17,776 
4,489 
4,937 

80,217 
18,024 
5,440 
2,169 

82,342 
15,022 
5,752 
4,135 

96,792 
— 
798,223  $ 

93,511 
— 
729,604  $ 

96,274 
220 
797,344 

$ 

Identifiable Assets
by Geographic Area (c)
2020
2021

Property, Plant & Equipment,
Net by Geographic Area (c)

2021

2020

$ 

398,749  $ 

363,106  $ 

135,310  $ 

132,268 

54,299 
16,355 
23,482 
30,521 
178 
523,584  $ 

49,157 
17,763 
71,508 
11,846 
1,490 
514,870  $ 

18,615 
14,889 
1,567 
n/a
— 
170,381  $ 

15,588 
16,245 
2,444 
n/a
— 
166,545 

$ 

72

Refer to Notes to Financial Tables that follow these tables.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Company’s facilities in Pottsville, PA (“PV”) and Guangzhou, China (“GZ”) have a tolling arrangement whereby 

certain surface protection films are manufactured in GZ for a fee with raw materials supplied from PV that are then shipped by 
GZ directly to customers principally in the Asian market but paid by customers directly to PV.  Amounts associated with this 
intercompany tolling arrangement are reported in the table above as export sales from the U.S. to Asia, and include net sales of 
$32.7 million in 2021, $35.1 million in 2020 and $32.1 million in 2019. 

Net Sales by Product Group

(In thousands)
Aluminum Extrusions:

Nonresidential building & construction
Consumer durables
Automotive
Machinery & equipment
Distribution
Residential building & construction
Electrical

Subtotal

PE Films:

Surface protection films
Packaging
LED-based products

Subtotal
Flexible Packaging Films

Total

2021

2020

2019

$ 

$ 

269,252  $ 
53,578 
43,256 
42,721 
45,639 
52,236 
32,643 
539,325 

88,436 
30,484 
— 
118,920 
139,978 
798,223  $ 

253,126  $ 
44,167 
35,895 
30,649 
28,339 
40,049 
23,486 
455,711 

109,097 
22,700 
7,491 
139,288 
134,605 
729,604  $ 

272,729 
57,607 
46,461 
38,657 
34,753 
43,554 
35,841 
529,602 

103,893 
22,542 
7,372 
133,807 
133,935 
797,344 

(a) See Notes 1, 9, 15, 16 and 17 for more information on losses associated with plant shutdowns, asset impairments and restructurings, unusual items, gains or 

losses from sale of assets, gains or losses on an investment accounted for under the fair value method and other items.

(b) Cash and cash equivalents includes funds held in locations outside the U.S. of $16.4 million and $9.4 million at December 31, 2021 and 2020, respectively.  
(c) Information on exports and foreign operations are provided on the previous page.  Export sales relate almost entirely to PE Films. Operations in China 

relate to PE Films.  Operations in Brazil relate to Flexible Packaging Films.  

(d) Depreciation and amortization for Aluminum Extrusions in 2019 excludes $10.0 million for accelerated amortization of trade names as a result of a 

rebranding initiative (see Note 5 for more information)

(e) Corporate depreciation and amortization are included in Corporate expenses, net, on the EBITDA from ongoing operations table above.
(f)

In December 2020, the Company completed the sale of Bright View.   See Note 15 for more details.  

 14.   SAVINGS PLAN

Tredegar has a savings plan that allows eligible employees to voluntarily contribute a percentage of their compensation, 

up to Internal Revenue Service (“IRS”) limitations.  The provisions of the savings plan provided the following benefits for 
salaried and certain hourly employees:

•

•

The Company makes matching contributions to the savings plan of $1 for every $1 an employee contributes per pay 
period up to a maximum of 5% of eligible compensation. 

The savings plan includes immediate vesting of matching contributions and automatic enrollment at 3% of eligible 
compensation unless the employee opts out or elects a different percentage.

The Company also has a non-qualified plan that restores matching benefits for employees suspended from the savings 
plan due to certain limitations imposed by income tax regulations (“restoration plan”).  Charges recognized for these plans were 
$3.3 million in 2021, $4.0 million in 2020 and $3.9 million in 2019.  The Company’s liability under the restoration plan was 
$0.7 million at December 31, 2021 (consisting of 56,570 phantom shares of common stock) and $1.0 million at December 31, 
2020 (consisting of 61,394 phantom shares of common stock) and valued at the closing market price on those dates.

The Tredegar Corporation Benefits Plan Trust (the “Trust”) purchased 7,200 shares of the Company’s common stock in 
1998 for $0.2 million and 46,671 shares of its common stock in 1997 for $1.0 million, which were intended as a hedge against 
the phantom shares held in the restoration plan.  There have been no shares purchased since 1998 except for re-invested 
dividends.  The cost of the shares held by the Trust is shown as a reduction to shareholders’ equity in the consolidated balance 
sheets. 

73

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 15.   DIVESTITURES AND ASSETS HELD FOR SALE

Divestitures

Personal Care Films

In 2020, the Company completed the sale of Personal Care Films for an aggregate purchase price of $60.5 million, subject 

to customary adjustments.  The Company agreed to provide certain transition services related to finance, human resources and 
information technology (“IT”) that ended during the second quarter of 2021, resulting in final cash proceeds of $64.1 million.  
Personal Care Films was previously reported in the PE Films segment.  

 The following table summarizes the financial results of discontinued operations reflected in the Consolidated Statements 

of Income for the year ended December 31, 2021, 2020 and 2019:

(In thousands)
Revenues and other items:

Sales
Other income (expense), net

Costs and expenses:

Cost of goods sold
Freight
Selling, general and administrative
Research and development
Asset impairments and costs associated with exit and disposal 
activities, net of adjustments
Adjustment to the fair value estimates used in the disposal of 
Personal Care Films (a)
Loss on sale of business

Total

Years Ended December 31
2020

2021

2019

$ 

—  $ 
— 
— 

110,246  $ 
(333)   

109,913 

— 
— 
739 
— 

— 

92,079 
5,229 
16,824 
8,863 

1,529 

146,034 
6,424 
152,458 

126,371 
7,083 
17,754 
11,743 

3,341 

(1,118)   
— 
(379)   
379 
490 
(111)  $ 

— 
50,027 
174,551 
(64,638)   
(6,027)   
(58,611)  $ 

— 
— 
166,292 
(13,834) 
(3,632) 
(10,202) 

Income (loss) from discontinued operations before income taxes
Income tax expense (benefit)
Income (loss) from discontinued operations, net of tax
(a)   Represents a net increase to the estimated fair value of Personal Care Films primarily due to lower costs associated with 
IT transition-related services to provide the seller developed assets, which did not exist at the time of the sale, to support 
the seller’s IT infrastructure. 

$ 

The assets and liabilities of the discontinued operations reflected in the Consolidated Balance Sheets as of December 31, 

2021 and 2020, respectively were as follows:

(In thousands)
Assets
Prepaid expenses and other (a)
Other assets

Total assets of discontinued operations

December 31

2021

2020

$ 

$ 

178  $ 
— 
178  $ 

1,339 
151 
1,490 

Liabilities
Accrued expenses (a)
7,521 
(a)  The consolidated balance sheet of discontinued operations as of December 31, 2021 includes $0.2 million of other receivables related to 
the settlement of customary post-closing adjustments and other miscellaneous accrued expenses of $0.2 million. The consolidated balance 
sheet of discontinued operations as of December 31, 2020 includes $0.4 million of other receivables related to the settlement of customary 
post-closing adjustments, deferred assets of $0.9 million and deferred obligations of $5.3 million related to transition services, accrued 
severance of $2.1 million, and other miscellaneous accrued expenses of $0.2 million.

193  $ 

$ 

74

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The following table provides significant operating and investing cash flow information for discontinued operations:

(In thousands)

Operating activities:

Year Ended December 31,

2021

2020

2019

Depreciation and amortization

$ 

—  $ 

5,511  $ 

Gain from the sale of the Shanghai manufacturing facility assets

Loss on sale of Personal Care Films

Other

Total

Investing activities:

Net proceeds on sale of Personal Care Films
Proceeds from the sale of the Shanghai manufacturing facility assets

Capital expenditures

Total

Bright View 

— 

— 

(1,118)   

(1,118)   

— 

50,027 

— 

55,538 

9,962 

(6,316) 

— 

— 

3,646 

$ 

$ 

—  $ 
— 

— 

55,115  $ 
— 

— 
10,936 

(1,912)   

(15,353) 

—  $ 

53,203  $ 

(4,417) 

In December 2020, the Company entered into a definitive agreement and completed the sale of Bright View, which 
resulted in the recognition of a pre-tax loss of $2.3 million ($1.8 million after-tax) included in “Other income (expense), net” in 
the consolidated statements of income for the year ended December 31, 2020.  The sale did not represent a strategic shift nor 
did it have a major effect on the Company’s historical and ongoing operations, thus all financial information for Bright View 
has been presented as continuing operations within the PE Films segment.

Assets Held For Sale

In July 2019, the Company committed to a plan to close its manufacturing facility in Lake Zurich, Illinois, which 
historically was reported within the personal care component of its PE Films segment.  As of December 31, 2020, the disposal 
group carrying value of $4.6 million was reported in "Prepaid expenses and other" in the consolidated balance sheet as the held 
for sale criteria was met.  During the third quarter of 2021, the Company completed the sale of the remaining assets in Lake 
Zurich, Illinois resulting in total cash proceeds of $4.7 million.

 16.   INVESTMENTS

In August 2007 and December 2008, the Company made an aggregate investment of $7.5 million in kaleo, Inc. (“kaléo”), 

a privately held specialty pharmaceutical company dedicated to building innovative solutions for serious and life-threatening 
medical conditions.  Tredegar historically accounted for its investment in kaléo under the fair value option.  At the time of the 
initial investment, the Company elected the fair value option of accounting since its investment objectives were similar to those 
of venture capitalists, which typically do not have controlling financial interests.  kaléo’s stock is not publicly traded.

On December 27, 2021, the Company completed the sale of its investment interests in kaléo (Series A-3 Preferred Stock, 

Series B Preferred Stock and common stock) that, taken together, represented on a fully-diluted basis an approximate 18% 
interest in kaléo.  Tredegar received closing cash proceeds of $47.1 million.  A pre-tax gain of $12.8 million on the Company’s 
investment in kaléo was recognized in the full year ended December 31, 2021 compared to a pre-tax loss of $60.9 million and 
pre-tax gain of $28.5 million in the full years ended December 31, 2020 and 2019, respectively, which are reported in “Other 
income (expense), net” in the consolidated statements of income.  The gain in 2021 includes a $0.3 million dividend received 
from kaléo in the first quarter of 2021 and the gain in 2019 includes a $17.6 million dividend received from kaléo.

 17.   ASSET IMPAIRMENTS AND COSTS ASSOCIATED WITH EXIT AND DISPOSAL ACTIVITIES 

In connection with the anticipated customer product transitions in Surface Protection, the Company recognized severance 

and other employee-related expenses of $1.6 million in the fourth quarter of 2020.  The Company recognizes termination 
benefits that are covered by a contract or an ongoing benefit arrangement when it is probable that employees will be entitled to 
benefits and the amount can be reasonably estimated.  Other accrued expenses and losses related to asset impairments and costs 
associated with exit and disposal activities for continuing operations were not material for the years ended December 31, 2021, 
2020 and 2019, respectively.

 18.   CONTINGENCIES 

Tredegar is involved in various stages of investigation and remediation relating to environmental matters at certain current 

and former plant locations.  Where the Company has determined the nature and scope of any required environmental 

75

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
remediation activity, estimates of cleanup costs have been obtained and accrued.  As efforts continue to maintain compliance 
with applicable environmental laws and regulations, additional contingencies may be identified.  If additional contingencies are 
identified in the future, the Company’s practice is to determine at that time the nature and scope of those contingencies, obtain 
and accrue estimates of the cost of remediation, and perform remediation.  While the Company believes it is currently 
adequately accrued for known environmental issues, it is possible that unexpected future costs for known or unknown 
environmental issues could have a material adverse effect on its financial condition, results of operations and cash flows at that 
time.

The Company is involved in various other legal actions arising in the normal course of business.  After taking into 
consideration the relevant information, the Company believes that it has sufficiently accrued for probable losses and that the 
actions will not have a material adverse effect on its financial position. 

From time to time, the Company enters into transactions with third parties in connection with the sale of assets or 

businesses in which it agrees to indemnify the buyers or third parties involved in the transaction, or in which the sellers or third 
parties involved in the transaction agree to indemnify Tredegar, for certain liabilities or risks related to the assets or business. 
Also, in the ordinary course of its business, the Company may enter into agreements with third parties for the sale of goods or 
services that may contain indemnification provisions.  In the event that an indemnification claim is asserted, liability for 
indemnification would be subject to an assessment of the underlying facts and circumstances under the terms of the applicable 
agreement.  For these reasons, Tredegar is unable to estimate the maximum amount of the potential future liability under the 
indemnity provisions of these agreements.  The Company does, however, accrue for losses for any known contingent liability, 
including those that may arise from indemnification provisions, when future payment is probable and the amount is reasonably 
estimable.  The Company discloses contingent liabilities if the probability of loss is reasonably possible and material.

76

 19.   SELECTED QUARTERLY FINANCIAL DATA

Tredegar Corporation and Subsidiaries
(In Thousands, Except Per-Share Amounts)
(Unaudited)

For the year ended December 31, 2021

Sales
Gross profit

Income (loss) from continuing operations, net of tax
Income (loss) from discontinued operations, net of tax
Net income (loss)

Earnings (loss) per share:

Basic:

Continuing operations
Discontinued operations

Basic

Diluted:

Continuing operations
Discontinued operations

Diluted

For the year ended December 31, 2020

Sales
Gross profit

Income (loss) from continuing operations, net of tax
Income (loss) from discontinued operations, net of tax
Net income

Earnings per share:

Basic:

Continuing operations
Discontinued operations

Basic

Diluted:

Continuing operations
Discontinued operations

Diluted

First
Quarter

Second
Quarter

Third
Quarter

Fourth
Quarter

184,822  $ 
37,313 

211,129  $ 
45,394 

209,517  $ 
31,497 

220,986 
34,328 

9,618 
(587)   
9,031  $ 

20,728 
508 
21,236  $ 

6,229 

(26)   
6,203  $ 

21,358 
(6) 
21,352 

0.29  $ 
(0.02)   
0.27  $ 

0.29  $ 
(0.02)   
0.27  $ 

0.62  $ 
0.02 
0.64  $ 

0.61  $ 
0.02 
0.63  $ 

0.19  $ 
— 
0.19  $ 

0.19  $ 
— 
0.19  $ 

0.64 
— 
0.64 

0.63 
— 
0.63 

192,136  $ 
40,092 

186,260  $ 
46,331 

184,370  $ 
41,909 

192,524 
42,305 

(20,663)   
(1,658)   
(22,321)  $ 

14,332 
(3,136)   
11,196  $ 

(16,976)   
(48,237)   
(65,213)  $ 

6,475 
(5,580) 
895 

(0.62)  $ 
(0.05)   
(0.67)  $ 

0.43  $ 
(0.10)   
0.33  $ 

(0.51)  $ 
(1.44)   
(1.95)  $ 

(0.62)  $ 
(0.05)   
(0.67)  $ 

0.43  $ 
(0.10)   
0.33  $ 

(0.51)  $ 
(1.44)   
(1.95)  $ 

0.19 
(0.17) 
0.02 

0.19 
(0.17) 
0.02 

$ 

$ 

$ 

$ 

$ 

$ 

$ 

$ 

$ 

$ 

$ 

$ 

Due to rounding, the sum of quarterly amounts presented in the table above may not add up precisely to the corresponding 

full year amounts.

Item 16.       FORM 10-K SUMMARY

Not Applicable.

77

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EXHIBIT INDEX
EXHIBIT INDEX

3.1
3.1

3.2
3.2

4.1
4.1

10.1
10.1

3.1.3
3.1.3

3.1.2
3.1.2

3.1.1
3.1.1

10.1.2
10.1.2

10.1.1
10.1.1

Amended and Restated Articles of Incorporation of Tredegar (filed as Exhibit 3.1 to Tredegar’s Annual Report on 
Amended and Restated Articles of Incorporation of Tredegar (filed as Exhibit 3.1 to Tredegar’s Annual Report on 
Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)
Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)
Articles of Amendment to Amended and Restated Articles of Incorporation of Tredegar (filed as Exhibit 3.3 to 
Articles of Amendment to Amended and Restated Articles of Incorporation of Tredegar (filed as Exhibit 3.3 to 
Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and 
Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and 
incorporated herein by reference)
incorporated herein by reference)
Articles of Amendment to Amended and Restated Articles of Incorporation of Tredegar, as of May 24, 2013 (filed 
Articles of Amendment to Amended and Restated Articles of Incorporation of Tredegar, as of May 24, 2013 (filed 
as Exhibit 3.1 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on May 29, 2013 and 
as Exhibit 3.1 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on May 29, 2013 and 
incorporated herein by reference)
incorporated herein by reference)
Articles of Amendment to Amended and Restated Articles of Incorporation of Tredegar, as of May 4, 2016 (filed as 
Articles of Amendment to Amended and Restated Articles of Incorporation of Tredegar, as of May 4, 2016 (filed as 
Exhibit 3.1 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on May 6, 2016, and incorporated 
Exhibit 3.1 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on May 6, 2016, and incorporated 
herein by reference)
herein by reference)
Amended and Restated Bylaws of Tredegar (filed as Exhibit 3.1 to Tredegar’s Current Report on Form 8-K (File 
Amended and Restated Bylaws of Tredegar (filed as Exhibit 3.1 to Tredegar’s Current Report on Form 8-K (File 
No. 1-10258), filed on March 30, 2020, and incorporated herein by reference)
No. 1-10258), filed on March 30, 2020, and incorporated herein by reference)
Description of Registered Securities (filed as Exhibit 4.1 to Tredegar’s Annual Report on Form 10-K (File No 
Description of Registered Securities (filed as Exhibit 4.1 to Tredegar’s Annual Report on Form 10-K (File No 
1-10258) for the year ended December 31, 2019, and incorporated herein by reference)
1-10258) for the year ended December 31, 2019, and incorporated herein by reference)
Amended and Restated Credit Agreement, dated as of June 28, 2019, among Tredegar, as borrower, the lenders 
Amended and Restated Credit Agreement, dated as of June 28, 2019, among Tredegar, as borrower, the lenders 
named therein, JPMorgan Chase Bank, N.A., as administrative agent, SunTrust Bank, Citizens Bank, N.A. and PNC 
named therein, JPMorgan Chase Bank, N.A., as administrative agent, SunTrust Bank, Citizens Bank, N.A. and PNC 
Bank, National Association, as co-syndication agents, and U.S. Bank National Association, Bank of America, N.A. 
Bank, National Association, as co-syndication agents, and U.S. Bank National Association, Bank of America, N.A. 
and Wells Fargo Bank, National Association, as co-documentation agents, and the other lenders party thereto (filed 
and Wells Fargo Bank, National Association, as co-documentation agents, and the other lenders party thereto (filed 
as Exhibit 4.1 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on July 1, 2019, and incorporated 
as Exhibit 4.1 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on July 1, 2019, and incorporated 
herein by reference)
herein by reference)
Amended and Restated Guaranty, dated as of June 28, 2019, by and among the subsidiaries of Tredegar listed on the 
Amended and Restated Guaranty, dated as of June 28, 2019, by and among the subsidiaries of Tredegar listed on the 
signature pages thereto in favor of JPMorgan Chase Bank, N.A., as administrative agent, for the ratable benefit of 
signature pages thereto in favor of JPMorgan Chase Bank, N.A., as administrative agent, for the ratable benefit of 
the Holders of Guaranteed Obligations (as defined therein) (filed as Exhibit 4.2 to Tredegar’s Current Report on 
the Holders of Guaranteed Obligations (as defined therein) (filed as Exhibit 4.2 to Tredegar’s Current Report on 
Form 8-K (File No. 1-10258), filed on July 1, 2019, and incorporated herein by reference)
Form 8-K (File No. 1-10258), filed on July 1, 2019, and incorporated herein by reference)
Amended and Restated Pledge and Security Agreement, dated as of June 28, 2019, by and among Tredegar and the 
Amended and Restated Pledge and Security Agreement, dated as of June 28, 2019, by and among Tredegar and the 
subsidiaries of Tredegar listed on the signature pages thereto and JPMorgan Chase Bank, N.A., as administrative 
subsidiaries of Tredegar listed on the signature pages thereto and JPMorgan Chase Bank, N.A., as administrative 
agent, for the ratable benefit of the Secured Parties (as defined therein) (filed as Exhibit 4.3 to Tredegar’s Current 
agent, for the ratable benefit of the Secured Parties (as defined therein) (filed as Exhibit 4.3 to Tredegar’s Current 
Report on Form 8-K (File No. 1-10258), filed on July 1, 2019, and incorporated herein by reference)
Report on Form 8-K (File No. 1-10258), filed on July 1, 2019, and incorporated herein by reference)
Amendment No. 1 to the Amended and Restated Credit Agreement, dated as of December 1, 2020, among Tredegar 
Amendment No. 1 to the Amended and Restated Credit Agreement, dated as of December 1, 2020, among Tredegar 
Corporation, as borrower, the lenders named therein, JPMorgan Chase Bank, N.A., as administrative agent, Truist 
Corporation, as borrower, the lenders named therein, JPMorgan Chase Bank, N.A., as administrative agent, Truist 
Bank, Citizens Bank, N.A. and PNC Bank, National Association, as co-syndication agents, and U.S. Bank National 
Bank, Citizens Bank, N.A. and PNC Bank, National Association, as co-syndication agents, and U.S. Bank National 
Association, Bank of America, N.A. and Wells Fargo Bank, National Association, as co-documentation agents, and 
Association, Bank of America, N.A. and Wells Fargo Bank, National Association, as co-documentation agents, and 
the other lenders party thereto (filed as Exhibit 4.1 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), 
the other lenders party thereto (filed as Exhibit 4.1 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), 
filed on December 3, 2020, and incorporated herein by reference)
filed on December 3, 2020, and incorporated herein by reference)
Reorganization and Distribution Agreement, dated as of June 1, 1989, between Tredegar and Ethyl Corporation 
Amendment No. 2 to the Amended and Restated Credit Agreement, dated as of November 22, 2021, among 
(filed as Exhibit 10.1 to Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 
Tredegar Corporation, as borrower, the lenders named therein, JPMorgan Chase Bank, N.A., as administrative agent, 
31, 2004, and incorporated herein by reference)
Truist Bank, Citizens Bank, N.A. and PNC Bank, National Association, as co-syndication agents, and U.S. Bank 
National Association, Bank of America, N.A. and Wells Fargo Bank, National Association, as co-documentation 
Employee Benefits Agreement, dated as of June 1, 1989, between Tredegar and Ethyl Corporation (filed as Exhibit 
agents, and the other lenders party thereto
10.2 to Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and 
incorporated herein by reference)
Reorganization and Distribution Agreement, dated as of June 1, 1989, between Tredegar and Ethyl Corporation 
(filed as Exhibit 10.1 to Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 
Tax Sharing Agreement, dated as of June 1, 1989, between Tredegar and Ethyl Corporation (filed as Exhibit 10.3 to 
31, 2004, and incorporated herein by reference)
Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and 
incorporated herein by reference)
Employee Benefits Agreement, dated as of June 1, 1989, between Tredegar and Ethyl Corporation (filed as Exhibit
10.2 to Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and 
Indemnification Agreement, dated as of June 1, 1989, between Tredegar and Ethyl Corporation (filed as Exhibit 10.4 
incorporated herein by reference)
to Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and 
incorporated herein by reference)
Tax Sharing Agreement, dated as of June 1, 1989, between Tredegar and Ethyl Corporation (filed as Exhibit 10.3 to 
Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and 
Tredegar Industries, Inc. Retirement Benefit Restoration Plan (filed as Exhibit 10.7 to Tredegar’s Annual Report on 
incorporated herein by reference)
Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)
10.5
Indemnification Agreement, dated as of June 1, 1989, between Tredegar and Ethyl Corporation (filed as Exhibit 10.4 
*10.6.1 Amendment to the Tredegar Industries, Inc. Retirement Benefit Restoration Plan (filed as Exhibit 10.7.1 to 
to Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and 
Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and 
incorporated herein by reference)
incorporated herein by reference)
Tredegar Industries, Inc. Retirement Benefit Restoration Plan (filed as Exhibit 10.7 to Tredegar’s Annual Report on
Tredegar Industries, Inc. Savings Plan Benefit Restoration Plan (filed as Exhibit 10.6 to Tredegar’s Annual Report 
Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)
on Form 10-K (File No. 1-10258) for the year ended December 31, 2013, and incorporated herein by reference)
*10.6.1 Amendment to the Tredegar Industries, Inc. Retirement Benefit Restoration Plan (filed as Exhibit 10.7.1 to
*10.7.1 Resolutions of the Executive Committee of the Board of Directors of Tredegar adopted on December 28, 2004 
Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and 
(effective as of December 31, 2004) amending the Tredegar Corporation Retirement Savings Plan Benefit 
incorporated herein by reference)
Restoration Plan (filed as Exhibit 10.9.1 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on 
December 30, 2004, and incorporated herein by reference)
Tredegar Industries, Inc. Savings Plan Benefit Restoration Plan (filed as Exhibit 10.6 to Tredegar’s Annual Report
on Form 10-K (File No. 1-10258) for the year ended December 31, 2013, and incorporated herein by reference)

10.4
*10.6

*10.3
10.5

10.2
10.4

*10.6
*10.7

10.1.3
10.1.3

10.2
10.1.4

*10.7

*10.3

1
78

 
*10.16

*10.9
*10.8

*10.15
*10.14

*10.14
*10.13

*10.10
*10.9

*10.11
*10.10
*10.12

*10.11
*10.13
*10.12

*10.7.1 Resolutions of the Executive Committee of the Board of Directors of Tredegar adopted on December 28, 2004 
*10.8
Tredegar 2004 Equity Incentive Plan as Amended and Restated Effective March 27, 2009 (filed as Annex 1 to 
Tredegar’s Definitive Proxy Statement on Schedule 14A (File No. 1-10258) filed on April 14, 2009 and 
(effective as of December 31, 2004) amending the Tredegar Corporation Retirement Savings Plan Benefit 
incorporated herein by reference)
Restoration Plan (filed as Exhibit 10.9.1 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on 
December 30, 2004, and incorporated herein by reference)
Form of Notice of Nonstatutory Stock Option Grant and Nonstatutory Stock Option Terms and Conditions (filed as 
Exhibit 10.3 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on February 27, 2013, and 
Tredegar 2004 Equity Incentive Plan as Amended and Restated Effective March 27, 2009 (filed as Annex 1 to 
incorporated herein by reference)
Tredegar’s Definitive Proxy Statement on Schedule 14A (File No. 1-10258) filed on April 14, 2009 and 
incorporated herein by reference)
Form of Notice of Stock Unit Award and Stock Unit Award Terms and Conditions (filed as Exhibit 10.1 to 
Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on March 1, 2016, and incorporated herein by 
Form of Notice of Nonstatutory Stock Option Grant and Nonstatutory Stock Option Terms and Conditions (filed as 
reference)
Exhibit 10.3 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on February 27, 2013, and 
incorporated herein by reference)
Form of Notice of Stock Award and Stock Award Terms and Conditions (filed as Exhibit 10.2 to Tredegar’s Current 
Report on Form 8-K (File No. 1-10258), filed on March 1, 2016, and incorporated herein by reference)
Form of Notice of Stock Unit Award and Stock Unit Award Terms and Conditions (filed as Exhibit 10.1 to 
Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on March 1, 2016, and incorporated herein by 
Form of Notice of Stock Award and Stock Award Terms and Conditions (filed as Exhibit 10.18 to Tredegar’s 
reference)
Quarterly Report on Form 10-Q (File No. 1-10258) for the quarterly period ended March 31, 2020, and incorporated 
herein by reference)
Form of Notice of Stock Award and Stock Award Terms and Conditions (filed as Exhibit 10.2 to Tredegar’s Current 
Report on Form 8-K (File No. 1-10258), filed on March 1, 2016, and incorporated herein by reference)
Form of Notice of Stock Appreciation Right Grant and Stock Appreciation Right Terms and Conditions (filed as 
Exhibit 10.19 to Tredegar’s Quarterly Report on Form 10-Q (File No. 1-10258) for the quarterly period ended 
Form of Notice of Stock Award and Stock Award Terms and Conditions (filed as Exhibit 10.18 to Tredegar’s 
March 31, 2020, and incorporated herein by reference)
Quarterly Report on Form 10-Q (File No. 1-10258) for the quarterly period ended March 31, 2020, and incorporated 
herein by reference)
Form of Notice of Nonstatutory Stock Option Grant and Nonstatutory Stock Option Terms and Conditions (filed as 
Form of Notice of Stock Appreciation Right Grant and Stock Appreciation Right Terms and Conditions (filed as 
Exhibit 10.20 to Tredegar’s Quarterly Report on Form 10-Q (File No. 1-10258) for the quarterly period ended 
Exhibit 10.19 to Tredegar’s Quarterly Report on Form 10-Q (File No. 1-10258) for the quarterly period ended 
March 31, 2020, and incorporated herein by reference)
March 31, 2020, and incorporated herein by reference)
Tredegar 2018 Equity Incentive Plan, as amended and restated (filed as Annex A to Tredegar’s Definitive Proxy 
Form of Notice of Nonstatutory Stock Option Grant and Nonstatutory Stock Option Terms and Conditions (filed as 
Statement on Schedule 14A (File No. 1-10258) filed on March 25, 2021, and incorporated herein by reference)
Exhibit 10.20 to Tredegar’s Quarterly Report on Form 10-Q (File No. 1-10258) for the quarterly period ended 
Form of Notice of Nonstatutory Stock Option Grant and Nonstatutory Stock Option Terms and Conditions (filed as 
March 31, 2020, and incorporated herein by reference)
Exhibit 10.1 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on May 7, 2018, and incorporated 
herein by reference)
Tredegar 2018 Equity Incentive Plan, as amended and restated (filed as Annex A to Tredegar’s Definitive Proxy 
Statement on Schedule 14A (File No. 1-10258) filed on March 25, 2021, and incorporated herein by reference)
Form of Notice of Nonstatutory Stock Option Grant and Nonstatutory Stock Option Terms and Conditions (filed as 
Exhibit 10.3 to Tredegar Corporation’s Registration Statement on Form S-8 (Registration No. 333-230386), filed on 
Form of Notice of Nonstatutory Stock Option Grant and Nonstatutory Stock Option Terms and Conditions (filed as 
March 19, 2019, and incorporated herein by reference) 
Exhibit 10.1 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on May 7, 2018, and incorporated 
herein by reference)
Subsidiaries of Tredegar 
Form of Notice of Nonstatutory Stock Option Grant and Nonstatutory Stock Option Terms and Conditions (filed as 
Consent of KPMG LLP, Independent Registered Public Accounting Firm
Exhibit 10.3 to Tredegar Corporation’s Registration Statement on Form S-8 (Registration No. 333-230386), filed on 
Certification of President and Chief Executive Officer (Principal Executive Officer) of Tredegar, pursuant to Rules 
March 19, 2019, and incorporated herein by reference) 
13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as adopted pursuant to Section 
Subsidiaries of Tredegar 
302 of the Sarbanes-Oxley Act of 2002
Consent of KPMG LLP, Independent Registered Public Accounting Firm
Certification of Vice President and Chief Financial Officer (Principal Financial Officer) of Tredegar, pursuant to 
Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as adopted pursuant to 
Certification of President and Chief Executive Officer (Principal Executive Officer) of Tredegar, pursuant to Rules 
Section 302 of the Sarbanes-Oxley Act of 2002
13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as adopted pursuant to Section 
302 of the Sarbanes-Oxley Act of 2002
Certification of President and Chief Executive Officer (Principal Executive Officer) of Tredegar, pursuant to 18 
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Certification of Vice President and Chief Financial Officer (Principal Financial Officer) of Tredegar, pursuant to 
Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as adopted pursuant to 
Certification of Vice President and Chief Financial Officer (Principal Financial Officer) of Tredegar, pursuant to 18 
Section 302 of the Sarbanes-Oxley Act of 2002
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Certification of President and Chief Executive Officer (Principal Executive Officer) of Tredegar, pursuant to 18 
XBRL Instance Document and Related Items
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Cover Page Interactive Data File (formatted in iXBRL and contained in Exhibit 101)
Certification of Vice President and Chief Financial Officer (Principal Financial Officer) of Tredegar, pursuant to 18 
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
XBRL Instance Document and Related Items
Cover Page Interactive Data File (formatted in iXBRL and contained in Exhibit 101)

Denotes compensatory plans or arrangements or management contracts.

+32.1
+101
+104
+32.2
*
+101
+
+104

+21
*10.17
+23
+31.1

*10.15
*10.17
*10.16

+21
+23
+31.2
+31.1

+32.1
+31.2
+32.2

Filed herewith

*

+

Denotes compensatory plans or arrangements or management contracts.

Filed herewith

2
79

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused 

this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SIGNATURES

Dated:   March 11, 2022

TREDEGAR CORPORATION
(Registrant)

By  

/s/ John M. Steitz

  John M. Steitz
  President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following 

persons on behalf of the registrant and in the capacities indicated on March 11, 2022.

Signature

Title

/s/

John M. Steitz
(John M. Steitz)

/s/ D. Andrew Edwards

(D. Andrew Edwards)

/s/ Frasier W. Brickhouse, II

(Frasier W. Brickhouse, II)

/s/

John D. Gottwald
(John D. Gottwald)

/s/ Gregory A. Pratt

(Gregory A. Pratt)

/s/ George C. Freeman, III

(George C. Freeman, III)

/s/ William M. Gottwald

(William M. Gottwald)

/s/ Kenneth R. Newsome

(Kenneth R. Newsome)

/s/ Thomas G. Snead, Jr.

(Thomas G. Snead, Jr.)

/s/ Carl E. Tack, III

(Carl E. Tack, III)

/s/ Anne G. Waleski

(Anne G. Waleski)

President, Chief Executive Officer and Director
(Principal Executive Officer)

Executive Vice President and Chief Financial Officer
(Principal Financial Officer)

Corporate Treasurer and Controller  
(Principal Accounting Officer)

Chairman of the Board of Directors

Lead Director

   Director

   Director

   Director

   Director

   Director

   Director

80

  
  
  
  
  
Corporate Information

Corporate Officers and Operating Company Management

John M. Steitz
President and  
Chief Executive Officer

D. Andrew Edwards
Executive Vice President and  
Chief Financial Officer

Kevin C. Donnelly
Vice President, General Counsel 
and Corporate Secretary

W. Brook Hamilton
President, Bonnell Aluminum

Arijit (Bapi) DasGupta
President, Surface Protection

Jose Bosco Silveira, Jr.
President, Flexible  
Packaging Films

Directors

John D. Gottwald2 
Chairman of the Board 
Tredegar Corporation 

George C. Freeman, III 3, 4, 5
Chairman of the Board
Universal Corporation 

William M. Gottwald2
Retired
Albemarle Corporation

Kenneth R. Newsome3, 5
President and
Chief Executive Officer
Markel Food Group

John M. Steitz2
President and  
Chief Executive Officer 
Tredegar Corporation

Gregory A. Pratt1, 4, 5
Retired
Carpenter Technology 
Corporation

Carl E. Tack, III1, 3, 4, 5
Adjunct Professor
Mason School of Business 
College of William and Mary

Thomas G. Snead, Jr.1, 5
Retired
Wellpoint, Inc.

Anne G. Waleski1, 3, 5
Retired 
Markel Corporation

1)  Audit Committee
2)  Executive Committee
3)  Executive Compensation 

Committee

4)  Nominating and Governance 

Committee

5)   Independent Director

Shareholder Information

CORPORATE 
HEADQUARTERS
1100 Boulders Parkway  
Richmond, Virginia 23225  
Phone: 804-330-1000  
Website: www.tredegar.com

NUMBER OF EMPLOYEES
2,400

STOCK LISTING
New York Stock Exchange 
Ticker Symbol: TG

Additional shareholder  
information is available  
on the investor section  
of the Tredegar website  
@ www.tredegar.com.

Operating Company Locations

PE FILMS
Division Headquarters
Richmond, Virginia

Manufacturing Sites

Technical Centers

Pottsville, Pennsylvania

Richmond, Virginia

Guangzhou, China

FLEXIBLE PACKAGING
Division Headquarters
São Paulo, Brazil

Cabo de Santo  
  Agostinho, Brazil

Bloomfield, New York

Cabo de Santo  
  Agostinho, Brazil

Bloomfield, New York

ALUMINUM EXTRUSIONS
Division Headquarters
Newnan, Georgia

Newnan, Georgia
Elkhart, Indiana
Niles, Michigan
Carthage, Tennessee
Clearfield, Utah

Annual Report Design by Curran & Connors, Inc. / www.curran-connors.com

T R EDEGA R  C OR P OR AT ION

110 0  B ou lder s  Pa rk w ay
R ic h mond ,  V i r g i n i a  2 32 2 5

w w w.t re degar.com

T

R

E

D

E

G

A

R

C

O

R

P

O

R

A

T

I

O

N

|

2

0

2

1

A

N

N

U

A

L

R

E

P

O

R

T